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Abstract 
This thesis has investigated and demonstrated the potential for developing 
prediction models using Machine Learning(ML) algorithms on registry 
datasets. Many current Acute Coronary Syndrome (ACS) prediction models, 
were developed using traditional statistical methods. In an era of big-data 
evolution, ML offers a spectrum of algorithms that aid in generating 
prediction models for ACS.  This study has explored 29 algorithms with 
which to build ACS prediction models for Asian (Malaysia) and Western 
(Leeds, UK) registries, covering patients withal types of ACS and those with 
the new standard ACS treatments. The internal and external validation of the 
models present satisfactory calibration measures, indicating the ability of ML 
algorithms to produce competitive models in comparison to traditional 
statistical methods. 
 To achieve simpler, yet competitive predictive performance, 
comprehensive ML feature selection methods have been evaluated, and 
Correlation-Based-Feature-Selection(CFS) emerged as the best method.  
This thesis also has evaluated the potential of predictors of existing ACS 
models to be adapted to other registries‘ data.  Despite different regions and 
different population characteristics, most of the existing predictors remains 
constant with the outcome.  Thus, the findings suggest that, with some 
adjustments customized  to the registry, the existing predictors can be 
adopted to develop a simple model and expedite the model development 
process.  Furthermore, the strength of the predictors of each clinical 
categories has also been evaluated.  The results suggest that, to construct a 
satisfactory ACS model, combination of predictors from various clinical 
events is essential.  At the very least, to achieve a satisfactory model, 
combination of demographic, medical history, and clinical presentation 
information categories is required.  However, predictors from medication 
history category has found to be worthless in terms of contributing to a better 
prediction model. 
- v - 
 Next, this study has investigated classifier degradation in ML model 
development.  The findings suggest that the overlapping instances in 
minority class of imbalanced dataset and missing values are the main 
problems of classifier degradation. 
 New methods i.e. the overlapped-undersampling method to handle 
imbalanced dataset and the mean-clustering-imputation method  to handle 
missing values have been introduced.  The overlapped-undersampling failed 
to boost the model performance of the datasets.  Nevertheless, the results 
suggest that more training samples on imbalanced datasets are sufficient to 
produce satisfactory models. The mean-clustering-imputation method 
produced better models compare to the simple imputation method and 
imputation method embedded in an algorithm. However, removing instances 
with missing data resulted in superior models. 
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Chapter 1:  Introduction 
This chapter presents the research background, objectives, and thesis 
overview. It begins with an overview of Acute Coronary Syndrome (ACS), 
the burden of ACS worldwide, and the use of risk prediction models for ACS.  
Next, the chapter discusses the research problem and motivation for the 
study. It ends with an elaboration on the thesis structure. 
1.1. Acute Coronary Syndrome (ACS) 
 Acute Coronary Syndrome (ACS) refers to a heart condition that is 
caused by the blockage of the blood supply to the heart, and is commonly 
due to the development of plaque inside the arteries (atherosclerosis).  
Blockages in the arteries reduce the oxygen supply to the heart, resulting in 
the sudden onset of angina (unstable angina (UA)) to severe chest pain, and 
subsequently, damaging the heart (myocardial infarction (MI) or acute MI).  
This life-threatening condition can become more severe if no early invasive 
management strategy is performed to restore blood flow to the heart.   .    
 Chest pain or pressure in the chest is a vital symptom of ACS.   Other 
symptoms include sweating; dizziness or fainting; difficulty in breathing; pain 
or feeling pressure or a strange feeling in the back, neck, jaw, or either arm; 
and fast or irregular heartbeat.  In addition, several existing risk factors also 
increase the possibility of ACS among patients.  Moreover, the risk factors of 
ACS are mainly the risk factors of cardiovascular disease (CVD), which 
include both non-modifiable risk factors, such as older age, being male, 
family history of CVD, ethnicity, and modifiable risk factors.  Some well-
known modifiable risk factors include excessive total cholesterol, obesity, 
diabetics, hypertension and stress, smoking status, and  a low-quality 
lifestyle(2009, Philip I. Aaronson and Ward., 2007., Swales and P. De Bono, 
1993).   
 The diagnosis of ACS in a patient begins with a thorough assessment 
of visible symptoms, an electrocardiogram (ECG), and measurements  of 
cardiac biomarker levels.  In addition, a patient‘s past medical history and 
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existing risk factors are essential in helping to both diagnose and manage 
ACS. 
 The varied categories of ACS, i.e., ST-elevation myocardial infarction 
(STEMI), non-STEMI(NSTEMI), and UA, distinguish the treatment and  
intensity of therapeutic intervention.  In fact, patients diagnosed with STEMI 
need immediate intervention to restore blood supply to the heart, as such a 
severe condition could lead to death.  After the condition has been 
stabilized, the next step is to prevent recurrence. Percutaneous coronary 
intervention (PCI) and fibrinolytic therapy are the standard treatments for 
patients with STEMI(Smith et al., 2015), while other coronary reperfusion 
may include coronary artery bypass graft (CABG).  On the other hand, 
patients with NSTEMI and UA are treated to stabilize and limit the 
progression of ischemic events.  Moreover, early invasive treatment is 
necessary for patients with a higher risk of NSTEMI/UA.  
1.2. Global Burden of Acute Coronary Syndrome (ACS) 
 ACS is a subgroup of coronary heart disease (CHD).  CHD is a 
leading cause of death worldwide, with 7.3 million deaths recorded in 
2001(Gaziano et al., 2010).  Nonetheless, the mortality rate for CHD has 
witnessed a decreasing trend in North America and many Western countries 
due to better prevention, diagnosis, and treatment, as well as changes made 
towards a healthier lifestyle.   Despite the decrease in mortality rate, it is still 
a major cause of morbidity, and a single cause of death in many nations.  
One out of five deaths in the United States of America(USA) were caused by 
CHD in 2005(Lloyd-Jones et al., 2009).  In addition, CHD also contributes to 
premature death in most European countries.  For instance, 20% of males 
and 18% of females below the age of 75 died of CHD in 2002 (Allender et 
al., 2008).  On top of that, there is evidence that depicts a growing burden of 
CHD in developing nations, mainly due to rapid economic development and 
social transformation (Gaziano et al., 2010).   
 Furthermore, the high rates of morbidity and mortality have become a 
major economic burden factor. More practice guidelines are required to 
provide treatment, care, and support options for managing overall CVD 
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treatment. Apart from the increasing cost in health care, such as treatment, 
medication, and prevention, countries with a high CHD rate also have to 
bear the loss of economically productive resources due to  the inability to 
work and premature deaths.  For example, In 1995, Germany spent USD 26 
billion for the direct cost of hospital care and rehabilitation, whereas it lost 
USD 48 billion due to lost productivity caused by short- and long-term 
disabilities, as well as short-term deaths attributed to CHD(Mackay et al., 
2004).   Meanwhile, Abegunde et al.(2007)discovered that the burden of and 
economic loss due to stroke, heart disease, and diabetes among 23 low- 
and middle-income countries was estimated to be USD 84 billion dollars 
between 2006 and 2015 if no effort was taken to reduce the risk of overall 
CVD. 
 Such concerns have led to constant efforts to improve all spectra of 
ACS treatment, care, and prevention.  The drastic improvement of CHD and 
overall CVD death rates in some regions has been due to prevention and 
treatment (Roth et al., 2015).  Better CHD management, early identification 
of high-risk patients, changes in lifestyle, and public awareness are some 
cost-effective strategies for managing the burden.   
1.3. Prediction Models and Uses of Risk Prediction Models in 
ACS 
 Risk prediction models, clinical prediction models, prediction and 
prognostic models, prediction rules, and risk scores refer to a range of 
terminologies used to describe a model used to predict an outcome. In this 
particular thesis, the notion ‗prediction model‘ is utilized.  A prediction model 
employs a set of predictors in predicting the presence (diagnosis) or the 
occurrence of a certain outcome (Toll et al., 2008).  For reference purposes, 
risk factors generally describe the factors that are causally related to getting 
the disease.  Meanwhile, predictors in a prediction model refer to the 
attributes found in a prediction model that may causally relate to the 
outcome, but not necessarily.  For example, cigarette smoking is associated 
with an increased risk of cancer (good predictor), but has never been 
actually proven to cause cancer. 
- 4 - 
 Prediction models are generally constructed by using standard 
statistical regression approaches, i.e., multiple linear, multiple logistic, or 
Cox regression. The regression approach, in general, has been employed in 
clinical prediction for some time because it generates simple correlations 
between the predictors and outcome. In particular, logistic regression (LG) 
has become a familiar approach that can be easily implemented in most 
statistical packages, such as Statistical Packages for Social Science 
(SPSS), STATA, and R. Linear regression is normally used when dealing 
with a continuous outcome, whereas LG is commonly used to predict a 
binary outcome. On the other hand, Cox or proportional hazard regression is 
normally applied when the effect of the variables is evaluated for a certain 
period of time. Hence, both linear and LG approaches are usually used for 
diagnostic or short-term prognostic model, e.g., predicting in-hospital 
mortality, while Cox regression is widely used for predicting long-term 
events, e.g. predicting a 10-year mortality rate. 
 Techniques based on Machine Learning(ML) have also been used in 
constructing prediction models.  Unlike statistical modelling, ML algorithms 
are used to learn the datasets for prediction purposes. Data Mining (DM) 
using ML (DM-ML) provides a spectrum of learning algorithms comprised of 
non-linear methods, linear methods, and ensemble methods (a combination 
of multiple learning techniques), which may better describe the relationships 
between the identified predictors in building prediction models. In 
comparison to the classical statistical method, although the ML approach 
does not appear to be a popular choice for clinical prediction modelling, the 
potential of these ML algorithms has been established in developing 
prediction models. Two of the most popular ML techniques that have been 
explored, particularly in ACS prediction models, are the artificial neural 
networks (ANN) (Baxt et al., 2002;Harrison and Kennedy, 2005;Green et al., 
2006b;McCullough et al., 2007;Bassan et al., 2004) and decision-tree- 
based algorithms (Karaolis et al., 2010, Lavesson et al., 2009, Fonarow et 
al., 2005). 
 Randomized control trials (RCTs) and registries are where the data is 
to be found when constructing prediction models.  The well-known ACS 
prediction models are generally derived from randomized controlled data 
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(Antman et al., 2000, Boersma et al., 2000, Lee et al., 1995, Morrow et al., 
2001). In RCT study design, more accurate and complete samples are 
collected within a defined prospective, method, and duration. Nonetheless, 
these samples may not represent the real population or scenario, thus 
affecting the generalisability of the model derived from clinical trials. 
Moreover, bias may exist, as the samples for RCT are selected based on 
certain defined inclusion and exclusion criteria. In real hospitals or 
healthcare centres, the practice methods and duration are varied and may 
not strictly adhere to a defined standard procedure. 
 The advent of  the electronic health record (EHR) within healthcare 
organizations has shifted the methodology of deriving, building, and 
validating prediction models(Cooney et al., 2009;Granger et al., 
2003;Hippisley-Cox et al., 2008). At present, the EHR-based registries are 
an essential asset in building prediction models. An EHR is a collection of an 
individual patient‘s records which comprehensively records both clinical 
information and administrative information in digital format.  Example of 
information collected by EHRs are medical histories, progress notes, 
medications/prescriptions, laboratory data and radiology reports, billings, 
and appointments.  On the other hand, a registry is a collection of 
information collected with defined purpose(s) and populations to observe a 
specified health outcome(Gliklich et al., 2014). Many registries are derived 
from EHRs, hence imposing the challenges of working with EHRs data.  The 
main disadvantage of working with EHR-based registry data is the data 
quality issue. More missing data, noise, and dirty data can be expected 
when working with this registry data. Thus, a longer time is needed to 
prepare the data for modelling. However, with proper strategies in data 
cleaning and transformation, this registry data can be advantageous in 
constructing a reliable prediction model. 
 The ACS prediction model aids clinicians in identifying patients at high 
risk for mortality following ACS events.  Patients with high risk can properly 
be advised with adequate and on-time treatment, whilst patients with low risk 
can be assigned less aggressive treatment.  In addition,  a reliable prediction 
model and categorization of summary measures could aid in the realization 
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of stratified medicine to provide individualized treatment and interventions 
according to individual needs. 
 A prediction model can also suggest better resource management, 
result in cost-savings, and minimise unnecessary treatment complications  
(Lloyd-Jones, 2010, SIGN, 2007).   Moreover, utilizing prediction model to 
identify patients with high risk has become an established practice for a cost-
effective and primary prevention strategy (Bassand et al., 2007, SIGN, 2007 
(Updated 2013), Gaziano et al., 2010). Furthermore, prediction models that 
estimate long-term outcomes are useful in managing the long-term care of 
high-risk patients.   
 Prediction models also provide prognostic information that is valuable 
not only to clinicians, but also for patients and their families.  Understanding 
the risk level, as well as the methods of prevention and care, can help in 
managing ACS events and preventing reoccurrence.   
 Furthermore, identification of patients with varying risk levels also 
helps in clinical trial analysis and epidemiological studies for it offers 
information for the examination of treatment effects by the varied risk levels 
of patients.  On top of that, it is also helpful in regulating baseline risk 
factors, as well as screening for both inclusion and exclusion in clinical trials. 
 Hence, a prediction model provides a significant contribution to vital 
prevention strategies, in addition to formulating effective treatment in clinical 
practise and resource management.  Thus, practical, reliable, and accurate 
prediction models are indeed helpful for medical decision-making in 
effectively implementing prevention strategies.  Moreover, a reliable 
prediction model exploits suitable techniques and strategies to build a 
model, which can be quantified by using valid performance measures and 
derived from an appropriate number of samples and risk factors (Cooney et 
al., 2009, Lloyd-Jones, 2010).Nevertheless, a prediction model or any tool 
that is derived from the model can never substitute for the decisions of or 
judgements made by clinicians. 
. 
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1.4. Background : Data Mining (DM) and Machine Learning 
(ML) 
 Data mining (DM) refers to the process of extracting useful knowledge 
from a large dataset by analysing not only the patterns, but also the 
correlations between its attributes (Han and Kamber, 2001). It also offers a 
platform for prediction modelling, in addition to revealing ‗hidden‘ knowledge.  
It employs intelligent techniques and structural methods to not only unravel 
and describe the pattern, but also to evaluate the pattern in accordance to 
several measures.  
 Machine learning (ML), on the other hand, denotes a multidisciplinary 
field of artificial intelligence, statistics, probability, computational complexity 
theory, information theory, learning theory, and other numerous fields 
(Meyfroidt et al.,2009), which is focused on the development of 
algorithms/techniques to learn from experience in the attempt to improve the 
performance of a system over time (Mitchell, 1997).The aims of ML are to 
allow for automatic 'learning' of data using computer algorithms and make 
generalizations on what has been learnt to new, but similar data.  Learning 
can be categorized into supervised and unsupervised learning.  Supervised 
learning identifies an approximate mapping function of input data to the 
output variable.  The tasks of supervised learning include 
classification/prediction, regression, and feature selection.  In contrast, 
unsupervised learning focuses more on learning the data by understanding 
the patterns in the data.  Tasks associated with unsupervised learning 
include clustering and making associations (Witten et al., 2005, Weiss and 
Indurkhya., 1998) 
 In the context of DM, ML offers intelligent techniques and methods for 
mining the data, i.e., for discovering and describing patterns while focusing 
on inductive learning (learning by example).  ML can be considered to be the 
core of DM.  In terms of  predictive modelling, unlike traditional statistics, 
which relies on small samples with pre-defined assumptions on data and its 
distribution, ML models the data on a given task through an heuristic 
approach with minimal pre-assumptions about the data and problem
 Advancements in software and hardware have further allowed vast 
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amount of data to be captured and stored, ranging from simple to complex 
data types. This scenario has created the need to intelligently process data, 
identify interesting patterns, and transform this into useful information and 
knowledge. Therefore, extracting the right and meaningful information is vital 
especially in acquiring economic advantage. As such, DM has appeared to 
be a major evolution in the information industry. Massive data have also 
encouraged the development and the evolution of DM applications.  
Moreover, DM has been applied in many areas, such as marketing and 
retail, finance and banking, engineering, sports, as well as the medical and 
health industry. For instance, DM has been employed to improve a present 
business process or the quality of a product in the attempt to anticipate 
future trends in planning strategies, predicting and identifying risks, 
formulating prevention measures, interpreting images, and recognising 
patterns(Kantardzic and Zurada, 2005, Han and Kamber, 2001, Wang et al., 
2012, Choudhary et al., 2009, Delen et al., 2012a, Witten et al., 2005).   
1.5. Background : DM in the Medical Field 
 The growth of medical data has encouraged the application of DM in 
the medical field.  Outcomes from vast studies in medical DM have 
highlighted a great potential for improving efficiency and cost-saving aspects 
in clinical administration, as well as in clinical treatment and care (Koh and 
Tan, 2011).  For example, the prediction model built by Zhong et al. 
(2012)applied a new hybrid DM using ML (DM-ML) technique, which 
exemplified the potential to improve the management of costs and budgeting 
for hospital administrations. Additionally, Chazard et al. (2011)and Bate et 
al.(2008)used DM to determine adverse drugs events. 
 Furthermore, DM possesses the ability to aid in making decisions for 
prognosis and diagnosis, as well as for treatment options(Pogorelc et al., 
2012, Delen et al., 2005).  DM-ML techniques have also been used in 
various developments of the Decision Support System (DSS) for rule 
generation (Tenorio et al., 2011, Del Fiol and Haug, 2009). In a typical 
medical DSS, rules are generated based on expert knowledge.  However, 
via DM, rules are generated by the system and, later, validated by the 
domain expert, thus promoting efficiency in developing the system.   
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 DM has also made a contribution to evidence-based medicine (Stolba 
and Tjoa, 2006).  Evidence-based medicine is the concept of making 
decisions related to patients‘ health care that integrate clinical expertise, 
patients‘ values, and the best external evidence(Masic et al., 2008).  The 
concept is an application of providing better health care and improving cost 
effectiveness. The knowledge extracted from a large and complex 
healthcare dataset turns out to be important evidence that should not be 
neglected in acquiring the best external evidence. For instance, Delen et al. 
(2010) applied DM to identifying more intricately predictive factors in 
estimating survival time after transplants.  Other than that, Chu et al. (2009) 
utilized the Bayes model in presenting an evidence-based expert system to 
detect CAD from hospital-based data and existing epidemiological study.  The 
evidence based expert system using the Bayes model has achieved 0.86 AUC 
rate on hospital based data and 0.86 on existing epidemiological study. 
 The capabilities of DM in handling huge datasets with tolerable 
performance time have encouraged the continuous employment of DM in 
medical studies(Delen, 2009, Sampson et al., 2011) . For example, Sitar-
Taut et al.(2009)ranked the significance of identifying risk factors for 
coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), 
which concluded that varied CVDs have varying ranks of important risk 
factors.  Meanwhile, Khalilia et al.(2011)used the Mean Decrease Gini 
measure to determine the essential variables linked to various diseases, 
whereas Delen et al. (2012b)employed the sensitivity analysis method to 
identify the most important variables that had an impact upon outcomes of 
CABG surgeries.   
 In addition, DM-ML can also be combined with conventional statistical 
methods to produce more commendable estimations. As such, Tham et 
al.(2003) used ANN to predict CHD by combining a set of gene marker 
attributes with some typical risk factors as predictors. In order to identify the 
gene markers‘ input for ANN, several statistical methods, i.e., principal 
components analysis (PCA) and factor analysis (FA), were used.
 Although a number of studies have demonstrated the potential of DM, 
such as by exhibiting potentially good predictive models or establishing new 
knowledge in the medical field, several works, such as work done by Sami 
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(2006), have been rejected by the medical community.  Sami claimed that 
the work had been rejected due to  the limited number of journals in the area 
of Urology that would consider the DM method that he used.  Medical DM, 
thus, is considered unique because it inherits the complexity of medical data 
and its domain. Medical data is huge and heterogeneous.  It is available in 
many forms, i.e., images, text, ECG readings, or even structured data, and 
comes  from different events (databases/systems) such as administration, 
diagnosis, treatment, and even follow up.  Moreover, there are a large 
number of missing values, inconsistencies, and imprecise and incomplete 
data in a medical dataset(Cios and Moore, 2002).  A substantial number of 
studies have been initiated to investigate the uniqueness of medical DM.  In 
fact, some examined issues surrounding medical DM, such as, privacy, 
ethics, and confidentiality issues; medical data intricacy and quality; and the 
exclusivity of medical approaches(Shillabeer and Roddick, 2007, Cios and 
Moore, 2002, Sami, 2006, Iavindrasana et al., 2009). 
 Thus, mining medical data means being able to handle the 
uniqueness of medical datasets.  The medical field is exclusive in its 
approach as it deals with life or death, which applies to everybody.  For 
example, DM, in general, concerns itself with digging out patterns and trends 
in a dataset.  In contrast, in medical research, more concern is placed on the 
minority events, such as mortality, which does not conform to patterns and 
trends.  As such, it is vital to conform to the medical paradigm in terms of 
measuring the error rate, i.e., the sensitivity and specificity measures of a 
prediction model, rather than measuring the accuracy rate as in general DM 
applications.  Another example is reporting the DM results from a medical 
dataset.  Cautious consideration of the language used is important as any 
information distortion in reporting medical results has the potential to be life 
threatening and have cost and political consequences.  Appropriate and 
precise descriptions of the data source with detailed and defined 
characteristics of populations must be adhered to. This is indeed essential in 
a clinical research setting.  Bouwmeester et al. (2012)concluded that many 
prediction models available in high-impact journals have very limited 
applicability due to not following the recommended methodologies. 
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1.6. Problem Statement  
 As mentioned previously, current prediction models are generally 
constructed by using standard statistical regression approaches, i.e., 
multiple linear, multiple logistic, or Cox regression. In this conventional way, 
the predictors of the models are generally identified from a set of candidate 
variables defined based on clinical expert opinions, risk factor findings from 
clinical studies, and/or previously developed models(Morrow et al., 2000, 
Boersma et al., 2000, Granger et al., 2003).  Univariate LG and multiple LG 
are then run on these potential predictors to identify the significance 
predictors of the model.  With ML, the paradigm of predictor selection is 
different.  In ML, any attributes can be considered as potential predictors, 
potentially suggesting new potential risk factors for diseases like ACS.  In 
this study, all attributes in the registries that fall under the scope of the 
research were considered as potential predictors and further evaluated using 
a comprehensive ML feature selection method to improve the prediction 
performance of the simplest model possible.  
 The huge and intricate registries dataset requires more advanced 
analytics and massive data technologies compared to the standard statistical 
approach. This is because the correlations between the attributes and the 
outcomes may be complex and multivariate, which may violate linearity 
assumptions in a statistical model. Thus, ML algorithms present a new 
opportunity to build clinical prediction models, in general. Hence, DM using 
ML algorithms is a potential alternative approach to the classic statistical 
method.  The two EHR-based registry datasets are the assets of this study 
to practically presents the need and potential of ML in prediction modelling. 
 ML has  been used in a limited way to develop prediction models.  
The earliest study to use ML to construct ACS prediction models was mainly 
focus on a specific ML algorithm.  In fact, one particular novel technique, 
which has been commonly researched, particularly in developing ACS 
prediction models, is ANN (Baxt et al., 2002;Harrison and Kennedy, 
2005;Green et al., 2006b;McCullough et al., 2007;Bassan et al., 2004). Even 
though ANN is an intricate technique, it excels at detecting complex and 
nonlinear correlations. The technique mimics human brain interactions in 
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processing and understanding relationships. In addition to ANN, the 
combined method of genetic algorithm (GA) and fuzzy rule has been utilized 
in developing a UA risk assessment tool(Dong et al., 2014), the decision tree 
(c4.5) was applied in assessing risk factors of CHD(Karaolis et al., 2010), 
and the Classification and Regression Tree (CART) was employed to 
develop mortality prediction models for patients with acute decompensated 
heart failure (ADHF)(Fonarow et al., 2005). However, there are a wide range 
of ML algorithms which can be explored  in building prediction models, as 
there is no one specific ML algorithm that best suits all datasets(King et al., 
1995, Ali and Smith, 2006).  Thus, this study explores a wide range of ML 
techniques suitable for developing ACS prediction models.  
 Limited number of studies has been found comparing ML algorithms 
in developing ACS prediction model.  For example, VanHouten et al. (2014) 
has assessed Random Forest (RF), elastic net, and ridge regression 
algorithms for building ACS prediction models; Hu et al.(2016) evaluated 
Support Vector Machine (SVM), RF, Naive Bayes (NB) and LG models for 
the same task, and Sladojević et al.(2015) compared seven ML algorithms 
for building an ACS prediction model.  These comparison studies were small 
and based on a limited number of ML algorithms.  Considering larger 
comparisons of ML algorithms, Kurz et al. (2009) tested several ML 
algorithms available in Waikato Environment for Knowledge Analysis 
(WEKA) to generate the best ACS prediction models.  However, the models 
that Kurz et al. (2009) developed can only be used for categorical predictors.  
The issue with models that use only categorical predictors is that they 
potentially lead to `loss of information.‘  Attributes, such as heart rate and 
systolic blood pressure (SBP), need to be discretized to a subset of 
categorical values, which generally leads to a loss of information from the 
original data.  For instance, within an interval, two numerical values may be 
at different extremes, but, because they both fall within the interval, the two 
values are considered equal.   Due to this, information is lost which 
eventually effects the predictive performance of a prediction model. On the 
other hand, this thesis includes all ACS- type patients and was able to 
accept both numerical and categorical types of predictors.  Furthermore, 
Kurz et al. (2009) only studied one registry, but our study has two registries 
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to work with simultaneously that will potentially enrich the discussion  on 
developing ACS models using ML from two different regions with different 
patient characteristics. It will also inform a discussion on how the 
characteristics of different datasets could affect the prediction capabilities of 
the different ML algorithms used. 
 Most of the models were found to exclude high-risk patients, such as 
patients with a history of stroke (Lee et al., 1995), patients with a history of 
cerebrovascular disease,  patients with high SBP and  diastolic blood 
pressure (DBP) (Morrow et al., 2001), and patients with persistent ST-
segment elevation(Boersma et al., 2000).   Also, most of the existing models 
were developed for a specific type of ACS, i.e., either STEMI(Lee et al., 
1995, Morrow et al., 2001, Sladojević et al., 2015) or NSTEMI(Antman et al., 
2000, Boersma et al., 2000).  Thus, this study, which presents 
comprehensive coverage with all ACS types and no exclusion of high-risk 
patients, widens the scope of prediction modelling.   
 In addition, the advent of new and standard treatments, such as the 
introduction of potent antiplatelet/antithrombotic agents and the 
establishment of PCI treatment, has become an issue among the present 
models.  Some of these models were developed before the introduction of 
this new and standard treatments and the impact of this on the models is still 
unclear(Kurz et al., 2009).  As such, the latest cohorts of patients in the 
registries used in the study accommodate the current gap in the present 
models.  To the knowledge of the author, this is the first time the Malaysian 
registry has been used to derive an ACS prediction model.  Derivation 
populations  for ACS prediction models have been predominantly Western 
(Antman et al., 2000, Boersma et al., 2000, Dorsch et al., 2001, D'Ascenzo 
et al., 2012, Kurz et al., 2009, Huynh et al., 2013, VanHouten et al., 
2014).The Malaysian and the UK populations used in this study enable 
geographical comparisons and furnish further insight into model 
development for different regions. 
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1.7. Aims and Objectives of The Study 
 The important of a reliable prediction model to support CVD and ACS 
prevention, as well as the availability of vast amount of EHRs within 
healthcare organizations, motivated this particular research. DM-ML 
techniques can possibly transform the paradigms of building ACS prediction 
models in parallel to the future revolution of big data in the medical and 
health industries.  In fact, the growing number of EHRs offers an opportunity 
for DM-ML to further prove its capability as the best computational solution 
for both classification and prediction model development in the medical field. 
Hence, exploring prediction models development for ACS via modern ML 
techniques could potentially enhance the benefits of using DM in the medical 
field, in general.   
This study aims to explore and investigate a practical method for developing 
prediction models for predicting ACS in-hospital mortality using DM and ML 
algorithms on registries‘ datasets. In the context of ML fields, this study also 
explores several ML optimization strategies suitable for registry datasets to 
enhance the overall performance of the developed models.   The objectives 
of the study are listed as follows: 
Objective 1:  To investigate ML methods and techniques suitable for 
developing ACS prediction models from registry datasets. The study also 
aims to establish sets of ML algorithms that are not suitable for building the 
prediction models.  
Objective 2: To investigate ML feature selection methods and techniques 
for building simpler models with improved prediction power. The thesis also 
evaluates the potency of predictors of existing ACS models to be adapted to 
other ACS registries data. Finally, to investigate the strength of predictors 
from different clinical categories in contributing to model development. 
Objective 3:To identify the main causes of misclassification when building 
ACS prediction models using ML, as well as to develop models using ML to 
predict the misclassified cases.  The study focuses on assessing 
misclassified cases in terms of minority class, overlapping class, outliers, 
and missing values.  
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Objective 4: To investigate and evaluate ML optimization strategies to  
address an imbalanced dataset and missing values.  Do these optimization 
strategies help in improving the overall model performance? As such, the 
overlapped-undersampling method is proposed to handle imbalanced 
datasets, while the mean-clustering-imputation approach is proposed to 
handle missing values. 
1.8. Outline of Chapters 
 The rest of this thesis is structured as follows: 
Chapter 2provides the literature review on the currently available ACS 
prediction models. This chapter also presents the review of methods and 
strategies in developing prediction models using DM and ML.   
Chapter 3 describes the relevant methods in achieving the outlined 
objectives. 
Chapter 4 describes and compares the characteristics, patient 
characteristics, patterns of care, and outcomes of the two datasets.  It also 
describes the process of cleansing, preparing, and transforming the raw 
datasets for model development.  The chapter also elucidates the processes 
and results of reviewing model development using WEKA, inclusive of 
several strategies that were employed in developing prediction models. 
Chapter 5 provides full documentation of identifying the best set of 
predictors  using ML techniques and its model development.  The chapter 
also presents the findings on the potency of the existing set of predictors in 
terms of being adapted to other ACS registry data and the strength of 
predictors from different clinical categories in contributing to the model 
development.   
Chapter 6 presents the results obtained from the misclassification analysis 
of the   classification algorithms.  The analysis of the misclassification cases 
was conducted in terms of the distribution of minority classes, overlapping 
classes, outliers, and missing values.  The chapter also introduces the newly 
developed model used to predict misclassified cases. 
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Chapter 7 specifies the optimization approaches used in handling 
imbalanced datasets and missing values. Moreover, this chapter presents 
the results of the strategies and discusses the effectiveness of these 
strategies in contributing to the betterment of the developed models. 
Chapter 8 reports on the model validation approach for the best models, 
specific to Malaysian and UK datasets, as well as the generic models that fit 
both datasets.  Internal validation was performed on each of the best models 
specific to the regions and generic models.  In addition, external validation 
was carried out on the generic models.  Briers scores and calibration graphs 
of these models are presented, compared, and discussed.   
Chapter 9 summarizes and discusses the overall findings.  Implications of 
the study, limitations and future directions are also discussed in this 
concluding chapter. 
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Chapter 2:  Literature Review 
This chapter presents the review of existing and researched ACS prediction 
models, the methods employed in developing clinical prediction models, as 
well as the challenges and issues that revolve around developing clinical 
prediction models using DM and ML algorithms.   
2.1. ACS Prediction Model 
 Prediction has always been a skill set among clinicians. Clinicians 
need this skill set to make decisions about a certain disease or its severity, 
and the most appropriate therapy and treatment based on the symptoms.  
These decisions are normally made based on "intuition" or experience from 
past cases.  Nonetheless, quantifying and rationalising the decisions made 
can only be made possible with rich clinical data and using the appropriate 
method. Statistics has been the most widely used and viable method with 
which to build prediction models up until this time. In addition, clinical 
prediction models are now being applied as prevention strategies to predict 
the existence of a disease or high-risk patients with a disease, or even to 
determine the most suitable therapies for a patient based on diagnosis. 
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Table 1: Summary of several reviewed ACS prediction models 
No Prediction 
Models 



































* 3 risk factors for CAD 
* Prior coronary 
stenosis of>=50% 
* At least 2 angina 




* Use of aspirin in 
prior 7 days 
* Elevated serum 
cardiac markers 
Death, MI or 
revascularisation 



















* ST- Segment 
depression 
* Heart rate 
* SBP 
* Heart failure 
* Cardiac enzyme 
* ST-Depression on 
presentation 











(Lee et al., 
1995) 











41021 STEMI * Age 
* Killip class 
* SBP 
* Heart rate 
* Anterior Infarction 
* Previous MI 
Death 30 days NA Logistic 
regression 
































* Cardiac arrest during 
presentation 
* Creatinine level 
* Heart rate 










2001 RR 1995 UK 3684 Acute MI * Age 
* Heart rate 
* SBP 














13253 STEMI * Age 
* Heart rate 
* SBP 






2013 RR 1999-2001 Canada 4627 STEMI, 
NSTE-ACS 
* Age  
* Killip class 
* SBP 













2012 RR 1997-2005 Switzerland 7520 UA, 
NSTEMI, 
STEMI 
* Age  
* Killip Class  
* SBP 




* History of heart 
failure 














en et al., 
2014) 
2014 EHR 2007 - 
2012 
USA 20078 ACS, 
NON ACS 




d et al., 
2015) 
2015 EHR 2008-2011 Serbia 2030 STEMI * Age 
* SBP 
* Diastolic blood 
pressure 
* Heart rate  
* Lvef 
* Troponin value 
Death In-
hospital 





(Hu et al., 
2016) 
2016 EHR NA China 2930 ACS 268/284 predictors Adverse 
cardiovascular 
events 
NA 0.724 Random 
forest 
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 Table 1 provides a summary of the reviewed ACS prediction models.  
As presented in the modelling techniques column (last column), 7 out of 11 
reviewed models were developed using a statistical method, i.e., LG.  As 
explained in Section 1.6, when using this conventional method, the 
candidate predictors are generally pre-selected based on clinical expert 
opinions, known risk factors, findings from clinical studies, and/or previously 
developed models.  The actual predictors used to developed the model are 
selected by running univariate and multivariate LG to identify the significance 
of the candidate predictors.  The approach  contrasts with the ML paradigm 
since, in ML, any attributes can be considered as candidate predictors, 
which allows for identification of potentially new potent predictors which can 
subsequently suggest new potential risks for ACS.  
 In a large dataset,  the assumption of data linearity using the 
conventional statistical modelling approach may be violated due to complex 
and multivariate correlations between the attributes and the outcome.  More 
advanced analytics and massive data technologies are required to handle 
the large and intricate data in a registry or EHRs.  Thus, DL-ML presents a 
new advancement in predictive model development compared to the 
statistical approach.  Table 1 demonstrates  that models developed using 
ML techniques such as AMIS, SD, and Serbia have better predictive power 
than models developed using the statistical approach (TIMI, PURSUIT, 
GUSTO-I, GRACE, EMMACE, SRI, C-ACS).  
 ML has  been used in a limited way to develop prediction models.  
The earliest study to use ML to construct ACS prediction models was mainly 
focus on a specific ML algorithm.  In fact, one particular novel technique, 
which has been commonly researched, particularly in developing ACS 
prediction models, is ANN (Baxt et al., 2002;Harrison and Kennedy, 
2005;Green et al., 2006b;McCullough et al., 2007;Bassan et al., 2004). In 
Table 1,the three reviewed ACS models that were developed using ML were 
compared to a limited number of ML techniques i.e., the SD - 1 ML 
algorithm, Serbia - 7 ML algorithms and MACE - 4 ML algorithms.  And, only 
the AMIS model was compared to broad number of ML algorithms from 
WEKA.  However, the AMIS model was only able to handle categorical 
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predictors.  As mentioned previously,  the potential for information loss is 
critical for those predictors that are originally numerical, such as SBP, DBP, 
heart rate, and creatinine level, and this, in turn, eventually affects the 
predictive performance of a model.  
 Different sets of predictors are observed for each of the models in the 
reviewed ACS models.  Each set of predictors seems to fit with the sample 
populations that the model was derived from, and most of the models were 
derived from a particular region, with the exception of TIMI, PURSUIT, 
GUSTO-I, GRACE and SRI.  Regardless of the varied clinical outcome of 
the models,  the most common predictors incorporated in ACS models are 
age, heart rate, SBP, and killip class, which are also the key risk factors for 
ACS and CVD, in general.  The potential predictors for ACS prediction 
models are generally derived based on the availability of information on the 
point in clinical cause, in which the model can be used for prediction or risk 
assessment.  For example, upon admission, any information obtained refers 
to demographic type, such as age, gender, and ethnicity, whereas basic 
clinical presentation denotes heart rate, SBP, height, and weight.  At this 
point, normally, both basic physical examination and typically occurring 
symptoms are assessed.  In addition, the medical history of patients and 
their basic health lifestyle, such as smoking status, is also recorded at this 
point.  Examples of predictors under this category that have been applied in 
the models of Table 1 are history of heart failure, diabetics, and history of 
cerebrovascular disease.  Upon completion of an ECG,  its related 
parameters, such as ST-segment, Q-wave, and T-wave, become another set 
of information that is made available at the first stage of ACS clinical cause.  
In fact, prediction models for use in an emergency department and some 
models  built with the objective of early-risk stratification, such as the C-ACS 
and AMIS models, mainly utilize such first-hand information as their 
predictors (Green et al., 2006b).Other than that, the results of biomarker 
tests offer more useful information in terms of distinguishing between the 
three ACS categories.  Depending on the symptoms and ECG status, 
biomarker tests, such as cardiac troponin and MB fraction of creatinine 
kinase (CK-MB) measurements,  usually take place at a later stage(Bassand 
et al., 2007).  GRACE and SD are examples of models that considered 
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biomarker data as predictors.  Although biomarker tests contain useful 
information with which to identify different categories of ACS, they may not 
be popular with those simple models with the need for early stratification, 
such as AMIS, EMMACE, SRI, and C-ACS.   
 DM-ML  can also be utilized to identify essential predictors in relation 
to the outcome known as feature selection.  Feature selection aids in 
choosing a set of predictors that improves the predictive power with less 
data.   It can identify nonessential, irrelevant, and redundant attributes that 
may affect the accuracy of the model. A model with cost effective predictors 
is preferable due to its simplicity, and ease of understanding and 
explanation(Guyon and Elisseeff, 2003).   Feature selection, when applied, 
needs to be embedded as part of the model selection process.  Models 
applying feature selection or different set feature selection methods and 
models without feature selection should be compared and analysed.   Better 
predictive power indicates the best set of predictors for the model. For 
example, Fonarow et al. (2005)developed a model for risk stratification of in-
hospital mortality for acute decompensated heart failure (ADHF).  They 
employed CART to establish the best predictors for the model, in addition to 
constructing a risk stratification model. Karaolis et al.(2010) evaluated a 
decision tree (DT) model in terms of identifying the significant risk factors for 
myocardial infarction (MI), PCI, and CABG.  The study claimed the 
promising correctly classified rate, indicating that the identified risk factors 
were the most important.  They found that age, smoking, and history of 
hypertension  were important risk factors for MI; family history, history of 
hypertension, and history of diabetes  were important risk factors for PCI and 
CABG; and age, history of hypertension, and smoking were important risk 
factors for CABG. In addition, Vinterbo and Ohno-Machado (1999)built a 
model based on LG and identified a set of predictors using a genetic 
algorithm.  By comparing the AUC results, the study suggested that a 
genetic algorithm was significantly better than the standard backward, 
forward, and stepwise variable selection methods.   
 From Table 1, the implementation of ML feature selection of models 
developed using ML as modelling technique (AMIS, SD, Serbia and MACE) 
was further reviewed.  Even though the Serbia model was developed using a 
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ML technique, the candidate predictors of the model are pre-selected, then 
further reduced using ML techniques.  The AMIS model, on the other hand, 
uses the common feature selection method, i.e., the sequential backward 
deletion method, to determine the best predictors for the model.   Whilst, the 
SD and MACE models do not apply any feature selection method in order to 
make the model simpler.  However, the MACE model is the only model from 
the reviewed list that retrieves its predictors from free text admission 
records.  The extraction of predictors is implemented by combining a rule-
based approach with an ML method known as Conditional Random Fields. 
 Most of the reviewed ACS models were derived either from RCT, 
registry, or EHR data.  RCT, which follows rigorous scientific principles, is 
considered the most powerful tool in clinical research.  The samples 
collected are considered more accurate and complete with defined 
prospective , methods, and duration.  However, the emergence of EHRs in 
medical field has promoted the use of registry or EHR data to derive the data 
for model development.  The registry or EHR-based data fills the gaps in 
RCT, such as not representing real populations and the potential of bias due 
to defined inclusion and exclusion criteria.   Also, a registry based on EHR 
data is considered essential evidence in acquiring the best external evidence 
in evidence-based medical applications.  Thus, many ACS models now 
derived their data from EHR-based registries, as in GRACE, EMMACE, C-
ACS, AMIS, SD, Serbia, and MACE models. 
 Furthermore, most cohorts of the reviewed ACS models in Table 1 
were derived from Western populations.  TIMI, PURSUIT, GUSTO-I, and 
SRI are examples of models derived from mainly Western countries. Other 
models, such as EMMACE, C-ACS, AMIS, SD, and Serbia were derived 
from a specific Western country.  The use of Asian populations has been 
limited in deriving ACS model.  Among the 11 models of Table 1, MACE is 
the only model that was built based on Asian cohorts i.e. China.  However, 
some of cohorts included in GRACE comes from Western Pacific that might 
includes some patients from Asian regions.   
 Mortality among patients with chest pain at varied time points is a 
common outcome in ACS prediction models. Nine out of 11 reviewed 
- 25 - 
models of Table 1 have mortality as the outcome.  Besides than mortality 
outcome, TIMI and PURSUIT also have MI as the end point.  SD, on the 
other hand, distinguishes between ACS and non-ACS patients as the 
outcome of the model, while MACE distinguishes adverse cardiovascular 
events.  
 In Table 1, the ACS models were mainly for selective patients with 
either STEMI or NSTEMI/UA.  Only GRACE, AMIS, and MACE models 
cover all the ACS spectrum.  There were also issues of exclusions of high 
risk patients in some of these models.  For example, the GUSTO-I model 
excludes patients with history of stroke, the SRI model excludes patients 
with high SBP and DBP, and the PURSUIT model excludes patients with 
persistence ST-segment elevation.    
 Among all of these models, the most popular ACS prediction models 
are TIMI and GRACE, as they have been validated by many other 
populations. The following further summarizes each of the reviewed ACS 
models. 
Thrombolysis in Myocardial Infarction (TIMI)  
 The TIMI prediction score appears to be the most widely used model, 
and it is known for its use for patients with NSTEMI and UA.  This prediction, 
or risk,  score was derived from 1957 patients from the TIMI 11B trial, which 
consisted of cohorts from  10 countries, including North America, South 
America, and Europe, in which the samples were given unfractionated 
heparin for the study(Antman et al., 1999).  The TIMI risk score predicts 
mortality, new MI, and urgent need of revascularization within 14 days of the 
event by summing the scores of 7 predictors (Antman et al., 2000).  The 7 
predictors are: age greater than 65 years old, at least three risk factors of 
CAD, prior coronary stenosis of 50% or more, ST Deviation on ECG,  two 
angina events that occur within 24 hours, use of aspirin in the past 7 days, 
and elevated serum cardiac markers. 
 The risk score was built by using multivariable LG and was validated 
with three different groups:1)  an enoxaparin group from TIMI11B  (n=1953), 
2) an unfractionated heparin group from the ESSENCE trial(n=1564), and 3) 
an enoxaparin group from the ESSENCE trial (n=1607).  The c-statistic for 
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the derivation cohorts was 0.65 and fell within the range between 0.65 
and0.59 for the validation cohorts.  Furthermore, the simplicity of the risk 
model has turned it into the present guidelines for admission and treatment 
decisions(Anderson et al., 2007). 
 The TIMI risk score was also used as the platform to generate risk 
score for STEMI patients(Morrow et al., 2000).  In fact, many had validated 
TIMI risk score in various cohorts, end points, and all types of 
ACS(D'Ascenzo et al., 2012).  For instance, TIMI risk score was validated on 
30 days and 1 year mortality of patients suffering from myocardial 
revascularization during their initial hospitalisation (de Araújo Gonçalves et 
al., 2005).  Meanwhile, Morris et al.(2006),  Chase et al. (2006)and  Hess  et 
al.(2010)validated TIMI risk score with patients who had chest pain at the 
emergency department.  As a result, the modified TIMI risk score with extra 
weight on ischemic ECG changes and tropinin elevations displayed better 
risk stratification among the patients with chest pain at the emergency 
department (Body et al., 2009). 
The Receptor Suppression Using Integrilin Therapy (PURSUIT) 
 PURSUIT is another risk model for UA and NSTEMI.  This model was 
derived from 9461 patientsin28 countries in Europe, and North and South 
America (Boersma et al., 2000).  The end point of this risk model is mortality 
or mortality and MI of UA and NSTEMI patients within 30 days.  The 
predictors are age, ST-Segment depression, higher heart rate, lower SBP, 
signs of heart failure, and cardiac enzyme upon admission.  Unlike the TIMI 
score, PURSUIT presents a more complex calculation.  For instance, age 
has a range of 0-6 scores depending on various age ranges to predict 
mortality.  Nonetheless, in a review of validated ACS models performed by 
D'Ascenzo et al.(2012), only two studies had validated the PURSUIT model. 
The Global Use of Strategies to Open Occluded Coronary Arteries 
(GUSTO) 
 The GUSTO risk score was drawn from 1081 hospitals located in 15 
countries in North America and Europe, and including Israel, Australia, and 
New Zealand (Investigators, 1993).  The GUSTO trial was a randomized 
clinical study involving MI patients eligible for fibrinolysis (Lee et al., 1995).  
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The study examined four thrombolytic agents with aspirin and BB.  The 
model predicts1 year and 30 day mortality after MI with the most significant 
predictors, which are age, SBP, heart rate, infract location, and prior MI 
conditions. The GUSTO risk model has been validated in predicting three 
vessel diseases together with the TIMI, GRACE, and PURSUIT models.  
The GUSTO risk model achieved an AUC of 0.63,  lower than the AUC 
scores achieved by TIMI (0.71), GRACE (0.68),  and PURSUIT (0.65) (Isilak 
et al., 2012).  The GUSTO model has also been used to validate the effect of 
medications, such as use of atenolol for acute MI after thrombolysis 
(Pfisterer et al., 1998).   
The Global Registry of Acute Coronary Events (GRACE) 
 The GRACE model is a widely-known ACS model derived from a 
patients‘ registry (n= 11 389) with a complete range of ACS(Granger et al., 
2003).  In addition, the registry was comprised of unselected patients from 
North and South America, Europe, and the Western Pacific region.  The 
primary function of the model is to predict in-hospital mortality.  Furthermore, 
the model was built using multivariable LG and was presented via an 
intelligent scoring system.  In comparison to the TIMI and PURSUIT scoring 
systems, the GRACE risk score presents a more complex calculation with a 
detailed gradation for each predictor.  The predictors for the GRACE model 
are age, killip class, SBP, ST-Segment deviation, cardiac arrest during 
admission, serum creatinine level, heart rate, and initial cardiac enzyme 
level.  Moreover, the model has achieved a rather excellent c-statistic of 
0.83.  The model was further validated in two varied cohorts with c-statistics 
of 0.84 and 0.79.  
 In addition, when compared to the TIMI score, the GRACE model 
emerges as one of the most validated ACS models. Furthermore, D'Ascenzo 
et al. (2012) claimed that the GRACE had been validated in 12 studies within 
multiple clinical settings with a total of 36,517 patients, and that the average 
AUC of the GRACE model in validation studies that consisted of ACS or 
UA/NSTEMI cohorts for both short- and long-term outcomes had been 0.85.  
Due to its exceptional prediction ability in varied clinical settings,  the 
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European Society of Cardiology has recommended GRACE as a suitable 
risk stratification model for NSTEMI patients(Bassand et al., 2008). 
Evaluation of Methods and Management of Acute Coronary Events 
(EMMACE) 
 According to Dorsch et al.(2001), the EMMACE model appears to be 
one of the simplest ACS prediction models with only three predictors, which 
are age, SBP, and heart rate.  In fact, EMMACE was derived from registries 
gathered in the Yorkshire region in the UK that predicted 30 day mortality 
among patients with acute MI.  The model achieved an AUC of 0.79, while 
an AUC of 0.76 was achieved by the tested cohorts. EMMACE has been 
validated over a wider ACS diagnosis and maintained its c-statistics of 0.77 
to 0.78(Gale et al., 2008b). 
Simple Risk Index (SRI) 
 Apart from the EMMACE model, the SRI model is another example of 
a simple and rapid risk score model that predicts 30 day mortality among 
STEMI patients(Morrow et al., 2001).  With predictors similar to those of the 
EMMACE model, the SRI model was derived from 800 hospitals found 
among Western and Eastern Europe, North America, and Latin America 
(Giugliano et al., 2001).  In fact, the c-statistics of the derivation model for 30 
day mortality have been 0.78 and 0.79 when validated on external cohorts. 
The Canada Acute Coronary Syndrome Risk Score (C-ACS) 
 C-ACS model was aimed to serve early risk stratification among 
patients with ACS.  The risk model was derived from two Canadian ACS-1 
(C-ACS) registries(Huynh et al., 2013).  C-ACS was a prospective study for 
STEMI and NSTE-ACS patients.  Additionally, it was claimed that the model 
was simple and had no need of a system or calculator to estimate in-hospital 
or 1 year mortality. It uses only four predictors, i.e., age, killip class, SBP, 
and heart rate.  However, all the predictors are categorical, which might 
result in loss of information, and thus could affect the reliability of the 
performance.  The model was also validated on four other datasets, with an 
average c-statistic of 0.75, for short-term mortality.  
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Acute Coronary Myocardial Infarction in Switzerland(AMIS) 
 The AMIS model was built by using the ML algorithm known as 
―Averaged One-Dependence Estimators (AODE)‖ to predict in-hospital 
mortality of 7520 patients with ACS obtained from the AMIS-Plus registries 
of 2001-2005.  In the study, several other ML algorithms available in WEKA 
were tested, and AODE emerged as the best.  Through the use of minimal 
features available at first patient contact, i.e., age, killip class, SBP, heart 
rate, pre-hospital cardiopulmonary resuscitation, history of heart failure, and 
history of cerebrovascular disease; a c-statistic value of 0.875was attained.  
The model was externally validated on the Krakow cohorts, achieving a c-
statistic of 0.842 (Kurz et al., 2009). 
Vanderbilt University Medical Centre’s Synthetic Derivative (SD) 
 VanHouten et al. (2014)developed ACS prediction models by using 
two ML algorithms, which were elastic net and RF, with 20,038 suspected 
ACS patients from EMRs.  The aim of the model was to provide an 
automated prediction model  where a new prediction is calculated as new 
data is entered into the EMR system.  In the study, all noisy data and 
missing values were embedded in the developed dataset.  The missing 
values were imputed with median value.  As a result, the best model with an 
AUC of 0.848 was built using RF with 88 predictors.  However, the model, 
although it has been internally validated, has never been validated with new 
data. 
The Serbia 
 This ACS model was derived from a cohort in the information system 
of the Institute for Cardiovascular Diseases of Vojvodina, Sremska 
Kamenica, Serbia (Sladojević et al., 2015).  Models were developed by 
using seven ML algorithms from WEKA.  As a result, Alternating Decision 
Tree (ADT) with a cost sensitive classification was found to be the best 
model for estimating mortality among STEMI patients who underwent PCI.  
Cost sensitive classification allows for the re-weighting of instances to reflect 
the defined misclassification cost(Witten et al., 2005). The final model was 
constructed based on 6 predictors.  New data from the same population was 
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used to validate the model.  The model maintained a good performance, with 
an AUC 0.82, when validated with new data. 
Major Adverse Cardiovascular Event (MACE) 
 Hu et al. (2016)employed a dataset derived from 2930 unstructured 
admission records from a Chinese hospital.  Information concerning potential 
predictors was extracted using rule-based medical language processing 
(RBMLP) and CRF, which had been used to develop the models based on 
four various ML algorithms (Hu et al., 2016).  As a result, the RF emerged as 
the best model with an AUC of 0.724.  As future research Hu et al. (2016) 
aim to validate the model on a large scale with an EHR dataset of different 
cohorts. 
2.1.1 The study 
This study is motivated by the belief that DM-ML is able to build a better 
model in terms of predictive power (c-statistic) compared to statistical 
methods.   Although TIMI and GRACE (both models were developed using a 
statistical method) are the most validated and accepted as present clinical 
guidelines, the author believes that DM-ML could produce a better 
discriminatory performance than a statistical method could. Further, by 
presenting a practical way of developing prediction models with application 
of other ML techniques such as feature selection method and ML 
optimization strategies , more validations could be initiated from this study to 
promote models using DM-ML for acceptance in clinical practise and 
preparation of big-data evolution in medical field. 
 Models developed using ML techniques are limited, and most of them 
only compared on limited number of ML techniques .  Although the AMIS 
model compared a broad range of ML algorithms, the model can only handle 
categorical predictors, which may, as mentioned previously, affect the 
performance of the model.  Thus, this study develops ACS prediction from 
29 ML algorithms that are able to handle numerical and categorical 
predictors from two EHR-based registries from Malaysia and Leeds, UK.  
The different region of the registries provide more insight into the different 
characteristics of two registries and the effect on different ML algorithms. 
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 In addition, the study also evaluated a number of ML feature 
selections methods as a way to improve the predictive performance of the 
model, as well as to make the model simpler.  None of the reviewed models 
in Table 1 explored ML feature selection methods as a way to improve the 
performance of the model. In addition, this study also investigates the 
reason for the degradation in performance of models developed using ML 
techniques.  
 The registry datasets used in the study include patients with all three 
types of ACS, patients with new treatment, and do not exclude high-risk 
patients.   Furthermore, the registry datasets used in the study contain the 
challenges found in EHR-based registries and practically present how DM-
ML methods could use strategies for handling the data quality issue in a 
registry dataset, as well as improving the predictive power of the prediction 
model. 
2.2. Medical DM Challenges and DM-ML Optimization 
Strategies 
2.2.1 Complexity of Medical Data  
 The nature of medical data is challenging for DM.  According to 
Fayyad et al. (1996), challenges may arise due to the nature of data and the 
granularities of knowledge to be extracted.  The intricacy of medical data 
mainly originates from the biological and social complexities of a patient 
(Beale, 2005).  Moreover, the growth of data is extremely rapid and sizeable.  
A patient admitted to an intensive care unit (ICU) may have 50 or more 
parameters collected per hour.  Heterogeneity, which lies in different sources 
of data, different kinds of data, and data originating from different systems, 
contributes to data complexity. Such data may originate from doctors, 
clinicians, or even health administrators(Hayrinen et al., 2008). Medical  data 
are captured for varied purposes.  Inputs for diagnosis, prognosis, and 
treatment have their own purposes and meaning in a medical dataset 
(Hayrinen et al., 2008).  Additionally, different types of data are captured in a 
medical database, ranging from numerical values, images, sounds, to 
unstructured free texts (Cios and Moore, 2002). Sounds and free text values 
can easily be ambiguous, inconsistent, and vague.  Thus, medical data, 
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which have no standard or formal structure, render further challenges in 
medical DM. 
 Therefore, it is vital to first comprehend the context of the domain and 
the cohorts involved in the study.   The attributes of the patients involved in 
the study, as well as the inclusion and exclusion criteria, need to be properly 
defined and reported.   The context of the dataset source has to be 
understood and should match with the objectives of the prediction model.  
Furthermore, target outcome, potential predictors, and target user of the 
prediction models are some essential aspects that have to be understood 
and described.  With that, understanding the characteristics of a dataset 
related to a prediction model should also suggest some suitable DM 
techniques and approaches. 
2.2.2 Feature Selection 
 The complexity and rapid growth of medical data have increased the 
dimensionality of the data, thus resulting in irrelevant, redundant, and noisy 
attributes.  In DM, a model built from a large number of attributes  ("curse of 
dimensionality") may possibly have deteriorated predictive power(Nisbet et 
al., 2009).  In fact, the term "curse of dimensionality," coined by Richard 
Bellman (1961), refers to the issue of data when they become sparse as the 
volume of data increases, hence causing inefficient predictive power. 
However, one way to reduce the dimensionality of a dataset in DM is to 
reduce the number of features or attributes to a manageable number without 
jeopardizing its DM objectives.  Moreover, prior studies have shown that the 
selection of a significant set of attributes facilitates data visualization, data 
understanding, reduces overfitting, and  improves the overall prediction 
performance (Das, 2001, Saeys et al., 2007, Guyon and Elisseeff, 2003, 
Tan, 2007, Hall and Smith, 1998, Blum and Langley, 1997, Kotsiantis et al., 
2007). In addition, upon reducing the attributes, a faster training time and 
simpler model can be attained.  Rapid training time is an important 
consideration when dealing with a huge dataset, while a simpler model 
offers deeper insight into the underlying processes that generate the data. 
 Within the context of classification modelling, the feature selection 
method can be classified into three categories: 1) the filter method, 2) the 
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wrapper method, and 3) the hybrid and embedded method.  The filter 
method ranks its features by evaluating an individual feature (univariate-
filter) or by evaluating an entire subset of features (multivariate-filter/subset).   
Some properties used in evaluating the features are information (e.g., 
information gain), distance (e.g., Euclidean distance), consistency, similarity, 
and statistical (e.g., Chi-square) (Jović et al., 2015).  As for the multivariate-
filter method, apart from evaluating features, the selection of a subset of 
feature relies on the search strategy for the set.  Commonly, the search 
proceeds in one of the following ways: 1) it starts with the empty set and 
features are added into the set (forward selection), 2)it starts with a full set of 
features and some are eliminated from the set (backward elimination)3) it 
starts with the empty set and a full set of features, simultaneously from both 
dimensions (bidirectional selection),or 4) it uses a genetic algorithm to 
identify the set of features (heuristic feature subset selection). 
 The main advantage of the filter method is that it does not depend on 
any classification algorithm.  Hence, the method is simple, fast, and can 
easily scale to a high-dimensional dataset.  However, in the univariate-filter 
method, the focus of evaluation is only on an individual feature and the 
outcome, thus dismissing its correlations with other features.  Hence, some 
important information gained by forming a combination of features that could 
generate a better model may be disregarded(Guyon and Elisseeff, 2003, 
Blum and Langley, 1997). 
 An example of the univariate-filter method is Information Gain.  
Information Gain measures the relevancy of each individual feature towards 
its outcome, while ignoring correlations with other features.  In addition, 
Correlation-Based-Feature-Selection (CFS) algorithms are an example of 
the subset approach.  CFS identifies a subset of features via selection with 
high correlation with the class, but low correlation with each feature(Hall and 
Smith, 1998).  Karegowda et al.(2010) stated that the CFS method was 
better than the Gain ratio in comparative studies on varied domains. In 
addition, Zhang  et al.(2008a) proposed a new filter method named the 
Constraint Score, which applied pairwise constraint, instead of class label 
information, when selecting the feature of classification development.  As a 
result, the Constraint Score offered better results compared to the Fisher 
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Score and Laplacian Score algorithms when tested on high-dimensional  
datasets(Zhang et al., 2008a).  Furthermore, Yin et al. (2012) introduced a 
new feature selection method that incorporated Hellinger distance to 
calculate a measure of distribution divergence, which is claimed to be more 
efficient and effective when dealing with high-dimensional datasets. 
 Next, the wrapper method is a method that incorporates a learning 
algorithm into evaluating the selection of features (Kohavi and John, 1997).  
The main advantage of this wrapper method derives from the advantages of 
subset feature selection and the specific classifiers.  Nonetheless, compared 
to the filter method, the wrapper method has a higher computational cost 
due to the additional evaluation of the subset of features with the specific 
learning algorithm.  This method also tends to overfit the learning algorithm 
used to evaluate the subset of features.  Hence, the recommendation is to 
develop the model on other classification algorithm, instead of using the 
algorithm used for feature selection.  For instance, John et al.(1994)wrapped 
around a subset selection with an induction algorithm to consider its 
biasness, in addition to defining two levels of relevancy in selecting a subset 
of features.    Additionally, Maldonado and Weber (2009)introduced a 
wrapped method using a SVM algorithm, which utilizes a sequential 
backward elimination method to remove insignificant features and applies a 
random split in each iteration of subset feature selection.   Therefore, the 
method presents better results than other filter and wrapper methods.  The 
method avoids overfitting and is flexible to any kernel function (Maldonado 
and Weber,2009).  Earlier, Weston et al.(2001)introduced a feature selection 
method on an SVM algorithm that is applicable to a non-linear kernel. 
 A hybrid method, on the other hand, combines both filter and wrapper 
methods.  The filter method identifies the potential subset features, while the 
wrapper method determines the best subset features.  For example, Yang et 
al. (2010) implemented the information gain approach to identify a potential 
of subsets features, and later used the wrapper method with a genetic 
algorithm to identify the best subset features in selecting relevant genes 
from a microarray dataset.  Meanwhile, Bermejo et al.(2012) improved the 
hybrid feature selection method by reducing the use of the wrapper method 
in selecting the best subset features.  Beyond this, the embedded method 
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embeds feature selection into the classification algorithm, hence becoming 
part of the model construction.  This feature selection method, however, 
depends on the classifier used.  The DT filter was used to weigh the 
attributes in the new weighted NB algorithm introduced by Hall (2007), while 
Guyon et al. (2002) incorporated Recursive Feature Elimination (RFE) in the 
SVM algorithm to select the best set of genes for cancer classification. 
 Hence, feature selection offers great utility in finding potential 
predictors in developing a prediction model.   In identifying the best 
predictors for the prediction model, A., Sudha et al. (2012)employed a 
subset feature selection algorithm, Huang et al. (2004)used the ReliefF 
algorithm,  Kurz et al. (2009) applied sequential the backward deletion 
method, and Khosla et al. (2010)proposed a novel feature selection 
algorithm called Conservative Mean feature selection. 
2.2.3 Missing Data 
 Medical databases, in particular, are dense with missing values(Cios 
and Moore, 2002).  Missing data can be completely at random (MCAR), 
missing at random (MAR),or missing not random (MNAR).  MCAR means 
that there is no obvious pattern to the missing values of the observed data, 
for instance, when a clinician unintentionally fails to record the height of a 
patient.  As for MAR, the missing values can be observed in a particular 
subsample or several subsamples, but no missing pattern appears in the 
entire sample, such as information on patients receiving PCI treatment being 
blank for those diagnosed with UA/NSTEMI.  In a standard guideline, PCI 
treatment is a specific treatment for STEMI.   Hence, both MCAR and MAR 
are known as ignorable patterns since any model explaining the missingness 
can be ignored, and the outcome from the analysis is still valid.  Even though 
a model for missingness can be ignored,  appropriate measures, such as 
excluding missing data from the sample or applying an imputation strategy, 
should be implemented to improve model performance(Pedersen et al., 
2017).  MNAR, on the other hand, refers to missingness that depends on the 
missing values or other unobserved predictors.  Hence, for missingness due 
to MCAR, a careful analysis has to be performed so as to understand why 
the data are missing and the probable values.  A model of the missing 
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values must be part of the process of inference to avoid bias. This review 
focuses on strategies for addressing MCAR and MAR.   
 One simple way of handling missing data of the MCAR or MAR is to 
exclude all cases or all features with missing values(if there are many 
missing values of the said feature).   However, this would reduce the total 
number of observations in the training set or remove important features that 
may happen to be crucial predictors.  As such, Delen et al. (2010) took an 
approach of excluding features with 95% missing values from the training 
set, as they were insignificant to the prediction model.  Another way to 
handle missing data is to impute a significant value, such as the mean or the 
common value of the categorical type (Green et al., 2006a, Dangare and 
Apte, 2012, Khosla et al., 2010). Meanwhile, Khosla et al.(2010) employed 
the Linear Regression and Regularized Expectation Maximization methods 
for data imputation. Hruschka et al.(2004)proposed an approach using 
clustering in estimating the imputation values.   In his study,  the approach 
was to first cluster the complete instances by class label, and, then, impute 
the mean of the nearest cluster for each instance that contains missing 
values. In addition, Zhang et al.(2008b) also used the cluster-based 
approach to propose an imputation strategy.   The study proposed a  kernel 
function nonparametric random imputation to estimate the imputation value 
of each cluster, by which the training samples were then clustered using the 
K-Means algorithm and ignoring the class label.  Apart from that, Grzymala-
Busse and Hu(2001) compared nine methods of handling missing data, 
which finally concluded that the C4.5 method, based on entropy and 
splitting, and excluding the missing attributes emerged as the two superior 
methods for addressing missing data.  Reviewing several practical 
imputation methods on risk modelling using real clinical datasets with binary 
outcomes,  Ambler et al. (2007) concluded that models developed by 
ignoring and using only complete instances potentially produce unreliable 
models with substantial bias.  Also, the study suggested that multiple 
imputation by chained equations (MICE) was the best multiple imputation 
method, and that conditional imputation worked well on those datasets with 
the same characteristics as their dataset. 
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 In addition, some ML algorithm can also handle missing values by 
itself, but there is no specific strategy for specific missing patterns (MCAR, 
MAR, or MNAR).  As such, Su et al. (2008) reviewed the methods used in 
handling missing values by each of ML algorithm in WEKA. These can be 
categorized into: 1) ignoring missing values - as applied in NB, DT, 
Projective Adaptive Resonance Theory(PART) algorithms2) imputing 
missing values with the mean or median of  the observed values - as applied 
in LG and RF3) replacing missing values with a default value - as applied in 
SVM and One Rule (OneR)  4) imputing missing values with a distance 
measure - as applied in K-Nearest Neighbour (KNN) and 5) having a specific 
algorithm to handle missing values- as applied in  ANN. 
2.2.4 Imbalanced Dataset 
 An imbalanced or skewed dataset is defined as having an uneven 
distribution between classes, where one class has a lower distribution than 
the other.  An imbalanced class is indeed a concern in DM(Yang and Wu, 
2006).  The imbalanced distribution of the dataset may create biased results.  
In fact, most ML algorithms, such as DT, tend to predict based on the 
majority class data; hence, this results in a higher probability of 
misclassification of the minority class.  Unfortunately, an imbalanced class 
distribution reflects many real-world situations, such as fraud detection in 
banking transactions, facial recognition,  and oil spill detection.  Similar 
scenarios also exist in medical DM, such as identification of a particular 
disease, and prediction of mortality among patients suffering from breast 
cancer.  
 A number of studies have suggested many approaches for handling 
imbalanced classes, which can be categorized into two groups: 1)data- level 
approaches, and  2) algorithm-level approaches.  A data-level approach 
balances the distribution of classes at the processing level (re-sampling), 
and reduces the effect of skewed data during the learning process.  Hence, 
there is no dependence on a learning algorithm.  In general, a balanced 
distribution can be achieved either by reducing the majority class 
(undersampling) or by increasing the distribution of the minority class 
(oversampling).  Meanwhile, an algorithm-level approach involves adjusting 
the decision threshold, specifying costs for each class, enhancing the 
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sensitivity of the existing algorithm towards the minority class, combining 
multiple algorithms for classification, and constructing a new algorithm that 
works better on imbalanced datasets.  Boosting and bagging are examples 
of algorithm-level approaches. 
 Due to a high number of negative classes, Barakat et al.(2010) used a 
K-Means algorithm as a sub-sampling method to select a dataset for 
training.  In addition, Rahman and Davis(2013) suggested a cluster-based 
oversampling method, where the majority and minority classes were 
clustered using K-Means clustering.  Next, the different sets of clusters for 
both the majority and minority classes were combined and learned by DT 
and FURIA classifiers.  The results showed that the whole set of minority 
classes and a cluster of majority classes, as well as two clusters from the 
minority class and a cluster from the majority class, improved the overall 
sensitivity and specificity of the models.  In addition, this method is better 
compared to the cluster-based undersampling approach proposed by Yen 
and Lee(2009). 
 Meanwhile, the Synthetic Minority Over-Sampling Technique 
(SMOTE) method generates synthetic  instances for the minority class by 
learning from examples in the minority class.  The synthetic instances were 
included in the training set to build the classification model (Chawla et al., 
2002).  Additionally, an analysis performed by Han et al.(2005) showed that 
the data points were far from the borderline with minimum impact upon 
classification.  Thus, the study suggested an approach to building synthetic 
instances of the minority class based on the examples of data points near 
the borderline.  This approach is known as borderline-SMOTE. Moreover, 
Ramentol et al. (2012) used SMOTE to create additional samples for the 
minority class, and utilized the Rough Set Theory to improve the quality of 
the minority samples created by SMOTE. 
 Due to the advantages offered by under-sampling and over-sampling 
methods, Batista et al.(2004) combined both methods in solving the issue of 
imbalanced dataset. Meanwhile, Kubat and Matwin(1997) removed 
instances labelled as noise from the majority class to balance the class 
distribution.  Moreover, Khalilia et al. (2011)implemented a repeated sub-
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sampling method based on ensemble learning to handle an imbalanced 
dataset. In addition, Stefanowski (2013) revealed that the small number in 
the minority class was not really due to performance degradation.  Instead, 
the problem lies in a minority class that consists of small sub-parts and 
overlapping borderlines between classes.  Hence, in tackling imbalance 
issue due to borderline examples in minority classes, the study found that 
the under-sampling method using Neighbourhood Cleaning Rule(NCR) and 
hybrid SPIDER techniques (framework that integrates a selective data pre-
processing with the ensemble method) displayed better results in 
comparison to the oversampling method using SMOTE and the one-sided 
method. 
 Boosting refers to a technique that iteratively increases the weight of 
misclassified instances and lowers the weight of correctly classified 
instances(Freund and Schapire, 1996).   Apart from reducing overfitting, the 
bagging technique can also handle an imbalanced dataset.   In the bagging 
technique, various training samples are generated by replacement (Bauer 
and Kohavi, 1999).  Meanwhile, Galar et al. (2012)reviewed the capability of 
varied ensemble methods in handling imbalanced datasets.  The 
combination of undersampling technique with a bagging ensemble algorithm 
led to positive results. 
 Moreover, Japkowicz et al.(2002) concluded that the imbalanced 
dataset issue is more severe when the training set is small, which would 
imply a greater impact on classifiers sensitive to imbalanced datasets.  The 
study also found that compared to multilayer perceptron (MLP)  and SVM,  
the C4.5 algorithm exhibited higher sensitivity towards imbalanced datasets. 
Additionally,  the study also found that a cost-modifying method was better 
at handling an imbalanced dataset than undersampling and oversampling 
methods.  Yin et al.(2012), on the other hand, focused on an imbalanced 
issue at the feature selection phase.  As such, two methods were introduced 
in feature selection for classification of imbalanced datasets: 1)  a 
decomposition-based framework  for any existing feature selection method 
that can be embedded into the framework, and 2)the Hellinger distance-
based methods.  The work showed that the set of features derived from 
these two methods led to a better classification model compared to three 
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existing feature selection methods: the CFS, Fisher, and Mutual Information 
methods.  In addition, Japkowicz(2000), Chawla(2010), and Kotsiantis et 
al.(2006) reviewed different strategies and algorithms in handling imbalance 
datasets. 
 In dealing with an imbalanced dataset, a more appropriate evaluation 
technique is required.  Evaluation based solely on the accuracy rate does 
not present true classification results.  For example, in an extremely 
imbalanced dataset, the accuracy may still be good, even though all the 
correctly classified cases are from the majority class and none are from the 
minority class.  Besides, the accuracy rate does not differentiate the correct 
classification of majority and minority classes.  In fact, the ROC Curve, AUC, 
and F-Score are some instances of evaluation metrics that can be employed 
to evaluate the performance of the model when dealing with imbalanced 
datasets (Witten et al., 2005, Baldi et al., 2000). 
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Chapter 3:  Research Methodology 
This chapter describes the methods employed in the study.  The 
methodology applied in this study was guided by the clinical modelling 
approach as depicted in Steyerberg(2009) and Lee et al. (2016), along with 
standard DM methodology, i.e., CRISP-DM (Nisbet et al., 2009). A summary 
of the methodology used in this research is portrayed in Figure 1. 
 
Figure 1: The research methodology 
3.1. Evaluation of the Present ACS Prediction Models 
 The present ACS prediction models are elaborated in the literature.  
Several aspects, for instance, overall study population, study design, 
predictors and outcome, prediction methods, and model performances were 
identified, evaluated, and compared(refer to Section2.1). 
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3.2. Data Extraction 
 The data were extracted from two sources, as follows: 
1) National Cardiovascular Disease Database (NCVD) - The Malaysian 
ACS Registry 
A Malaysian national ACS registry has been recording ACS events 
from 18 hospitals located in Malaysia since 2006. 
2) Improving Prevention of Vascular Events in Primary Care (IMPROVE-
PC) – The UK ACS dataset 
 The dataset is an outcome of the IMPROVE-PC project.  The 
 project-linked registry data is from the Myocardial Ischemia National 
 Audit Project (MINAP) with Hospital Episode Statistics (HES) and 
 Primary Care data extracted from nine General Practices (GP) in 
 Leeds for patients diagnosed with Coronary Artery Disease (CAD) 
 from 2000 until 2010.  For the purpose of this study, the data 
 information derived from the UK dataset has been limited to MINAP 
 and HES.    
The raw datasets retrieved from the two sources were in .csv file format.  
3.3. Data Understanding and Baseline Data Preparation 
 The objective of this phase is to understand the overall population in 
the datasets, potential predictors for model development, and outcomes.  
Hence, the characteristics of each dataset were defined, and the similarities 
and differences were evaluated.  In addition, data dictionaries for each 
dataset were used as the main reference to comprehend the overall context 
of the extracted datasets. The final outcomes of this phase are: 1) the 
baseline datasets - used to define the population characteristics, and 2) the 
baseline modelling datasets - for model development. 
 The summary of baseline datasets and baseline modelling datasets 
formation are illustrated in Figure 2. 
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Figure 2: Formation of baseline datasets and baseline modelling datasets 
 
The baseline datasets were extracted from raw datasets.  In fact, only ACS 
entries that met the criteria for each patient entry to the registry at first 
hospital admission have been considered for this study.  The outcome of the 
model is in-hospital mortality.  Thus, relevant in-hospital outcome attributes 
were identified, coded into binary outcomes, and an appropriate strategy 
was applied to ascertain missing values.  The candidate predictors 
functioned as attributes with regard to patients‘ clinical, demographic, and 




 Status Before Event - Smoking Status, Aspirin Used, Past Medical 
History, Past Medical Treatment 
 Clinical Presentation 
 ECG 
 Clinical Investigations and Examinations 
 Clinical Diagnosis 
 Treatment and Interventions 
 Medical - Pre Admission, During Admission, Post Admission 
 Clinical Outcomes 
 Geographical score 
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Other irrelevant attributes were excluded from the baseline datasets.  The 
datasets were then cleaned up and transformed to ensure the quality of 
data.  As such, graphical charts and descriptive statistics were used to 
examine the baseline dataset in light of in-hospital mortality.  Hence, any 
potential outlier or noise (miscoding, suspicious data, or just plain error) 
found within the datasets has been highlighted 
 After that, using the baseline datasets, baseline modelling datasets 
were generated.  The baseline modelling dataset incorporates only attributes 
that were used for model development.  The model is meant to aid doctors 
or medical practitioners in making diagnoses for further treatment.  The 
criterion of choosing the attributes is to include only attributes that were 
captured before making diagnosis or/and any decision regarding the 
diagnosis.  With that, four groups of attributes were excluded, which were: 
 Admission 
 Clinical Diagnosis 
 Treatment and Interventions 
 Medical - During Admission, Post Admission 
 Clinical Outcomes, except for in hospital mortality 
Then, the final baseline modelling dataset was divided into training and 
testing datasets (i.e., 2/3 training dataset, and 1/3 testing dataset). 
During preparation, ‗dirty‘ records and ‗dirty‘ attributes were deleted.  
Additionally, some key attributes were imputed, some values in attributes 
were transformed and several new attributes were created.  
3.3.1 Methodology Review 
 The objective of this task is to review the process of developing the 
model using WEKA.  WEKA is an open-source software developed by the 
University of Waikato, New Zealand using Java (Witten et al., 2005, Hall et 
al., 2009).  The software, under the GNU General Public License,  provides 
a collections of ML algorithms for DM tasks supported by visualization tools.  
The software also provides a platform for a developer to develop new DM 
and ML algorithms.  It is globally accepted for data analysis and predictive 
modelling by many practitioners and research scholars.  
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 A preliminary study was executed using the Malaysia dataset with a 
smaller number of attributes to compare three ML algorithms in WEKA.  The 
preliminary  study was presented in the 33rdd SGAI International Conference 
on Artificial Intelligent(Jaafar et al., 2013). Also, the objectives of the task 
were to identify 'unsuitable' ML algorithms for the datasets derived from 
WEKA involving 29 ML algorithms, explore the effect of missing values in 
developing a model, and evaluate the varied proportions of the random 
sampling method. 
3.4. Feature Selection 
 Each Malaysian and UK baseline dataset exceeded 50 attributes in 
size.  The study employed a feature selection method using ML as a 
technique to simplify the model, yet retain its good predictive power.  
Different sets of predictors were also grouped to achieve Objective 2 of the 
study, i.e., to investigates the potency of the current set of predictors in 
developing ACS prediction using ML techniques, and to investigate the 
strength of predictors from different clinical categories in producing good 
predicting models.  As such, various sets of predictors were established.  
These subsets of predictors were employed as input datasets to build the 
models based on varied learning algorithms.  
3.5. Model Development and Evaluation 
 The complete model development in WEKA embeds the process of 
preparing the input files, inclusive of feature selection, placement of the input 
dataset for training, and training the dataset by using a specified 
classification algorithm (development of a model).  Next,  the model was 
tested for its validity with the testing datasets.  In this study, the AUC was 
employed to measure the discrimination performance of the models. Figure 
3 portrays the feature selection process, model development, model 
evaluation, and model validation implemented in this study.  
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Figure 3: Detailed methodology of model development, model evaluation, and model validation 
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 As depicted in Figure 3, from the baseline modelling dataset, several 
subsets were extracted as a result of the feature selection task.  These 
subsets functioned as the input datasets to develop the ACS prediction 
models on various classification algorithms.  These models were then 
validated by using the validation dataset.  Next, the AUCs of the models 
were assessed and compared to determine the best classification models.  
In fact, some of these models were applied to analyse the reasons for 
misclassification.  Hence, based on the misclassification analysis, the 
models were further optimized by employing some methods to handle 
imbalanced datasets and missing values.  Furthermore, the varied methods 
employed to handle imbalanced datasets and missing values were 
compared with the methods proposed in this study, i.e. the overlapped 
undersampling method and  mean-clustering-imputation method. In addition, 
the prediction models that estimated the misclassification instances were 
also built as a result of the misclassification analysis task.  Later, the best 
classification models were tested on both internal and external datasets (if 
applicable).  Lastly, AUC, Brier score (BS), and calibration plots were 
compared to identify the best classification models. 
3.5.1 Classification Algorithms 
 One of the objectives of this study is to establish the best ML 
algorithms for developing ACS prediction models.  Subsequently, this study 
also identified 'unsuitable' algorithms for the dataset, as set out in Objective 
1 of the study.  As such, 29 ML algorithms with a default parameter setting 
available in WEKA were evaluated.  These classification algorithms 
originated from distinct basic learning concepts, namely, Naive Bayes, 
Linear/Non-Linear, SVM, Neural Networks, Instance-based Rules, and Tree 
models.  These are the basic concepts of learning that ML algorithms are 
developed from. 
 Furthermore, Gibert et al.(2010) asserted that to select potential ML 
algorithms for classification modelling, the primary task of the modelling and 
the dataset structure appear to be the two parameters that must be factored 
in.  In fact, these 29 selected algorithms suit with the study objectives and 
attributes of the datasets.  Moreover, these algorithms support the 
classification task (prediction capabilities with some algorithms supporting 
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description capabilities, in which the patterns could be understood by 
humans) with a dichotomous outcome, as well as both continuous and 
categorical attributes. 
 The 29 algorithms as depicted in Section3.3.1were first evaluated.  In 
addition, the 'unsuitable' classification algorithms for the ACS datasets 
generated in this study were eliminated, while the rest were used for model 
development.  Table 2 presents the evaluated modelling algorithms. 
Table 2: List of evaluated classification algorithms 
Basic Algorithms  WEKA Modelling Algorithms/Classifiers 
Naïve Bayes Learning Bayes Net (BN) 
Naïve Bayes (NB) 
Linear Models/Non-Linear Logistic (LG) 
SVM SMO(SVM) 
Neural Networks MultiLayerPerceptron (MLP) 
VotedPerceptron (VP) 
Instance-Based Learning K-Nearest Neighbour (KNN) 
Locally Weighted Naive Bayes (LWL) 
Rules Conjunctive Rules (CR) 
Decision Table (DT) 
Decision Tables and Naive Bayes (DTNB) 
Repeated Incremental Pruning to Produce Error Reduction (Jrip) 
OneRule (OneR) 
Projective Adaptive Resonance Theory (PART) 
RIpple-DOwn Rule (Ridor)  
ZeroR (ZR) 
Tree-Based Alternating Decision Tree (ADT) 
Bloom-Filter Tree (BFT) 
Decision Stump (DS) 
Functional Tree (FT) 
C4.5 decision tree (J48) 
Grafted C4.5 decision tree (J48Graft) 
Logistic Alternating Decision Tree (LT) 
Logistic Model Trees (LMT) 
Nave Bayes Tree (NBT) 
Random Forest (RF) 




The evaluated ML classification algorithms are grouped into seven basic 
learners as illustrated in Table 2.  Algorithms under the NB learner uses the 
classical statistical theory i.e. Bayes theorem(John and Langley, 1995) as 
the basis of the algorithm.  The LG algorithm in WEKA uses regression 
technique with a ridge estimator(Witten et al., 2005).  On the other hand, 
SVM algorithm uses the maximum-margin hyper-plane to determine the best 
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separation for the classes(Vapnik, 1998).  Neural Network is a learner which 
uses the basis of  human brain interactions in processing and understanding 
relationships.  As for instance based learning, a distance function is used to 
determine the shortest distance between the training samples and test 
samples(Witten et al., 2005).  While rule and decision tree learners are 
based on divide-and-conquer approach which normally work on top-down 
manner.  At each stage, the best identified attribute is split into classes, and 
recursively process the sub problems resulted from the split.  Unlike decision 
tree, rule based learner comes with a rule in selecting the instances at each 
stage.  Thus, the rule based learner will lead to a set of rules rather than a 
decision tree(Witten et al., 2005).  Different rules, different splitting methods 
and different pruning strategies (to reduce number of nodes in a tree) 
differentiate the algorithms under rule and decision tree learners.   
3.5.2 Evaluation Methods 
3.5.2.1 Hold Out Method - Random Sampling 
 Due to the massive size of the dataset to be learnt by the classifiers, a 
hold-out strategy was employed to evaluate performance metrics (Witten et 
al., 2005).  The baseline datasets were randomly divided into two sets: 1) a 
training set - to construct and evaluate the model, and 2) a test set - to 
estimate the final performance of the selected model.  In the methodology 
review, various proportions of both training and validation sets were 
examined for the29 ML algorithms, primarily to identify the best range of hold 
out method for the datasets. 
3.5.2.2 Discrimination 
 In the clinical prediction models, two primary aspects are considered 
for measuring model performance, namely, discrimination and calibration 
(Steyerberg, 2009).  Discrimination refers to the ability portrayed by a 
predictive model in distinguishing outcomes.  A perfect discrimination refers 
to the ability of a model to perfectly place the tested elements into their true 
classes.  One of the widely used performance measures used to evaluate 
discrimination within the context of dichotomous classification is the receiver 
operating characteristics (ROC) curve. The ROC curve presents the relative 
trades-off between true positive (sensitivity) and false positive (1-specificity) 
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(Pepe, 2003).  Apart from a medical clinical decision and diagnostic tests, 
the ML community recommends discrimination as a performance measure 
with which to compare prediction models (Bradley, 1997, Fawcett, 2006, 
Kumar and Indrayan, 2011).  The summary measure of ROC is an area 
under the ROC curve is AUC, which is also known as a c-statistic.  
Moreover,  AUC has been widely used in medical journals to assess 
predictive performance.  Even though some issues have been raised in 
applying AUC, or the c-statistic(Lobo et al., 2008, Cook, 2007),  the 
application of AUC-ROC has been utilized by various disciplines, including in 
recent developments in ACS mortality prediction models (Huynh et al., 2013, 
Kurz et al., 2009).   
 Therefore, the AUC was used in this study to access the 
discrimination capability among the models.  Besides, using AUC, 
comparison in terms of predictive performance between the developed 
models and the existing ACS models is relevant since AUC/c-statistics has 
been the way of measuring the predictive performance of existing ACS 
models.   
3.6. Misclassification Analysis 
 The objective of misclassification analysis is to determine the causes 
of misclassified instances resulted from model development.  Hence, this 
analysis focused on examining misclassified instances in minority classes, 
overlapping classes, outliers, and missing values.  Based on the results 
obtained from the misclassification analysis, a prediction model that 
estimated misclassified instances for ACS was developed.  
3.7. Model Optimization 
 Model optimization refers to applying several strategies to increase 
model performance.  The two methods proposed in this study to improve the 
model performance were: 1) the overlapped-undersampling method - to 
address issues related to imbalanced datasets, and 2) the mean-clustering-
imputation method - to handle missing values. 
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3.8.  Model Validation 
 Model validation validates the best models for the datasets.  The best 
models for the datasets go through internal and external validation 
processes.  The calibration measure of the best models in this study was 
calculated by using the Brier Score (BS).  Additionally, calibration plots were 
applied to illustrate the calibration of these models. 
3.8.1 Internal and External Validation 
 Internal validation incorporates testing a model with similar underlying 
populations, whereas external validation tests a model on other populations.  
As for this study, the testing dataset reserved earlier in the data 
understanding and data preparation processes has been employed to 
internally validate the models.  In order to validate a model, the testing set 
must display similar features to the derived model.  For instance, if the 
model were built with four features: 1) Age,  2) Heart rate,  3) SBP, and 4) 
Height, those features must also exist in the testing set.  Therefore, the 
predictors of the best models were decreased to compromise with the 
external testing dataset.  As for external validation, models built based on 
the Malaysian dataset were tested on the UK dataset, while models 
developed on the UK dataset were tested on the Malaysian dataset. As a 
result, a generic ACS prediction model for both the Malaysian and UK 
datasets had been identified after executing external validation. 
3.8.2 Brier Score (BS) 
 Another essential measurement for prediction models is calibration 
(Steyerberg, 2008, Van Calster et al., 2015).  A well-calibrated model is vital 
for later use in risk adjustment.  In addition, calibration refers to the 
assessment of how well a model could predict, in comparison to the actual 
events.   In this study, the best models were calibrated by using BS.  BS, 
which is a method proposed by Glenn W. Brier in the 1950s,denotes a 
scoring rule based on a simple mean squared error of the predicted value (in 
comparison to the actual outcome).   
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The formula is presented as below: 
𝐵𝑆 =  
1
𝑁





N is the number of samples 
f is the predicted probability 
o is the outcome (1 if the event occurred, 0 if did not occur) 
is the summation of the values 
 
A BS value close to zero means good prediction, whereas a score towards 1 
indicates otherwise. 
 In the study, the predicted probability of each instance was obtained 
from one of the output options provided by WEKA. The sample output from 
WEKA is depicted in Figure 4.  The predicted probability is represented in 
the "probability distribution" column of Figure 4 which represents the 
predicted probability of negative and positive cases of each instance. 
 
Figure 4:A snippet of sample output produced by WEKA 
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3.8.3 Calibration Plots 
 A calibration graph was generated for each model to visually illustrate 
models prediction versus the actual outcome.  The graph was plotted with 
the predicted mean values on the x-axis, while the values in the y-axis 
represented the recorded values.   
 Due to the binary outcome, using the actual outcomes of 0 or1 fails to 
provide meaningful variances.  Hence,  a method of binning, as 
recommended by John Tukey, has been adopted in this study.  The binning 
method divides the mean values of predicted probabilities in a number of 
bins with each bin consisting of similar prediction probability values.  In this 
study, the mean values were divided using ten quantiles.  As such, the 
predicted mean value for each of the ten bins was compared with that of the 
actual outcome.  Additionally, a model is said to be well-calibrated if the 
predicted and the actual mean values for each bin are close in value.  
Therefore, a well-calibrated model should show the points on the graph lying 
close to the 45-degreediagonal line. Moreover, plotting these values on a 
graph offers a better view of the ability of the predicted values to calibrate 
the observed values. 
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Chapter 4:  Data Understanding, Data Preparation, and 
Methodology Review 
This chapter describes the characteristics of the two datasets employed in 
this study, derived from Malaysia and the UK.  In addition, the chapter 
elaborates on the processes of preparing the baseline and baseline 
modelling datasets. Furthermore, the chapter explains the process of 
reviewing model development using WEKA, as well as several strategies 
applied in model development. 
4.1. Overview of ACS Datasets 
4.1.1 Malaysian Dataset - National Cardiovascular Disease 
Database (NCVD) 
 The Malaysian ACS registry, which is hosted by NCVD, is supported 
by the Malaysian Ministry of Health (MOH).  This database is central and 
‗live,‘ as it integrates all CVD databases in Malaysia to strategically manage 
CVD treatment and improve overall cardiac services in Malaysia.  Given this, 
the registry is comprised of information pertaining to patients diagnosed with 
ACS, including STEMI, NSTEMI, and UA, aged 18 years old and above, and 
admitted to one of 18 participating sites throughout Malaysia.   
 As a standard procedure in Malaysia, a patient record is created upon 
admission to the hospital.  Additionally, records in the ACS registry are 
captured from patients‘ records at the hospitals.  In fact, it was ascertained 
that these records satisfied the ACS enrolment criteria before being 
transferred to the ACS registry.  Moreover, all the records were first 
validated and cleaned before being transferred into the registry.  The data 
stored in the registry were designed by the content experts in the discipline, 
led by a team from the Cardiology Department of the MOH, universities, 
National Heart Institute, and Department of Medicine at the Kuala Lumpur 
Hospital.  The information was designed based on international registries 
and guidelines issued by the Australian National Data Elements for ACS, the 
European Cardiology Audit and Registration Data Standards (CARDS), as 
well as the American College of Cardiology Clinical Data Standards(Chin et 
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al., 2008).  Follow-up data of 30 days and 12 months upon initial registration 
were also captured in the ACS registry. 
 The information in the registry includes admission details, 
demographics, past medical history, clinical and procedure information, as 
well as pharmacotherapy.  Since the data is derived from the registries of 18 
hospitals that cover all 14 states in Malaysia, both ACS events and trends in 
the registry were assumed to reflect ACS events and trends throughout 
Malaysia, mirroring the varied races and ethnicities in Malaysia(Ahmad et 
al., 2011). 
4.1.2 The Leeds, UK Dataset - Improving Prevention of Vascular 
Events in Primary Care (IMPROVE-PC) 
 The IMPROVE-PC dataset refers to the outcome from a small part 
(Cardiovascular Healthcare Information Linkage Study) of the overall 
IMPROVE-PC project.  The main aim of the IMPROVE-PC project has been 
to promote healthy lifestyles by changing the behaviour among those with a 
high risk of being diagnosed with CVD in the Leeds area.  Hence, to attain 
the aim, it is crucial to find patients at high risk, which can be done by going 
through patient records in GP and/or hospitals.  As such, data recorded in 
both health care systems must be of good quality, reliable, complete, and 
consistent.  Thus, the Cardiovascular Healthcare Information Linkage Study 
is a project that links both primary and secondary care data in Leeds in order 
to evaluate the quality of recorded data in both health care 
systems(CLAHRC for Leeds).   
 In fact, the project linked three databases, which were the: 1) GP - 
SystemOne primary care, 2) MINAP, and 3) HES.  MINAP denotes the 
registry for hospital admission records for all ACS patients in England and 
Wales, whereas HES is composed of details of hospital episodes in NHS 
hospitals within England and all other hospitals that offer services to NHS 
patients.  The selected sample for the linkage studies included patients 
diagnosed with CVD, who had Leeds postcode, were registered under a 
selected GP using SystemOne, and were registered as an inpatient and 
outpatient at the hospitals(House et al., 2011).  
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4.2. Data Extraction 
 Data extraction refers to the process of extracting datasets from the 
registries.   
4.2.1 The Malaysian Dataset 
 In order to employ the Malaysian data for this study, initially, the data 
had to be requested from and approved by the NCVD board.  As such, the 
data were approved on 3rd October 2012 and released on 19th October 2012 
through a secured network protocol equipped with a password.  The secured 
network protocol was open for extraction for 7 days (19thuntil 25th October 
2012), and, on 26th October all the contents were removed.  The dataset 
was securely stored and processed in a private storage (m drive) located at 
the University of Leeds, which could only be accessed by the main 
researcher.  All the records were anonymized and were saved in a csv file.  
In fact, the details of the NCVD have previously been published(Chin et al., 
2008).  A total of 13,591patient records from year 2006-2010 were extracted 
with 215 attributes in each record.   
4.2.2 The Leeds, UK Dataset 
 Similarly,  the UK dataset was requested from and approved by Steve 
Magare, the data manager for the linkage project.  In fact, data were 
requested for HES- and MINAP-linked data for the years 2000 to 2010 for 
first admissions only.  Hence, the dataset only consists of ACS patients 
derived from the MINAP registry, and additional information on the attributes 
obtained was from HES.  The data were approved and released on 
10thOctober 2013 through a secured network protocol, together with secured 
encrypted password.  The data were securely stored and processed in 
private storage located at the University of Leeds (m drive), which could only 
be accessed by the main researcher.  All records were anonymized and 
saved as a csv file.  The total records gathered were 50,588 records with 
236 attributes in each record. 
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4.2.3 Attributes of The Datasets 
 Each entry of the raw dataset (Malaysian and the UK) is identified by 
its unique id.  The attributes of the datasets are inclusive of clinical, non-
clinical, and database-specific data.  The clinical information covers data 
related to admissions, demographics, past medical history, clinical and 
procedure information, as well as pharmacotherapy, which were further 
divided into various clinical categories.  Meanwhile, non-clinical information 
refers to data that are unrelated to ACS, whereas database information 
denotes attributes used for database and meta-data purposes.  The 
attributes are comprised of numerical (discrete and continuous), categorical 
(ordinal and nominal), date, and text data types.  The detailed summary of 
attributes for the raw datasets are summarized in Appendix A, withA.1.1 
Summary of Attributes describing the Malaysian dataset, and A.2.1 
Summary of Attributes describing the UK dataset. 
4.3. Data Preparation 
4.3.1 Baseline Dataset Preparation 
 A baseline dataset was used to comprehend the populations in the 
study, as well as to statistically summarize the characteristics of the study 
populations.  Baseline datasets is a subset of the raw dataset.  Moreover, 
these baseline datasets were the outcome of cases filtered in accordance to 
the study scope, formation of the outcome attribute, and selected candidate 
predictors, as well as the overall cleaned up and transformed datasets. 
4.3.1.1 Study Population 
 The sources of both the Malaysian and UK datasets were registries, 
which were mainly derived from hospital records.  Before the hospital 
records were transferred into registries, specific data validation and cleaning 
procedures were executed  (Gale et al., 2008a, Chin et al., 2008).  Hence, 
an assumption was made that all records in the dataset were related to 
those diagnosed with ACS based on the specification of  the registries.  
Nonetheless, the data were still validated to ascertain that only patients 18 
years old and above and admitted between 2006 and 2010 for Malaysian 
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dataset, and 2000 and 2010 for the UK dataset, were included.  All records 
that failed to meet the criteria were excluded from the dataset. 
4.3.1.2 Selection of First Entry 
 In addition, it is important to note that the study only considered the 
first hospital admission for each patient.  All subsequent entries were 
considered duplicates, and were thus excluded from the dataset. 
 As for the Malaysian dataset, multiple admission dates of a patient 
were used to identify duplicate patients.  As such, 669 patients were 
detected with multiple entries.  Thus, the first admission date was 
considered as the first entry, while the remaining entries were considered as 
subsequent entries, and hence excluded from the dataset.  However, 29 
patients with multiple entries had a similar admission date.  For such cases, 
the entries were first evaluated to determine the available information that 
led to the identification of first entry.  If this did not work, the strategy was to 
look for an entry with more valuable information, for example, fewer missing 
values and less noisy data.  If the entries shared similar valuable 
information, the one with the lowest notification id was selected as we 
assumed that the notification id was generated in an incremental manner. 
There were also 11 cases in which admission was detected at two different 
hospitals either on the same date or  on two consecutive days.  These 
particular cases were due to immediate transfer of patients to another 
hospital.  Hence, the entry for the second hospital was selected, primarily 
because the patients stayed longer at the second hospital, when compared 
to the initial hospital (discharged on the same date or the next after being 
admitted), thus suggesting more data collection during the stay.  Moreover, it 
is also notable that all these cases referred to patients who were transferred 
to the National Heart Institute or a specialized hospital for heart problems.  
Thus, it was assumed that more reliable and thorough data were collected 
from these hospitals. On top of that, records for four patients had similar 
admission dates, but the information between the records were totally 
sparse, thus leading to dead ends.  Hence, these records were excluded 
from the dataset.  Finally, there were two other special cases which, in each 
case, involved the same patient, but had varied admission dates with 
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overlapping durations of stay at two hospitals.  These records were also 
deleted from the dataset.   
 As for the UK dataset, a request was made to only extract the first 
admission entry for each patient.  Therefore, the records retrieved were 
assumed to contain no duplicates.  Besides, no attribute in the dataset could 
function as an indicator of duplicate patients. 
4.3.1.3 Preparation of In-Hospital Outcome 
 The dichotomous, categorical outcome for the prediction model is 
either dead or not dead.  In addition, in supervised learning or classification 
modelling, it is required that there be no missing values for the outcome, as 
the correlations between predictors and outcome cannot be analysed, but 
such relationships are indeed of key interest.  Moreover, in studies 
pertaining to prediction, cases with missing outcomes are generally 
discarded. 
 In terms of the Malaysian dataset, the attribute that reflected the in-
hospital outcome was ptoutcome.  The attribute is of type categorical, with 
two values: 1) Died – indicating that the patient died during his/her stay at 
the hospital, and 2) Discharged – indicating that the patient lived to leave the 
hospital.  Nonetheless, some 353 records were found to have missing 
outcomes in the dataset.  Each record in the Malaysian dataset has dead or 
alive information attached,  that was recorded by the National Registration 
Department of Malaysia (NRDM).  NRDM is a department within the 
Malaysian Ministry of Home Affairs that records and manages each 
important event in the life of an individual in Malaysia, such as birth, death, 
marriage, divorce, and citizenship status.  Therefore, the dead or alive 
information from NRDM was applied to impute the missing in-hospital 
outcome for the dataset.  Nevertheless, only records with ‗Not Died‘ (alive) 
status recorded in NRDM were considered for imputation.  This is because 
those that were listed as deceased could have died for reasons unrelated to 
the ACS event recorded in the registry.  After deliberate consideration, 309 
records with missing outcomes were imputed with a ‗Discharged‘ value, 
while all other records were deleted from the dataset. 
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 When considering  the UK dataset,  the in-hospital outcome attribute 
was referred to asX404.Death.in.Hospital, which was derived from MINAP.  
The attribute is of type categorical with seven different values, namely, 1) No  
- indicating that the patient had not died, 2) From MI – indicating that the 
patient died due to MI, 3) From complication of treatment – indicating that 
the patient died due to complications from treatment, 4) Other cardiac cause 
– indicating that the patient died due to other cardiac issues,  5) Other non-
cardiac cause – indicating that the patient died due to a non-cardiac cause,  
6) Unknown – status is unknown, and 7) NA – unavailable information.  The 
missing values in the attribute are indicated with ‗Unknown‘, ‗NA,‘ or a blank.  
No attributes in the datasets could possibly suggest a reliable imputed value 
for the outcome attribute.  As such, a total of 45,328 records were 
considered as missing and were deleted from the dataset. 
4.3.1.4 Selection of Candidate Predictors 
 Candidate predictors were selected by identifying relevant attributes 
for the research.  All attributes pertaining to ACS and clinical elements were 
considered as potential predictors.  These attributes, even excluded from 
model development ,were important for dataset characteristics and 
generalization analyses.   After careful analysis, six categories of attributes 
were considered to be irrelevant to the research objectives outlined, and 
were thus discarded. 
1. Duplicate attributes 
Some attributes were notably duplicates.  For example, the attributes 
contactinstitutionname and sdpid, in which contactinstitutionname 
reflected the hospital/centre, while sdpid denoted the code for each 
hospital/centre.  They were a one-to-one match. 
Refer to Appendix A for lists of the dataset attributes that were 
duplicates. In particular, seeA.1.2 List of Duplicate Attributes and A.2.2 
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2. Database-related attributes 
These attributes were irrelevant to model development or for any 
analysis purposes. 
Refer to Appendix A for lists of irrelevant attributes. In particular, 
seeA.1.3 List of Database Attributes and  
A.2.3 List of Database Attributes for the Malaysian and UK datasets, 
respectively. 
3. Unknown attributes 
These attributes did not reflect clinical elements and did not provide any 
information.  In addition, these attributes were not described in the data 
dictionary or data definitions. 
Refer to Appendix A for further information. In particular, see 
A.1.4 List of Unknown Attributes and  
A.2.5 List of Unknown Attributes for the Malaysian and UK datasets, 
respectively. 
4. Irrelevant attributes 
These attributes were irrelevant for modelling or generalization in this 
study.  The specific reasons for excluding these attributes are described 
in Appendix A.   
Refer to A.1.5 List of Irrelevant Attributes and 
A.2.5. List of Irrelevant Attributes for the Malaysian and UK datasets, 
respectively
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5. Non-standardized data collection attributes 
This particular category of attributes only existed in the Malaysian 
dataset.  The attributes referred to information in which the values were 
neither standardized nor reliable for this study. For instance, information 
concerning Peak Troponin was captured in various manners, depending 
on the equipment used in the hospitals/centres.  Additionally, different 
equipment led to different values.   
Refer to Appendix A: 
A.1.6 List of Non-standardized Data Collection Attributes. 
6. Dependent attribute for missing values 
This scenario only existed in the Malaysian dataset.  The missing values 
were represented in varied ways, such as specifying the missing value 
with  ―Missing,‖ ―Not Available,‖ ―Unknown,‖ or simply a ‗blank.‘ However, 
missing values were also represented by specifying values in another 
dependent attribute.  In actual fact this dependent attribute is duplicate of 
the actual attribute.  For example, attribute heightna refers to an attribute 
that records the missing values of patient's height.  However, if the height 
of a patient is not captured or found missing, the value was represented 
as ‗blank‘ in the attribute height.  These ‗blank‘ values in height indirectly 
represents the information heightna was supposed to capture. 
Refer to Appendix A:A.1.7 List of Dependant Missing Attributes.. 
4.3.1.5 Data Cleaning and Transformation 
 New attributes were created to simplify the existing information.  Refer 
to Appendix A: A.1.8 List of New Attributes and A.2.7 List of New Attributes 
for the Malaysian and UK datasets, respectively. 
4.3.2 Baseline Modelling Dataset Preparation 
 The baseline modelling dataset refers to baseline datasets meant for 
modelling.  This incorporates a process of reducing the candidate predictors 
in a baseline dataset to suit the objectives outlined for model development.  
In this case, the model is targeted to help doctors or medical practitioners in 
making a diagnosis for further treatment.  Hence, this study only considered 
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attributes that were captured before making any decision on diagnosis and 
decision about the diagnosis. As a result,  attributes from the following 
categories were discarded. 
 Admission 
 Clinical Diagnosis 
 Treatment and Interventions 
 Medical - Post Admission 
 Clinical Outcomes - Advice, Rehab, Therapy(Only applicable in the 
UK dataset) 
4.4. Results 
4.4.1 Baseline Datasets 
 After filtering, selecting, and cleaning up the cases and attributes, a 
total of 12,710 records with 75 attributes were left for the Malaysian baseline 
dataset (down from 13,591 records with 215 attributes),and 5,127 records 
with 65 attributes were left for the UK baseline dataset (from an original  
50,588 records with 236 attributes).  The final baseline dataset resulted from 
the deletion of approximately 90% of the raw dataset.  The large number of 
excluded records from UK dataset was due to quality issues, as mentioned 
earlier.   
 Although a large number of  records were deleted from the raw 
dataset, the sample size of the UK dataset (n=5,127)is still considered 
appropriate for prediction modelling.  In terms of ML classification modelling, 
Mukherjee et al. (2003) identified that, in the treatment outcome problem, the 
minimum size for a training sample for a classification problem is more than 
50 observations (Mukherjee et al., 2003).  For validating a ML classification 
model, Beleites et al.(2013) suggested that, in order to validate a model from 
a small sample (i.e., 25 samples per outcome), a minimum of 75-100 
observations are needed.  Moreover, Hu et al.(2016) demonstrated  how 
they had achieved a good performance model with a small sample size.  The 
study evaluated the effect of different sample sizes on the AUC by modelling 
with different sample sizes.  The result illustrated that at 20% (586/2930) of 
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the sample size, the performance of the models were found to be relatively 
stable.  Thus, the sample size of the UK dataset is  sufficient to produce a 
reliable model.  Two thirds of the baseline datasets were reserved for model 
derivation, while the remaining one third of the datasets were reserved for 
model validation. 
 The variation in attributes between the Malaysian and UK datasets 
was mainly due to the slightly varying levels of information captured from the 
datasets.  Otherwise, most of the attributes reflected standard information for 
ACS.  As such, 31 common attributes were generated from both the 
Malaysian and UK datasets. Refer to Appendix A:A.3The Mapping of 
Malaysian and The UK Datasets for a list of common attributes. 
4.4.1.1 Data Quality Issues 
 Generally, as mentioned, both datasets had issues related to 
duplicates and unknown attributes, as well as missing data.  The 
duplications of attributes in the UK datasets were mainly due to the varied 
sources of data, such as MINAP and HES.  Both sources of data possessed 
their own attributes, which stored similar information.  Meanwhile, unknown 
attributes refer to attributes that are not specifically defined in the data 
dictionary.  In fact, this case could be suggested to the contributors of 
datasets so as to improve their data dictionary specification, and, probably, 
the overall database design.  Furthermore, many attributes had missing 
values for both datasets.  Moreover, after applying missing value analysis to 
the baseline datasets, no complete case was detected in the UK dataset, 
while only 317 complete cases were found in the Malaysian dataset.  The 
UK dataset might not have any complete case due to the lower number of 
cases in the dataset in comparison to that in the Malaysian dataset. 
 The study has identified that, within the Malaysian dataset, several 
attributes,  such as tropinin and creatine kinase MB (CK-MB), were not 
captured via standard metrics, as different hospitals or centres employed 
varying forms of metrics.   Hence, although these attributes were vital as 
candidate predictors, they were discarded mainly for being described by 
non-standardized values.  Furthermore, data standardization is a key 
criterion towards attaining the maximum benefits of a registry (Workman and 
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A, 2013).  Therefore, the findings from this study will be brought to the 
attention of the NCVD in order to improve the overall data collection 
strategy.  On the other hand, for the UK dataset, some attributes only 
consisted of a single value, which was mainly associated with "Not 
Applicable."  This indicates that the attributes might not be applicable for the 
population in the study.  In addition, outliers, such as in the attributes SBP, 
height, weight, and cholesterol reading, were also noted in the UK dataset, 
were eliminated before initiating model development.
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4.4.1.2 Study Population Characteristics 
Table 3: Baseline characteristics of both the Malaysian and UK datasets 
Characteristics  Malaysian dataset UK dataset 









Age (years) 59.0 (12.1) [0%] 58.7 (11.9) [0%] 68.8 (13.4) [0%] 68.9 (13.2%) [0%] 
Male 7225 (75.8%) [0%] 2439 (76.8%) [0%] 2464 (64.1%) [0%] 817 (63.7%) [0%] 
SBP 139.1 (28.7) [1.7%] 139 (28.7) [1.9%] 147.8 (242.8) [23.1%] 143.5(29.6) [23.8%] 
Height 161.7 (8.3) [45%] 162.2 (8.2) [45.4%] 166.1 (65) [70.9%] 163.1 (26.1) [73.3%] 
Weight 67.6 (14.1) [38.1%] 68.2 (14.1) [38.6%] 78.3 (18.2) [60.6%] 79.4 (42.6) [62.8%] 
Heart rate (beats/mins)  83.6 (21.3) [1.7%] 83.7 (21.3) [1.7%] 83.7 (34.8) [23.1%] 85.2 (27.4) [23.7%] 
Total Cholesterol 5.31 (1.3) [28%] 5.3 (1.4) [27%] 11.8 (140.9) [40%] 6.7 (29.7) [41%] 
Killip:> 1 2264 (23.8%) [24.6%] 758 (23.8%) [10.1%] NA NA 
Previous MI 1569 (16.5%) [20.8%] 524 (16.5%) [21.7%] 2623 (22.1%) [9.7%] 287 (22.4%) [10.9%] 
History of heart failure 616 (6.5%) [17.2%] 208 (6.5%) [18.6%] 207 (6.5%) [17.3%] 75 (5.8%) [18.0%] 
History of stroke(cerebrovascular) 328 (3.4%) [19.5%] 118 (3.7%) [20.6%] 272 (7.1%) [18.1%] 82 (6.4%) [18.7%] 
History of peripheralvascular disease 74 (1.0%) [20.7%] 19 (0.6%) [21.7%] 195 (5.9%) [13.0%] 62 (4.8%) [14.4%] 
History of renal failure 586 (7.6%) [19.4%] 185 (5.8%) [21.0%] 159 (5.0%) [18.0%] 62 (4.8%) [18.3%] 
Aspirin taken  3056 (32%) [9.7%] 990 (31.2%) [10.6%] 815 (21.2%) [6%] 255 (19.9%)[7.4%] 
History of hypertension 5773 (60.6%) [13.8%] 1878 (59.1%) [14.4%] 1566 (40.7%) [10.6%] 513 (40%) [11.9%] 
Current smoker 3231 (33.9%) [5%] 1076 (33.9%) [6%] 1009 (26.2%) [12.7%] 336 (26.2%) [14.2%] 
History of diabetics 3964 (41.6%) [17.1%] 1318 (41.5%) [17.7%] 567 (14.8%) [8.9%] 227 (17.7%) [9.2%] 
BB Given 2269 (27%) [11.9%] 698 (22.0%) [12.5%] 1654(60.5%) [28.9%] 535 (41.7%) [30.5%] 
Statin Given 2724 (32.3%) [11.6%] 874 (27.5%) [12.5%] 1993 (72.6%) [28.6%] 658 (51.3%) [30.7%] 
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Previous PCI  NA NA 348 (9.1%) [18%] 111 (8.7%) [18.6%] 
Previous CABG NA NA 259 (6.7%) [16.8%] 78 (6.1%) [17.7%] 
ECG 
    
ST elevation Level 1 1910 (20%) [0%] 615 (19.4%) [0%] 
1431 (37.2%) [4.7%] 454 (35.4%) [6%] 
ST elevation Level 2 3146 (33.3%) [0%] 1066 (33.6%) [0%] 
Q Wave NA NA NA NA 
ST Depression 2488 (26.1%) [0%] 815 (25.7%) 580 (15.1%) [4.7%] 180 (14%) [6%] 
T Wave 2104 (22.1%) [0%] 684 (21.5%) 530 (13.8%) [4.7%] 180 (14%) [6%] 
BBB 475 (5%) [0%] 136 (4.3%) NA NA 
LBBB NA NA 171 (4.4%) [4.7%] 60 (4.7%) [6%] 
Diagnosis 
    
STEMI 4651 (48.8%) [0%] 1284 (40.4%) [0%] 1342 (34.9%) [15.1%] 414 (32.3%) [17%] 
Non-STEMI 2653 (27.8%) [0%] 695 (21.9%)  [0%] 1811 (47.1%)  [15.1%] 607 (47.3%) [17%] 
UA 2229 (23.4%) [0%] 845 (26.6%) [0%] 116 (3.1%)  [15.1%] 42 (3.3%) [17%] 
No of stays  
in the hospital 
4.9 (3.6) [16%] 4.7 (3.4) [16%] 7.1 (9) [0%] 7.82 (11.6) [0%] 
Treatment 
    
Fibrinolytic therapy 3430 (88.33%) [0%] 1110 (86.4%) [0%] 65 (1.7%)[46%] 24 (1.9%)[45.5%] 
Cardiac catherization 1871 (19.6%) [0%] 609 (19.2%) [0%] NA NA 
CI 1422 (14.9%) [0%] 467 (14.7%) [0%] 534 (13.8%) [46.0%] 164 (12.8%) [45.5%] 
CABG 112 (1.2%) [0%] 39 (1.2%) [0%] 44 (1.1%) [46.0%] 16 (1.2%) [45.5%] 
Died - In hospital 681 (7.1%) [0%] 221 (7%) [0%] 184 (4.8%) [0%] 57 (4.4%) [0%] 
   Values are number (%) or mean (standard deviation) [% of missing values]  
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 As presented in Table 3, Malaysian patients were found to be smaller 
by weight and height, in addition to being strikingly younger (mean age of 58 
years old) when compared to patients from the UK (mean age of 69 years 
old).  Additionally, both populations had a higher proportion of male patients, 
and the Malaysian dataset recorded about 10% more male patients than 
found in the UK dataset.    
 Overall, there were noticeable more patients with a history of MI, 
hypertension, and diabetes than other types of medical  history in both 
populations.  Nonetheless, the Malaysian population had extremely high 
percentages of patients with hypertension (~61%) and diabetes(~42%).  
Meanwhile, the prevalence of hypertension (~41%) was the highest among 
the UK population. 
 Furthermore, patients taking aspirin were more common in the 
Malaysian population, while patients taking statins and BBs were more 
prevalent in the UK population. 
 Other than that, those diagnosed with STEMI (~48%) were more 
noticeable in the Malaysian population, as compared to that in the UK 
(~35%).  In fact, the UK population was found to have more prevalence of 
NSTEMI (47%) cases and a very limited number of UA cases (~3%).  The 
Malaysian population, however, had patients diagnosed with NSTEMI  and 
UA in almost similar percentages (~22-27%). 
 Out of the 4,651 Malaysian patients diagnosed with STEMI, 2,832 
(60.9%) were treated with fibrinolytic therapy, 991 (21.3%) had cardiac 
catherization, 877 (18.9%) had undergone PCI, and only 24 (0.5%) had 
CABG.  Meanwhile, PCI (28.6%) and thrombolytic therapy (13.4%) emerged 
as the main procedures used for those diagnosed with STEMI in the UK 
population. 
 In addition, the mean duration of hospital stay among UK patients was 
higher than that of Malaysian patients.  Nevertheless, in-hospital mortality 
among Malaysian ACS patients was higher (7%) in comparison to that in the 
UK (4%).  Furthermore, among the three ACS spectrums, those diagnosed 
with STEMI and NSTEMI had higher mortality rates in both cohort studies. 
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4.4.1.3 The Leeds, UK  Population Representativeness 
 As the UK dataset only involved patients from a particular part of the 
UK, i.e., Leeds, the sample may not represent the UK as a whole.  To 
validate the representativeness of the studied dataset, the dataset was 
compared to the dataset used in the study by Gale et. al.(2008b), which 
utilized the MINAP dataset covering all patients in England and Wales from 
2003-2005.    As described in Section 4.2.2,the Leeds, UK dataset mainly 
consists of ACS patients from 2003-2010 of MINAP data. Since the datasets 
are from the MINAP registry, the comparison of these two sets of data is 
relevant.  Table 4 compares the demographic characteristics, medical 
history, and presenting clinical features used in Gale et. al.‘s (2008b) study 
and this study. 
Table 4: Comparison of the Gale et. al. (2008b) MINAP dataset and studied 
dataset in terms of demographic characteristics, medical history, and 
presenting clinical features 




Demographics   
   Age, years (mean (SD)) 68.9 (13.79) 68.8% (13.4) 
   Female 36 198 (36%) 1381 (35.9%) 
   White 76 111 (76%) 2585 (67.2%) 
   Asian 3234 (3%) 105 (2.7%) 
Medical history   
   Myocardial infarction 22 638 (22%) 2623 (22.1%) 
   Hypertension 42 528 (42%) 1566 (40.7%) 
   Angina 32 029 (32%) 1017 (26.4%) 
Chronic renal failure 3109 (3%) 159 (5.0%) 
Cerebrovascular disease 7482 (7%) 272 (7.1%) 
Peripheral vascular disease 4319 (4%) 195 (5.9%) 
Heart failure 5889 (6%) 207 (6%) 
Diabetes 17 125 (17%) 567 (14.8%) 
Smoking 25 164 (25%) 1009 (26.2%) 
Cardiac enzymes   
Elevated CK or troponin 70 378 (70%) 3103 (80.7%) 
ECG changes   
ST-segment elevation 33 723 (33%) 1431 (37.2%) 
LBBB 5068 (5%) 171 (4.4%) 
ST-segment depression 13 023 (13%) 580 (15.1%) 
T-wave changes only 13 020 (13%) 530 (13.8%) 
Arrhythmia or conduction abnormality 13 248 (13%) 473 (12.3%) 
Normal 8870 (9%) 247 (6.4%) 
Aspirin status   
Already taking aspirin before admission  22 363 (22%) 815 (21.2%) 
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 Comparing these two sets of MINAP data, no obvious differences in 
most of the patients' characteristics were observed.  As illustrated in Table 4, 
the noticeable differences of patients' characteristics are highlighted  in grey. 
Demographically, there were about 10% more white patients in Gale et. al.‘s 
(2008) sample than in the studied dataset. There were also 6% and 3% 
more patients with history of angina and diabetics, respectively, in Gale et. 
al.‘s (2008) dataset.  However, in comparison to Gale et. al.‘s (2008) 
dataset,  the studied dataset has about 10%  more patients with elevated 
cardiac enzymes during an acute phase.  Having more patients with cardiac 
enzyme in the studied dataset may possibly explain the higher number of 
patients with ECG- ST-segment elevation in the studied dataset (>4% higher 
than in Gale et al.‘s (2008) dataset), and the fewer number of patients with 
normal ECG(>3% more with abnormal results than in Gale et. al.‘s (2008) 
dataset).   Thus, from the comparison of these two sets of MINAP datasets, 
the Leeds, UK dataset is assumed to reflect the UK (Western) population, as 
a whole. 
4.4.2 Baseline Modelling Datasets 
 Upon filtering candidate predictors, a total of 75 attributes were 
chosen for the Malaysian baseline modelling dataset, while 65 attributes 
were chosen for the UK baseline modelling dataset.  Each baseline 
modelling dataset had one id attribute and one outcome attribute, whereas 
the remaining attributes were considered as candidate predictors. Figure 5 
illustrates the distribution of candidate predictors by their clinical categories.
  
- 71 - 
 
Figure 5: Candidate predictors by clinical categories 
SBE- Status before event; Geo-Score- Geographical Score 
The distinct number of attributes in the clinical category was observed at 
clinical admission, status before event-medical used and ECG categories; 
otherwise they were about the same.  An extensive list of medication history 
for each patient was recorded in the Malaysian dataset, and detailed 
information for clinical admission was captured in the UK dataset.  
Nevertheless, when considering the ECG category, for example, the 
information on the ECG is similar across datasets, and the different number 
of attributes were due to the distinct way of storing the information in the 
registries.  In addition, no geographical score was stored in the Malaysian 
dataset. Approximately 77% of the attributes in the baseline modelling 
datasets were categorical variables, while the rest were numerical. 
 The missing values were highlighted as a quality issue among the 
datasets.  Figure 6 presents the distribution of missing values, while Figures 
7 and 8portray the missing values by their clinical categories. 
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Figure 7: Mean percentage of missing values by clinical category - The 
Malaysian dataset 
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Figure 8: Mean percentage of missing values by clinical category-The UK 
dataset 
 
Overall comparing Figure 7 and Figure 8, the UK datasets had more missing 
values when compared to the Malaysian dataset.  These missing values 
were dominated by attributes in clinical investigations and examinations, 
clinical presentation, and medical status before the event for medical used 
categories. Meanwhile, for the Malaysian dataset, a high percentage of 
missing values were detected for status before the event in terms of past 
medical history and aspirin use.  On the other hand, the UK dataset also had 
notable missing values in attributes under the ECG category. 
4.5. Methodology Review 
 This section describes the findings upon reviewing the model 
development using WEKA classification algorithms, effect of missing values, 
and evaluation of random sampling methods. 
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4.5.1 Prediction Modelling Using WEKA 
 A preliminary study was carried out, and the related paper was 
presented at the 33rd SGAI International Conference on Artificial Intelligence 
(2013) in Cambridge, England.  The study evaluated the process of 
developing prediction models using WEKA.  Hence, some  960 Malaysian 
patients were employed for model development of NB, DT, and MLP.  
4.5.2 WEKA Classification Algorithms 
 The objective of this review was to determine which algorithms were 
'unsuitable' for the datasets as part of the Objective 1 of the study.  
Therefore, in the next phase, the datasets were not trained using the 
'unsuitable' algorithms.  In addition, this serves as a basic guideline for other 
researchers working with datasets that have similar characteristics.  
 Three input datasets were generated for each Malaysian and UK 
dataset, as described in Table 5.  
Table 5: Input datasets for review of classification algorithms 
Input Datasets Descriptions No. of 
predictors 
(Malaysia/UK) 
Baseline modelling datasets These are datasets prepared for model 
development 
75/65 
Common datasets Subsets of baseline modelling datasets that 
included only the common attributes found in 
both the Malaysian and UK datasets. 
Refer to Appendix A:A.4The Common Datasets. 
18/18 
AMIS datasets Subsets of baseline modelling datasets that only  
employed attributes from the AMIS model(Kurz 
et al., 2009). 
Refer to Appendix A: A.5Characteristics of AMIS 
Model Vs The UK and Malaysian datasets. 
6/5 
 
 The three input datasets as presented in Table 5 used for this 
particular task was to have a variation of input datasets as to look into how in 
general, each of the ML algorithm reflect the performance of the model even 
when the predictors is reduced.  Baseline modelling datasets considered all 
the attributes - allow for broad range of possible predictors to predict the 
outcome, and common datasets and AMIS datasets are the datasets with 
pre-selected attributes.  The attributes in common datasets were selected 
solely based on the common attribute in the Malaysia and the UK dataset, 
regardless of its importance to the outcome and without any clinical 
- 75 - 
reasoning. AMIS dataset on the other hand, presented the set of attributes 
that have been used to develop ACS model i.e. AMIS model.  Thus, the set 
of predictors used has been significantly evaluated.  
 In addition, as mentioned previously, two thirds of each dataset was 
used for training, while the remaining one third was reserved for validation.  
The datasets were trained on 29 algorithms and validated. The performance 
of each model was examined using AUC.  As such, an AUC score of 0.65 
and below is considered unsuitable. 
 Four algorithms have obtained an AUC score of 0.5 for all input 
datasets; these algorithms, VP, CR, Ridor, and ZR, were thus considered 
‗unsuitable.‘ Further, the SVM, JRip, OneR, and BFT algorithms were also 
deemed 'unsuitable' as their AUC scores were consistently below 0.6.  
Finally, j48, j48Graft, SC, and KNN resulted in fluctuating AUC scores 
between the three input datasets.  Nevertheless, each of these algorithms 
has an average AUC score of below 0.65 for the three input datasets. 
Hence, j48, j48graft, SC, and KNN were also considered to be 'unsuitable.'  
As a result, only 17 algorithms were found suitable for further evaluation and 
model development.  
 In addition, the study also noted that LWL, MLP, DTNB, BFT, and 
LMT required notably more time for training and validating a model.  On the 
other hand, KNN, RF, RT and PART were notably prone to overfitting.   
 Detailed results can be found in Appendix B: B.1 WEKA Classification 
Algorithms. 
4.5.3 Missing Values 
 Since the datasets consist of a large number of attributes and quite a 
large percentage of missing values, it was not possible to create large 
enough training sets with complete cases.  Therefore, removing incomplete 
cases as a way of handling missing values was not possible. Hence, this 
study explored the possibility of removing attributes with missing values.  As 
such, this exercise explored the effect of removing attributes with various 
percentages of missing values. 
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 The baseline datasets were employed in this exercise.  Another five 
sets of input datasets were formed from the baseline datasets. They were:- 
1) Baseline datasets with no missing values (BD_No_Mssg) - 
Removed all attributes with missing values. 
2) Baseline datasets with 5% missing values (BD_5Prct_Mssg) - 
Removed all attributes with more than 5% missing values. 
3) Baseline datasets with 10% missing values (BD_10Prct_Mssg)  - 
Removed all attributes with more than 10% missing values. 
4) Baseline datasets with 15% missing values (BD_15Prct_Mssg)  - 
Removed all attributes with more than 15% missing values. 
5) Baseline datasets with 20% missing values (BD_20Prct_Mssg) - 
Removed all attributes with more than 20% missing values. 
All the datasets were split into training (2/3) and validation (1/3) sets.  The 
training sets were used to develop the models using 17 algorithms, and the 
validation sets were used to validate the model.  The AUCs of each model 
were then compared and analysed.  
 Collectively, the results suggest that removing all attributes with 
missing values resulted in poor model performance. The performance of the 
models started to improve when more attributes with a larger percentage of 
missing values were included in the datasets.  Generally, most of the 
algorithms in both the Malaysian and UK datasets showed  better AUC for 
the BD_15Prct_Mssg and BD_20Prct_Mssg datasets. This result suggests 
the possibility that most of the attributes with 15-20% missing values are 
indeed important predictors for the model.  Thus, it  does not appear to be 
wise to remove attributes with missing values, as this might remove 
important predictors.  As a result, it was decided to first execute the feature 
selection tasks with all the attributes, including those with missing values.  
Once the attributes were reduced, the incomplete cases were handled 
accordingly.   
 Detailed results can be found in Appendix B: B.2.Missing Values 
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4.5.4 Random Sampling 
 The objective of this section was to determine and confirm the best 
proportion of training and validation sets for the random sampling method.  
Generally, two thirds for training is a common practice with which to 
randomly split datasets.  In this section, nevertheless, different random splits 
were applied to the training and validation sets. The input datasets used for 
the exercise were the baseline modelling datasets. Thus, the input datasets 
were randomly divided into 90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 
20:80, and 10:90 proportions for training and validation, respectively.  These 
datasets were trained on 29 algorithms. 
 No pattern emerged that suggested that a specific proportion of 
random splitting was good for both datasets and all algorithms.  The AUC of 
similar algorithms produced good results with varied percentages of random 
splitting when different datasets were applied.  However, the results showed 
that a range of 70:30 to 40:60 splits yielded convincing AUC results on 
almost all classifiers run on both the Malaysian and UK datasets.  As such, 
following the standard practice, this study opted to randomly divide the 
datasets into a2/3 split for model development.   
4.6. Discussion and Conclusion 
 This chapter introduced the derivation cohorts for the study, along with 
a summary of the datasets and populations‘ characteristics. As a result, the 
final outcome of this chapter has been the baseline datasets and baseline 
modelling datasets. Baseline datasets were used to annotate the population 
characteristics, and the baseline modelling datasets were used for model 
development in the study. 
 The cohorts originated from two different regions: Asian and Western.  
The Asian dataset was comprised of Malaysian patients as a whole, while 
the Western dataset contained only a specific part of the UK: Leeds.  
Although, the Leeds, UK dataset represents only part of the UK, the sample 
was assumed to reflect the whole of the UK as there were no obvious 
difference in most of the patients' characteristics between our sample and 
the whole of the UK, as studied by Gale et al. (2008). The Asian and 
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Western datasets resulted in different characteristics within the samples. 
Moreover, the datasets were composed mainly of standard information 
pertaining to ACS, as the registries were developed based on standard 
international registries, as well as guidelines for ACS and CVD. 
 Nevertheless, the sole limitation of these datasets has been their 
quality.  This issue was expected as the data were derived originally from 
EHR.  Although the data had been validated and cleaned before being 
transferred into the registry, the quality of the datasets continued to be an 
issue to be addressed.  The quality issue resulted in excluding 
approximately 90% of the UK records.  However, the number of records left 
in the UK dataset was sufficient for the development of a reliable prediction 
model using ML, as well as for validating the model (Mukherjee et al., 2003, 
Beleites et al., 2013).  Moreover, existing ACS models, such as MACE, were 
developed from samples smaller than the UK dataset (Hu et al., 2016).  The 
quality issue in the datasets also required that a hefty amount of time be 
spent preparing the datasets for model development.  In addition, issues 
related to the quality of the data dictionary were time constraining, especially 
when comprehending the datasets.  It is also important to note the risk in 
having to exclude large number of observations from model development 
when data quality is at stake. 
 From the 29 ML algorithms identified, only 17 displayed the potential 
to be exercised in model development.  In addition, LWL, MLP, DTNB, BFT, 
and LMT were found to be time-consuming in developing models, whilst 
KNN, RF, RT, and PART were inclined to overfitting. 
 Furthermore, as the datasets consists of a large number of attributes 
and contain a large number of missing values, removing all the incomplete 
cases from the datasets was not viewed as a strategic way of handling the 
missing values.  However, removing attributes that hold the missing values  
was also not deemed a worthy strategy.  The investigation into removing 
attributes that contained a certain percentage of missing values revealed 
that, as more attributes were removed (to minimised missing values of the 
datasets), the performance tended to degrade. This result indicates that 
most of attributes with missing values are indeed important predictors.  
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Hence, the study retained all attributes and missing values of the baseline 
modelling datasets when identifying a set of predictors for model 
development (feature selection).   Only after the feature selection had been 
executed for model development, appropriate measures were applied to 
handle  the missing values.  
 Moreover, the findings from reviewing varied proportions of hold-out 
random sampling were consistent with the standard hold-out strategy, i.e., 
the 2/3  distribution.  In addition, the study also found that a range between a 
70:30 split and 40:60 split yielded convincing AUC results. Therefore, this 
study had decided to use a hold-out random sampling method with a2/3 
distribution to evaluate the developed models. 
 The following chapter demonstrates the implementation of feature 
selection methods to generate the input datasets for model development.   
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Chapter 5:  Feature Selection and Model Development 
This chapter describes the process of evaluating various subsets of 
predictors to fulfil Objective 2 of the study.  As a result, varied sets of 
predictors were identified and were further used as input datasets for model 
development.  The predictive performance of the developed models are also 
analysed and presented in this chapter. 
5.1. Method 
 In the data preparation stage, attributes from raw datasets were 
thoroughly scanned and analysed to choose potential predictors that met the 
objectives of developing ACS prediction models.  With that, all attributes that 
were duplicates, database-related, unknown, irrelevant, non-standardised, 
and dependent (functioned as additional attribute to cater missing 
values),have been excluded from the datasets.  However, even after 
eliminating some of these attributes, the remaining number of attributes was 
still considered massive as there were more than 50 attributes.  Therefore, 
to construct a simpler model with good predictive power, feature selection 
was applied in the model development process.   
 As such, in selecting sets of predictors for model development, 
various ML automated feature selection methods were evaluated. The 
potency of predictors from existing ACS models that were appropriate for 
adoption in developing simplified and customized prediction models was 
also assessed. In addition, the strength of predictors from different clinical 
categories in producing good models was also investigated. Sets of 
predictors from these three outcomes were then employed as input datasets 
for model development.  The prediction models were then built on 17 
classification algorithms. The best models for each of the Malaysian and UK 
datasets were chosen by comparing the AUC scores obtained by using the 
validation datasets.   
- 81 - 
5.1.1 Handling Missing Values 
 In the methodology review, specifically Section4.5.3 on missing 
values, it was decided to execute feature selection with all attributes, 
regardless of missing values, and, later, to remove the incomplete cases 
before model development.  For future note, the amount of training and 
testing data was decreased when incomplete cases were omitted.  
Nonetheless, some incomplete cases could not be dismissed as they 
considerably reduced the number of training cases.  As a result, for such 
cases, all the missing values were left for the algorithms to handle, as each 
selected algorithm has a method for handling missing values(Su et al., 
2008). 
5.1.2 Evaluating Automated ML Feature Selection 
 Two main methods from WEKA were employed to assess and identify 
subsets of attributes from both  the Malaysian and UK datasets.  As the 
study evaluated a range of ML algorithms suitable for the datasets, selecting 
a feature selection method that runs together with model development 
process could have been tricky and intricate.   Thus, the chosen feature 
selection methods evaluated in the study were implemented as pre-
processing procedures, i.e., before the model development process.   The 
feature selection methods employed were the subset and wrapper methods. 
The subset method refers to a type of filter method that does not depend on 
any classification algorithm.  This method selects subsets of attributes during 
the pre-processing steps before running the dataset into any classifier 
algorithm.  Two types of filter methods are: 1) univariate-filter, and 2) 
multivariate-filter (subset) methods. The study adopted the latter method 
because it considers the relationship of individual attributes, as well as the 
correlation between attributes towards the outcome. 
 The subset methods applied in the study were: 1) Correlation-Based-
Feature-Selection (CFS), and 2) FilterSubset.  CFS identifies a subset of 
attributes by selecting attributes with high correlation with the class, yet low 
correlation with each other (Hall and Smith, 1998).  In WEKA, this subset 
method is known as CfsSubsetEval. On the other hand, the FilterSubset 
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employs a similar technique to CFS, except that, in selecting the attributes, 
FilterSubset divides a dataset into subsamples. 
 The wrapper method (Kohavi and John, 1997) incorporates a learning 
algorithm in the selection of attributes.  As in WEKA, the subset evaluator 
will first detect all the possible subsets of attributes within the dataset.  Next, 
these sets of attributes are trained on a specified classifier algorithm using a 
cross-validation technique.  The best set of attributes is the one that 
performed the best on the clarification algorithm.  As such, this study 
adopted two classification algorithms for the wrapper method, which were 
NB and LG.  NB and LG retained their exceptional predictive performances 
in the prior task(refer to the Section4.5.2), in which the average AUC scores 
for these two classification algorithms exceeded 0.7.  
 In WEKA, the feature selection method implements a specific search 
method to determine a set of attributes.  The search method utilized in this 
study was the Greedy search strategy using the forward selection approach.  
The Greedy search strategy forms a subset of attributes by progressively 
adding attributes to the subset until the best subset appears.  It has been 
claimed that the Greedy search is computationally advantageous and robust 
against overfitting (Guyon and Elisseeff, 2003). 
5.1.3 Evaluating Predictors of Existing ACS Models 
 Sets of predictors were manually select based on the attributes of the 
existing ACS prediction models.  The ACS prediction models referred to in 
this task were: 1)  TIMI(Antman et al., 2000),2) PURSUIT(Boersma et al., 
2000), 3) Grace (In-hospital) (Granger et al., 2003), 4) GUSTO-I(Lee et al., 
1995), 5) AMIS(Kurz et al., 2009), 6) Serbia(Sladojević et al., 2015), 7) C-
ACS (Huynh et al., 2013), 8) EMMACE (Dorsch et al., 2001), and 9) MACE 
(Hu et al., 2016).  The purpose of this task was to evaluate the potency  of 
the existing sets of predictors to be adopted in building customized 
prediction models on other cohorts (e.g., the Malaysian and UK 
cohorts)using ML algorithms.  A set of predictors was selected from the 
combination of predictors from the selected nine ACS prediction models.  
These predictors were then  matched with the attributes available in the 
Malaysian and UK datasets.    
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 Sets of predictors were also extracted from each of the seven 
selected ACS models, which were: 1) AMIS, 2) EMMACE,3) Canada ACS 
Risk Score, 4) GRACE, 5) PURSUIT, 6) GUSTO-I, and 7) Serbia. 
5.1.4 Evaluating Predictors of Different Clinical Categories 
 In the data processing phase, the datasets were categorised based on 
clinical reasoning.  By categorising these datasets, the clinical data were 
grouped into similar or related items/events for better visualisation and 
understanding of the datasets.  The attributes were grouped into id, 
demographics, status before event (medical history and medication pre- 
admissions), clinical presentation, ECG, and baseline investigations.  The 
purpose of selecting predictors based on clinical categories is to evaluate 
the impact predictors from each clinical category had in constructing good 
prediction models.  Another reason was to assess the effect of having 
predictors concerning medication taken before admission as part of the 
predictors..  
 Thus, sets of predictors were grouped into five combinations of clinical 
categories, which were:- 
CATA1 - demographics and medical history 
CATA2 - demographics, medical history, and medication  pre-admissions 
CATA3 - demographics,medical history,medication pre-admissions, and 
clinical presentation 
CATA4 - demographics, medical history,medication  pre-admissions, clinical 
presentation, and ECG 
CATA5 - demographics, medical history,medication  pre-admissions, clinical 
presentation, ECG, and baseline investigations 
Each combination has its own set of predictors, for which the models were 
then developed. 
 Another set of predictors was also formed using the same approach, 
but also applying the CFS feature selection method.  Predictors in each 
clinical category were filtered using the CFS feature selection method, and 
then all the filtered predictors from each category were combined to form  
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CATA7.  CATA7 was formed to examine the benefits of having fewer 
predictors when using ML feature selection in evaluating predictors from 
different clinical categories. 
5.2. Results 
 This section presents the sets of predictors resulting from the three 
tasks described in Sections 5.1.2 - 5.1.4.  It also demonstrates the results of 
models developed based on the established sets of predictors from these 
three tasks.  The best prediction models for both the Malaysian and UK 
datasets were examined based on their discrimination capability using AUC.  
The best prediction models also subsequently represent the best subsets of 
predictors for each of the datasets.  Lastly, the final part of this section 
describes the performances of the models built by ML algorithms.  
5.2.1 Evaluating Automated ML Feature Selection: Sets of 
Predictors 
 The subsets of predictors chosen by applying CFS, FilterSubset, 
wrapper with LG algorithm (WrapperLG), and wrapper with NB algorithm 
(WrapperNB) methods on the Malaysian and the UK datasets are tabulated 
in Table 6.   
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Table 6: Subsets of predictors selected  by ML automated feature selection 
Automated feature 
selection methods 
Malaysian The UK 
List of predictors List of predictors 
CFS 1) ptageatnotification  1) Age.At.Admission 
2) heartrate  2) X224.Beta.Blocker* 
3) bpsys  3) X220.Systolic.BP 
4)bpdias  4) X314.Where.cardiac.arrest* 
5) ecgabnormtypetwave* 5) X424.Reinfarction* 
6) lvef   
FilterSubset 1) ptageatnotification  1) X314.Where.cardiac.arrest* 
2) heartrate    
3) bpsys   
4)bpdias   
WrapperLG 1) sdpid* 1) ADMISSION_YEAR* 
2) ptageatnotification  2) Age.At.Admission 
3) cdm* 3) X204.Where.Aspirin.Given* 
4) chpt * 4) X314.Where.cardiac.arrest* 
5) canginamt2wk* 5) Clopidogrel* 
6) weight     6) X228.Glucose* 
7) ecgabnormlocationrv* 7) X315.Presenting.Rhythm* 
8) lvef 8) X236.Site.of.Infarction* 
WrapperNB 1) chpt* 1) ADMISSION_YEAR* 
2) ccap* 2) ADMISORC* 
 3) canginamt2wk* 3) X222.Admitting.Consultant* 
4) cpvascular* 4) Age.At.Admission 




7) weight 7) X218.Previous.PCI* 
 8) waistcircumf 8) X219.Previous.CABG* 
9) ecgabnormtypenonspecific* 9)ONSET_SYMPTOMS_BEFORE_ADMISSION* 
10) ecgabnormlocationll* 10) X314.Where.cardiac.arrest* 
11) ecgabnormlocationtp* 11) ATTEND_NON_INTERVENTIONAL_ 
HOSPITAL* 
12)  ecgabnormlocationrv* 12) X238.Thienopyridine.inhibitor.use* 
13) tc 13) X220.Systolic.BP 
14) hdlc 14) X230.Weight 
15) ldlc 15) X315.Presenting.Rhythm* 
16) tg 16) X424.Reinfarction* 
17) asapre* 17) X237.ECG.QRS.Complex.duration* 
18) adpapre* 18) X236.Site.of.Infarction* 
19) gpripre* 19) X215.Cholesterol 
20) heparinpre* 20) X231.LVEF 
21) lmwhpre* 21) X347.Assess.at.non.intevention.hospital* 
22) bbpre*   
23) aceipre*   
24) arbpre*   
25) statinpre*   
26) lipidlapre*   
27) diureticpre*   
28)calcantagonistpre*   
29) oralhypoglypre*   
30) insulinpre*   
31) antiarrpre*   
The underlined predictors represent the predictors from the category of medication 
received before admission; The strikethrough predictors illustrate the 




- 86 - 
 Considering Table 6, the WrapperNB method has the most predictors.  
The method identified 31 and 21 attributes as potential predictors for the 
Malaysian and UK datasets, respectively.  In contrast, FilterSubsetreduced 
the attributes to only one potential predictor for the UK dataset. 
 The potential predictors identified in all ML feature selection methods 
reflecta mix of varied clinical categories of clinical admission and 
demographics, past medical history, medication received before admission, 
clinical presentation, ECG, and clinical investigation.  Age was selected by 
all the methods, with the exception of theWrapperNB method; this suggests 
that age is the most essential predictor for the datasets.  In addition, 
predictors under clinical presentation (e.g., SBP, heart rate, and presentation 
of cardiac arrest) and ECG categories emerged as the most selected 
predictors by the four ML feature selection methods.  On the other hand, 
attributes from the category  describingmedication received before 
admission were the least selected by most of the feature selection methods, 
with the exception of theWrapperNBmethod on the Malaysian dataset, for 
which almost all attributes in this category were selected.  Hence, the effect 
of having predictors under the category of medication received before 
admission has been further investigated.  
 As described in Section 5.1.1, to handle missing values, only 
complete cases were considered for model development.  Therefore, the 
missing cases of the datasets from applying CFS and FilterSubsetwere 
excluded before model development.  Nonetheless, the approach to 
addressing the missing values was different for the datasets when applying 
the wrapper methods.  This is because the wrapper method extracted a 
considerably substantial number of predictors with large percentages of 
missing values. Thus, excluding the incomplete cases from the datasets 
applying the wrapper methods was not practical as it reduced a large 
number of cases for model development.  Therefore, the predictors selected 
by the wrapper method were further filtered by discarding predictors with 
missing values >20%. As a result, for the Malaysian dataset, one predictor of 
the eight predictors selected by the WrapperLG method and eight predictors 
from the 31 predictors selected by the WrapperNB method were dismissed.  
Filtering the missing values on the UK dataset, four attributes were excluded 
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from set of predictors selected by the WrapperLG method, while only 11 
predictors remained on the list of predictors selected by the WrapperNB 
method.  All the predictors that had been removed are represented as 
strikethrough in Table 6. After applying the strategy in handling missing 
values for the datasets, the reduced sample size for model development is 
illustrated in Figure 9. 
 
Figure 9 : Sample size for model development of evaluating ML feature 
selection method 
 
5.2.2 Evaluating Automated ML Feature Selection: The 
Prediction Models 
 Tables 7and 8 tabulate the performances of the models developed 
based on sets of predictors extracted from ML automated feature selection 
methods for the Malaysian and UK datasets, respectively. 
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Table 7: The Malaysian models developed based on sets of predictors 
extracted from ML automated feature selection methods 
Models CFS_MY FS_MY WR_LG_MY WR_NB_MY 
BN 0.762 0.765 0.640 0.615 
NB 0.794 0.765 0.667 0.609 
LG 0.801 0.777 0.676 0.605 
MLP 0.773 0.776 0.558 0.549 
LWL 0.500 0.723 0.660 0.524 
DT 0.500 0.768 0.500 0.500 
DTNB 0.500 0.768 0.500 0.500 
PART 0.702 0.616 0.673 0.513 
ADT 0.773 0.768 0.769 0.569 
DS 0.645 0.613 0.626 0.532 
FT 0.500 0.500 0.500 0.500 
LT 0.774 0.787 0.708 0.576 
LMT 0.802 0.776 0.500 0.500 
NBT 0.762 0.767 0.640 0.619 
RF 0.758 0.753 0.731 0.570 
RT 0.533 0.544 0.533 0.499 
REPT 0.500 0.616 0.679 0.500 
The underlined values represent AUC>0.8; the blue-coloured values indicates the 
three best models; the grey-shaded attribute denotes the overall best model 
 
 In Table 7, CFS_MY, FS_MY, WR_LG_MY, and WR_NB_MY 
represent models developed for the Malaysian dataset using CFS, 
FilterSubset, and wrapper methods (WrapperLG and WrapperNB), 
respectively. 
 The results in Table 12 generally suggest that the models developed 
based on predictors from subset methods (CFS and FilterSubset) generated 
better AUC scores in comparison to the wrapper methods (WrapperLG and 
WrapperNB).  In fact, the average AUC scores for WR_LG_MY and 
WR_LG_MY models were 0.621 and 0.546, respectively.  Moreover, the 
lowest AUC score produced by the WR_NB_MY  model may have resulted 
from loss of several essential predictors due to removal of attributes in 
addressing missing values.  The results also showed that having predictors 
from the category of medication received before admission(selected by 
WrapperNB) did not improve the models.   
 Comparing the models developed by predictors of subset methods, 
generally, CFS_MY performed better than FS_MY.  In developing CFS_MY 
- 89 - 
models, two classification algorithms attained an AUC > 0.8, i.e., LG (AUC = 
0.801) and LMT (0.802).  Additionally, NB also displayed a considerably 
good AUC score (0.794) in building the CFS_MY model.  On the other hand, 
the results demonstrated that LT (AUC = 0.787), LG (AUC = 0.777), LMT 
(AUC = 0.776), and MLP (AUC = 0.776) emerged as the best algorithms for 
the FS_MY models. 
Table 8: The UK models developed based on sets of predictors extracted 
from ML automated feature selection methods 
Models CFS_UK FS_UK WR_LG_UK WR_NB_UK 
BN 0.793 0.668 0.789 0.824 
NB 0.889 0.595 0.818 0.847 
LG 0.869 0.706 0.809 0.847 
MLP 0.859 0.609 0.765 0.773 
LWL 0.815 0.702 0.741 0.795 
DT 0.709 0.668 0.798 0.700 
DTNB 0.714 0.668 0.781 0.817 
PART 0.653 0.621 0.779 0.758 
ADT 0.794 0.656 0.807 0.805 
DS 0.628 0.664 0.669 0.695 
FT 0.850 0.706 0.590 0.635 
LT 0.764 0.689 0.780 0.844 
LMT 0.868 0.667 0.807 0.867 
NBT 0.791 0.668 0.795 0.822 
RF 0.713 0.646 0.800 0.778 
RT 0.603 0.583 0.657 0.618 
REPT 0.500 0.651 0.676 0.699 
The underlined values represent AUC>0.8; the blue-coloured values indicate the 
three best models; the grey-shaded attribute denotes the overall best model 
 
 In Table 8, CFS_UK, FS_ UK, WR_LG_ UK, and WR_NB_ UK 
represent models developed for the UK dataset using CFS, FilterSubset, 
and wrapper methods (WrapperLG and WrapperNB), respectively. 
 As in the Malaysian dataset, CFS_UK also exhibited the best 
performance for the UK dataset (Table 8) in comparison to other automated 
feature selection methods by obtaining the highest AUC for NB (AUC 
=0.889).  To the contrary,  models developed with  predictors chosen by  
FilterSubset had the lowest AUC score in most of the algorithms.  In fact, the 
models developed  with predictors selected by the wrapper methods 
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achieved noticeably good AUC scores, with more than half of the algorithms 
hitting AUC> 0.75.  Among the best algorithms that achieved AUC > 0.8 in 
CFS_UK, WR_LG_UK, and WR_NB_UK were NB, LG, and LMT. 
 In conclusion, for both the Malaysian and UK datasets, CFS methods 
appeared to be the best feature selection methods. FilterSubset also 
appeared to be a good feature selection method for the Malaysian dataset, 
unlike the wrapper methods.  Unfortunately, the results showed otherwise for 
the UK dataset, in which wrapper method seemed to produce better models 
than the FilterSubset method.   The results from both tables also indicate 
biasedness on models developed using the same algorithm used by wrapper 
feature selection methods (i.e., NB and LG).Nevertheless, the cases of 
biasedness were not too vivid. 
5.2.3 Evaluating Predictors of Existing ACS Models : Sets of 
Predictors 
 Table 9 presents the sets of predictors derived from extracting 
predictors from ACS models. 
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Malaysian  The UK  
List of predictors List of predictors 
All_LR 1) ptsex* 1) Age.At.Admission 
  2) ptageatnotification 2) X107_Gender* 
  3) statusaspirinuse* 3) X213.Heart.Failure* 
  4) cheartfail* 4) X204.Where.Aspirin.Given* 
  5) ACS_SYMPTOMS_BEFORE_ADMISSION* 5) X220.Systolic.BP 
  6) heartrate 6) X221.Heart.Rate 
  7) bpsys 7) X314.Where.cardiac.arrest* 
  8) bpdias 8) ST_Segment_Deviation* 
  9) killipclass*   
  10) lvef  ** Attributes lvef was deleted due  
To large amount (94%) of missing 
values 
AMIS 1) ptageatnotification 1) Age.At.Admission 
 2) cheartfail* 2) X210.Cerebrovascular.Disease* 
 3) ccerebrovascular* 3) X213.Heart.Failure* 
 4) heartrate 4) X220.Systolic.BP 
 5) bpsys 5) X221.Heart.Rate 
 6) killipclass* ** No Pre-hospital 
cardiopulmonary  
  ** No Pre-hospital cardiopulmonary 
resuscitation attribute 
resuscitation attribute 
EMMACE 1) ptageatnotification 1) Age.At.Admission 
 2) heartrate 2) X220.Systolic.BP 
  3) bpsys 3) X221.Heart.Rate 
C-ACS 1) ptageatnotification ** Same as EMMACE ** No killip 
class attribute 
2) heartrate   
3) bpsys   
4) killipclass*     
GRACE  1) ptageatnotification 1) Age.At.Admission 
 2) heartrate 2) X221.Heart.Rate 
 3) bpsys 3) X220.Systolic.BP 
 4) killipclass* 4) X314.Where.cardiac.arrest* 
 5) ACS_SYMPTOMS_BEFORE_ADMISSION* ** No killip class attribute 
 ** No  serum creatinine attribute ** No  serum creatinine attribute 
  ** No  positive initial cardiac enzyme 
attribute 
** No  positive initial cardiac 
enzyme attribute 
PURSUIT  1) ptageatnotification 1) Age.At.Admission 
 2) gender* 2) X107_Gender* 
 3) heartrate 3) X221.Heart.Rate 
 4) bpsys 4) X220.Systolic.BP 
 5) st_segment depression* 5) st_segment depression* 
 ** No  sign of heart failure attribute ** No  sign of heart failure 
attribute 
  ** No  cardiac enzyme attribute ** No  cardiac enzyme attribute 
GUSTO-i   ** Same as C-ACS ** Same as EMMACE  
** No  anterior infraction attribute ** No killip class attribute 
   ** No killip class attribute 
      ** No  anterior infraction attribute 
Serbia 1) Ptageatnotification 1) Age.At.Admission 
 2) Bpsys 2) X220.Systolic.BP 
 3) Heartrate 3) X221.Heart.Rate 
 4) Bpdias 4) X231.LVEF 
 5) Lvef ** No  DBP attribute 
  ** No  troponin value attribute ** No  troponin value attribute 
The * denotes categorical predictors 
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Referring to Table 9, the sets of predictors that matched the combination of 
predictors of the nine existing ACS prediction models are represented by 
All_LR.  Ten predictors from the Malaysian dataset, and eight predictors 
from the UK dataset matched the combined set of predictors from the nine 
ACS prediction models (All_LR).  The extra predictor for the Malaysian 
dataset was the Killip class.  For the UK dataset, nine predictors were 
initially matched, but the lvef predictor was discarded due an enormous 
number of missing values(94%).  Predictors with a large number of missing 
values could lead to misleading conclusions from a prediction model.  
Hence, the final set of predictors matching the UK dataset consisted of just 
eight predictors.  
 Meanwhile, the other sets of predictors that were drawn from each of 
the seven ACS models were represented by the names of the ACS models, 
i.e. AMIS, EMMACE, C-ACS, GRACE, PURSUIT, GUSTO-I, and Serbia. 
 As described in Section 5.1.1, in order to handle missing values, only 
complete cases were considered for model development.  Thus, all the 
incomplete cases were removed, and the final sample size for model 
development of each input datasets is illustrated in Figure 10. 
 
Figure 10: Sample size for model development for evaluating predictors of 
existing ACS models
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5.2.4 Evaluating Predictors of Existing ACS Models: The 
Prediction Models 
 The performance of models constructed with sets of predictors 
adapted from existing ACS models are presented in Tables 9 and 10.  Table 
9 represents the results of the Malaysian models, while Table 10 presents 
the results of the UK models. 
Table 9: The performance of Malaysian models adopting predictors from 
existing ACS models 
Models 
 
All_LR_MY AMIS_MY EMMACE_MY C-ACS_MY 
 
GRACE_MY PURSUIT _MY Serbia_MY 
BN 0.843 0.815 0.749 0.813 0.844 0.789 0.763 
NB 0.845 0.829 0.775 0.822 0.906 0.836 0.795 
LG 0.842 0.827 0.773 0.822 0.904 0.826 0.802 
MLP 0.767 0.792 0.771 0.814 0.890 0.811 0.793 
LWL 0.792 0.806 0.729 0.780 0.858 0.741 0.705 
DT 0.500 0.785 0.768 0.795 0.774 0.500 0.500 
DTNB 0.773 0.821 0.768 0.823 0.774 0.500 0.790 
PART 0.669 0.719 0.732 0.730 0.596 0.762 0.674 
ADT 0.807 0.811 0.757 0.794 0.789 0.787 0.773 
DS 0.647 0.593 0.611 0.603 0.684 0.696 0.645 
FT 0.606 0.827 0.500 0.822 0.902 0.500 0.802 
LT 0.811 0.832 0.783 0.824 0.823 0.804 0.774 
LMT 0.861 0.829 0.782 0.823 0.868 0.500 0.802 
NBT 0.768 0.815 0.749 0.813 0.846 0.789 0.763 
RF 0.821 0.806 0.737 0.778 0.828 0.790 0.775 
RT 0.563 0.568 0.542 0.574 0.644 0.549 0.607 
REPT 0.761 0.714 0.717 0.721 0.829 0.500 0.500 
The underlined values represent AUC>0.8; the blue-coloured values indicate the 
three best models; the grey-shaded attribute denotes the overall best model 
 
 In Table 9, All_LR_MY, AMIS_MY, EMMACE_MY, C-ACS_MY, 
GRACE_MY, PURSUIT_MY, and Serbia_MY represent models developed 
for the Malaysian dataset using predictors from a combination of nine ACS 
models, and predictors from each of AMIS, EMMACE, C-ACS, GRACE, 
PURSUIT, and Serbia models, respectively. 
 The overall results of Table 10for the Malaysian dataset indicate that 
the best AUC rate was achieved by adapting predictors from the GRACE 
model, in which three classification algorithms achieved AUC > 0.9, i.e., NB 
(AUC=0.906), LG (AUC=0.904), and FT (AUC=0.902).  AMIS_MY, C-
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ACS_MY, PURSUIT_MY, and Serbia_MY also produced fairly good AUC 
scores, for which at least the best three algorithms of each model achieved 
an AUC score >0.8.  Although EMMACE_MY seemed not to perform as well 
as the other models (AUC>0.8), it still obtained an AUC rate of >0.75 in 
several algorithms, such as NB (AUC=0.775), LT (AUC=0.783), and LMT 
(AUC=0.782). 
Table 10: The performance of the UK models adopting predictors from 
existing ACS models 
Models All_LR_UK AMIS_UK EMMACE_UK GRACE_UK PURSUIT_UK Serbia_UK 
BN 0.872 0.709 0.769 0.818 0.749 0.723 
NB 0.917 0.819 0.829 0.826 0.770 0.783 
LG 0.874 0.844 0.833 0.827 0.775 0.782 
MLP 0.855 0.816 0.819 0.810 0.771 0.787 
LWL 0.850 0.812 0.789 0.783 0.719 0.739 
DT 0.693 0.500 0.500 0.799 0.731 0.500 
DTNB 0.850 0.500 0.500 0.830 0.731 0.500 
PART 0.772 0.643 0.500 0.717 0.752 0.500 
ADT 0.799 0.713 0.793 0.786 0.752 0.736 
DS 0.690 0.718 0.700 0.606 0.611 0.689 
FT 0.902 0.500 0.500 0.827 0.549 0.500 
LT 0.836 0.818 0.804 0.831 0.783 0.735 
LMT 0.639 0.500 0.500 0.826 0.772 0.500 
NBT 0.870 0.709 0.769 0.818 0.749 0.752 
RF 0.840 0.779 0.769 0.782 0.751 0.704 
RT 0.656 0.558 0.535 0.571 0.571 0.621 
REPT 0.696 0.500 0.500 0.729 0.717 0.500 
The underlined values represent AUC>0.8; the blue-coloured values indicate the 
three best models; the grey-shaded attribute denotes the overall best model 
 
 In Table 10, All_LR_UK, AMIS_UK, EMMACE_UK, GRACE_UK, 
PURSUIT_UK, and Serbia_UK represent models developed for the UK 
dataset using predictors from a combination of nine ACS models, and 
predictors from each of AMIS, EMMACE, GRACE, PURSUIT, and Serbia 
models, respectively. 
 Table 10 presents results of the UK models.  All_LR_UK displayed 
outstanding results with two classifiers obtaining AUC>0.9.  In addition, 
another seven algorithms scored AUC>0.8 on All_LR_UK.  On the other 
hand, none of the algorithms obtained AUC>0.8 for PURSUIT_UK and 
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Serbia_UK.   Nevertheless, some of these algorithms on PURSUIT_UK and 
Serbia_UK did gain AUC >0.75.  All in all, a numbers of algorithms achieved 
AUC >0.8 on AMIS_UK, EMMACE_UK, and  GRACE_UK.  
 Furthermore, the performance of the models was then compared with 
the c-statistics of the existing ACS models.  Table 11 presents the 
comparison between the best models derived from this task and published c-
statistics/AUC of existing ACS models. 
Table 11: Comparison of predictive performance of the developed models 
and the existing ACS models 
Prediction Models Published C-Statistics/AUC Malaysian The UK 
AMIS 0.875 ( AODE) 0.832 (LT) 0.844 (LG) 
EMMACE 0.76(Multivariable logistic regression) 0.783 (LT) 0.833 (LG) 
C-ACS 0.75 (Multivariable logistic regression) 0.824 (LT) 0.833 (LG) 
GUSTO-I N/A (Logistic multiple regression) 0.824 (LT) 0.833 (LG) 
GRACE In-Hospital 0.83 (Multivariable logistic regression) 0.906 (NB) 0.831 (LT) 
PURSUIT 0.81 (death only) (Multivariable logistic 
regression) 
0.836 (NB) 0.783 (LT) 
Serbia 0.91 (ADT) 0.802 (LG) 0.787 (MLP) 
The underlined values represent the AUC of developed model and gained better 
performance than the existing model 
 
 Comparing the AUC results obtained from this exercise with those of 
the published c-statistics/AUC of the seven existing ACS models as 
demonstrates in Table 11, the models constructed in this study displayed 
better performance than most of the five existing ACS models developed 
with traditional LG.   In fact, almost half of the ML algorithms used in the 
study performed exceptionally better than the current models developed 
using traditional LG.  As such, the results suggest that ML algorithms 
possessed the ability to construct better ACS prediction models.  
Nevertheless, models developed by adapting predictors from the AMIS and 
Serbia models(AMIS_MY, AMIS_UK, Serbia_MY, and Serbia_UK )showed 
lower predictive power than the AUC of the original AMIS and Serbia 
models.  The AMIS and Serbia models were developed using ML algorithms, 
namely AODE and ADT, respectively. 
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 The best models for the Malaysian dataset were developed by 
adapting predictors from the GRACE model, while the UK dataset achieved 
better models by adopting predictors of the combination of nine existing ACS 
models (All_LR_UK).   To the contrary, employing EMMACE predictors 
resulted in the worst models for the UK dataset, as no algorithm achieved 
AUC>0.8.  A similar scenario was noted when adapting predictors of  the 
PURSUIT and Serbia models for the UK datasets. 
5.2.5 Evaluating Predictors of Different Clinical Categories: Sets 
of Predictors 
 Five subsets of predictors were extracted from five groups of 
combinations of clinical categories.  The groups were CATA1, CATA2, 
CATA3, CATA4, and CATA7.  The detailed predictors for each group are 
tabulated in Appendix C.1 Set of Predictors by Combination of Clinical 
Category. As illustrated in the table in Appendix C.1, the number of 
predictors grew as more predictors of different clinical categories were 
added.  For the Malaysian dataset, CATA1 had 19 predictors, CATA2 had 
34 predictors,  CATA3 had 43 predictors,  CATA4 had 54 predictors, and 
CATA5 had 60 predictors.  In terms of the UK dataset, CATA1 had 18 
predictors, CATA2 had 23 predictors,  CATA3 had 32 predictors,  CATA4 
had 37 predictors, and CATA5 had 40 predictors.  Excluding missing cases 
was not feasible as huge number of cases would need to have been 
removed.  Thus, in this particular case, the missing values were handled by 
the learned algorithm and no exclusion of instances was removed.  All of the 
instances allocated to the training set as reserved in the earlier chapter were 
used for constructing and evaluating the models for this particular case. A 
total of 9533 instances in the Malaysian dataset, and a total of 3793 
instances in the UK dataset were used to develop models with predictors of 
different clinical categories.   
 As described in Section 5.1.4, another set of predictors used in 
evaluating predictors of different clinical categories is represented by 
CATA7.  CATA7 was formed by filtering the predictors from each clinical 
category using the CFS method,  and combined all the filtered predictors of 
each clinical category. Table 12 presents the predictors of CATA7 for the 
Malaysian and UK datasets. 
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Table 12: Subsets of predictors for CATA7 
Malaysian The UK 
List of predictors Clinical Category List of predictors Clinical Category 
1)  yradmit Demographic 1) Age.At.Admission Demographic 
2) ptageatnotification Demographic 2)  X210.Cerebrovascular.Disease Medical history  
3) cpremcvd Medical history  3)  X212.Chronic.Renal.Failure Medical history  
4) cheartfail Medical history  4)  X213.Heart.Failure Medical history  
5) clung Medical history  5)  X217.Diabetes Medical history  
6) crenal Medical history  6)  X216.Smoking.Status Medical history  
7) heartrate Clinical presentation 7)  X204.Where.Aspirin.Given Medical history  
8) bpsys Clinical presentation 8)  X224.Beta.Blocker Medical received 
9) bpdias Clinical presentation 9)  X220.Systolic.BP Clinical presentation 
10)  ecgabnormtypetwave ECG 10)  X314.Where.cardiac.arrest Clinical presentation 
11)  ecgabnormtypebbb ECG 11)  X424.Reinfarction ECG 
12)  ecgabnormtypenonspecific ECG 12)  X203.ECG.Determining.Treatment ECG 
13)  ecgabnormlocational ECG 13) X337.Troponin.Assay Baseline investigations 
14)  ecgabnormlocationrv ECG    
15) ldlc Baseline investigations   
16) fbg Baseline investigations   
17) lvef Baseline investigations   
18) lmwhpre Medical received    
19) aceipre Medical received    
20) diureticpre Medical received    
21) antiarrpre Medical received       
The * denotes categorical predictors 
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 For the CATA7 group, only complete cases were considered for 
model development.  Therefore, all instances with missing values were 
removed, and the final sample size for model development is depicted in 
Figure 11. 
 
Figure 11: Sample size for model development for evaluating predictors from 
the CATA7 group 
 
5.2.6 Evaluating Predictors of Different Clinical Categories: The 
Prediction Models   
 Tables13and 14indicatethe performances of the models with 
predictors of different clinical categories for the Malaysian and UK datasets, 
respectively. 
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Table 13: The Malaysian models with predictors of different clinical 
categories 
Models CATA1_MY CATA2_MY CATA3_MY CATA4_MY CATA5_MY CATA7_MY 
BN 0.665 0.683 0.760 0.780 0.779 0.850 
NB 0.658 0.679 0.758 0.776 0.788 0.789 
LG 0.696 0.701 0.789 0.804 0.808 0.837 
MLP 0.599 0.606 0.758 0.762 0.798 0.647 
LWL 0.663 0.665 0.748 0.753 0.756 0.699 
DT 0.500 0.500 0.783 0.772 0.772 0.500 
DTNB 0.465 0.499 0.479 0.490 0.490 0.750 
PART 0.648 0.635 0.710 0.693 0.731 0.735 
ADT 0.647 0.658 0.795 0.795 0.807 0.801 
DS 0.618 0.618 0.680 0.680 0.680 0.677 
FT 0.500 0.500 0.642 0.690 0.723 0.834 
LT 0.668 0.662 0.735 0.740 0.740 0.743 
LMT 0.500 0.500 0.767 0.768 0.790 0.837 
NBT 0.655 0.675 0.654 0.628 0.798 0.569 
RF 0.618 0.650 0.750 0.774 0.799 0.803 
RT 0.598 0.594 0.678 0.640 0.720 0.515 
REPT 0.618 0.622 0.663 0.659 0.734 0.500 
The underlined values represent AUC>0.8; the blue-coloured values indicate the 
three best models; the grey-shaded attribute denotes the overall best model 
 
 In Table 13, CATA1_MY, CATA2_MY, CATA3_MY, CATA4_MY, 
CATA5_MY, and CATA5_MY represent models developed for the Malaysian 
dataset using the CATA1, CATA2, CATA3, CATA4, CATA5, and CATA7 
groups, respectively. 
 Observing the results of Table 13,the model performances of 
CATA1_MY and CATA2_MY were unsatisfactory. This indicate that the 
combination predictors from the demographic, status before events, and 
medication received before admission categories failed to produce good 
ACS models.  However, the performance of the models started to improve 
when predictors from the clinical presentation, ECG, and baseline 
investigation categories were included (i.e., CATA3_MY, CATA4_MY, and 
CATA5_MY). Nevertheless, only two algorithms managed to achieve 
AUC>0.8 in either CATA3_MY, CATA4_MY, or  CATA5_MY, which were LG 
and ADT.  In fact, the best three classification algorithms for CATA3_MY 
were LG, DT, and ADT with AUC scores of 0.789, 0.783, and 0.795, 
- 100 - 
respectively.  Following the results obtained from CATA3_MY, ADT and LG 
remained as two out of the three best algorithms for CATA4_MY and 
CATA5_MY.  Additionally, BN and RF emerged among the best three 
algorithms for CATA4_MY and CATA5_MY. 
 Meanwhile, overall better models (in most of the algorithms) were 
developed using predictors from CATA7 compared to CATA1_MY, 
CATA2_MY, CATA3_MY, CATA4_MY, and CATA5_MY. This might be due 
to applying the feature selection method, making the CATA7_MY simpler 
than the other models.  However, surprisingly, for several algorithms, such 
as DT, NBT, RT, and REPT, CATA7_MY displayed a sharp plunge in their 
performances to AUC values around 0.500; indicating nil discriminatory 
ability.  Nevertheless, other classification algorithms exhibited improvement, 
with six algorithms achieving AUC scores above 0.8.  All in all, the best 
algorithms were BN (AUC = 0.850), LG (AUC = 0.837), and LMT (AUC = 
0.837) for models with CATA7 predictors. 
Table 14: The UK models with predictors of different clinical categories 
Models CATA1_UK CATA2_UK CATA3_UK CATA4_UK CATA5_UK CATA7_UK 
BN 0.738 0.687 0.812 0.832 0.832 0.808 
NB 0.725 0.738 0.832 0.848 0.847 0.866 
LG 0.746 0.743 0.817 0.820 0.818 0.742 
MLP 0.637 0.762 0.804
*
 0.769 0.798 0.669 
LWL 0.709 0.724 0.693 0.696 0.670 0.741 
DT 0.500 0.500 0.668 0.664 0.664 0.598 
DTNB 0.448 0.500 0.672 0.786 0.774 0.595 
PART 0.700 0.500 0.812 0.798 0.804 0.810 
ADT 0.726 0.735 0.821 0.833 0.841 0.835 
DS 0.689 0.689 0.669 0.669 0.669 0.596 
FT 0.592 0.500 0.824 0.822 0.822 0.565 
LT 0.741 0.752 0.781 0.781 0.781 0.770 
LMT 0.500 0.500 0.824 0.830 0.830 0.888 
NBT 0.725 0.720 0.788 0.825 0.826 0.810 
RF 0.677 0.623 0.802 0.818 0.812 0.693 
RT 0.640 0.570 0.717 0.664 0.740 0.604 
REPT 0.725 0.500 0.676 0.762 0.762 0.548 
 The underlined values represent AUC>0.8; the blue-coloured values indicate 
the three best models; the grey-shaded attribute denotes the overall best 
model 
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 In Table 14, CATA1_UK, CATA2_UK, CATA3_UK, CATA4_UK, 
CATA5_UK,and CATA5_UK represent models developed for the UK dataset 
using the CATA1, CATA2, CATA3, CATA4, CATA5, CATA7 groups, 
respectively. 
 Similar to the results for the Malaysian dataset, the results for the UK 
models showed that CATA1_UKand CATA2_UK were the worst models 
when compared to CATA3_UK, CATA4_UK, and CATA5_UK.  Thus, again, 
suggesting that adding additional predictors, other than predictors of 
demographic, medical history, and medication received before admission 
categories, generally improved the performance of the prediction models.  
Beginning with the addition of predictors from the clinical investigation 
category (CATA3_UK), many algorithms achieved AUC > 0.8, such as BN, 
NB, LG, PART, ADT, FT, LMT, NBT, and RF.  In fact, NB and ADT 
appeared to be the best classification algorithms for CATA3_UK (NB=0.832, 
ADT = 0.821), CATA4_UK (NB=0.848, ADT = 0.833), and CATA5_UK 
(NB=0.847, ADT = 0.841).  Additionally, BN was also identified as the best 
classification algorithm for both CATA4_UK and CATA5_UK. 
 However, the performances displayed by DT, MLP, NBT, RT, and 
REPT dropped for CATA7_UK, which is similar to the scenario observed for 
the Malaysian dataset.   Nonetheless, the best algorithms for CATA7_UK, 
which were NB and LMT, demonstrated improvement in their performances 
from AUC=0.847 to  AUC=0.866, and AUC=0.830 to AUC=0.888, 
respectively. 
 In conclusion, the predictors forCATA1 and CATA2 failed in 
generating convincing AUC results.  In fact, the performances of the models 
began to improve upon inclusion of predictors from varying clinical 
categories.  Furthermore, the results suggest that selecting essential and 
relevant predictors was more substantial than having a simple model with 
meaningless predictors.  The inclusion of predictors solely from the 
demographic, medical history, and medication received before admission 
categories was proven to be insufficient in constructing good ACS models 
 Nevertheless, in CATA7, the number of predictors was reduced after 
filtering the predictors of each clinical category using a ML feature selection 
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method.  Hence, the CATA7 models had been expected to enhance the 
performance of CATA5 via reduction of features.  Although a drop was noted 
in the performances of the models developed on several algorithms, such as 
DT, MLP, NBT, RT, and REPT, most of the algorithms for both the 
Malaysian and UK datasets did show enhanced results, when compared to 
models with CATA5.  Overall, the UK models exhibited more predictive 
scores than the Malaysian models. 
5.2.7 Classification Algorithms on Feature Selection 
 This section presents the model performance of classification 
algorithms for the three main tasks in this chapter.  A total of 16 input 
datasets were used to construct the three tasks using 17 ML algorithms. 
Note that models that achieved AUC>0.8 were assumed to be good.  Thus, 
to reflect the best algorithms for model development, the frequency of each 
algorithm that achieved AUC>0.8 is depicted in Figure 12.  
 
 
Figure 12: Frequency of classification algorithms producing good prediction 
models 
 
 Figure 12 presents the frequency of good models (AUC>0.8) by 
algorithm for the Malaysian and UK datasets.  In total,  79 UK models 
attained an AUC> 0.8 compared to 56 Malaysian models.  The three best 
algorithms for the UK models, based on the frequency of obtaining AUC>0.8, 
were NB, LG, and LMT.  In addition, NB, LG, and LMT also emerged as the 
three best algorithms for the Malaysian models, despite the variability in 
frequency.  Furthermore, DT, DS, RT, and REPT appeared to be unsuitable 
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 From another stance, the performance of ML algorithms was further 
scrutinized from the best models constructed from the three main tasks of 
this chapter.  Table 15 summarizes three best models constructed for the 
three main tasks. 
Table 15: The best models for evaluating ML feature selection method, 
evaluating predictors of existing ACS models and evaluating predictors 
of different clinical categories 
Task Methods Malaysian The UK Comparisons 
Evaluating ML feature 
selection method 
CFS LMT (0.802) LMT (0.868)  
 LG (0.801)    LG  (0.869)    
  NB (0.794)   NB (0.889)     
Evaluating predictors of 
existing ACS models 
GRACE NB (0.906)    0.826 (UK) 
 LG  (0.904)   0.827 (UK) 
  FT   (0.902)     0.827(UK) 
All_LR  NB (0.917)    0.845 (Malaysia) 
  FT (0.902)    0.606(Malaysia) 
    LG (0.874)   0.842(Malaysia) 
Evaluating predictors of 
different category 
CATA7 LMT (0.837) LMT (0.888)   
 BN (0.850)  0.808 (UK) 
 LG (0.837)    0.742 (UK) 
  NB (0.866)  0.789 (Malaysia) 
    ADT (0.835) 0.801 (Malaysia) 
 
 As illustrated in Table 15, in evaluating ML feature selection methods 
for both the Malaysian and UK datasets, the best models were constructed 
by applying the CFS method using the LMT, LG, and NB algorithms. 
 On evaluating predictors of existing ACS models, the best models 
developed for the UK dataset were found when adapting a combination of 
nine ACS models (All_LR), while the best models developed for the 
Malaysian dataset adapted predictors of GRACE models.  Although the 
Malaysian and UK datasets revealed their best models from different sets of 
predictors, predictors of All_LR and GRACE were able to produce good 
models with the same ML algorithms, i.e., NB, LG and FT, with the exception 
of the FT algorithm on the Malaysian All_LR model. 
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 Furthermore, on evaluating the effect of predictors of different clinical 
categories, the best models for the Malaysian and UK datasets were 
produced when predictors from the CATA7 group were used.  The 
algorithms used to develop the Malaysian models were the LMT,BN, and LG 
algorithms, while the LMT, NB and ADT algorithms were used for the UK 
models. 
5.3. Discussion 
 In this chapter, various ML feature selection methods were evaluated 
in order to produce better models.  ML feature selection methods extract a 
set of predictors based on the patterns discovered (learning process of a 
machine) in a modelled dataset in order to simplified the model and gain 
good predictive power.  The study also evaluated the potency of producing 
models by adapting predictors of existing ACS models using ML algorithms.  
Moreover, the effects of predictors from different clinical categories in 
constructing good models were also assessed. 
 Among the evaluated ML feature selection methods, the results 
suggest that CFS as the best method to identify the best set of predictors for 
both the Malaysian and UK datasets. Nevertheless, no clear conclusion 
could be made regarding the subset method being better than the wrapper 
method, mainly because the UK models displayed better discriminative 
ability when using the wrapper methods, as compared to the FilterSubset 
method.  Meanwhile, the results for the Malaysian dataset support the 
findings from the study by Hall (2000), i.e. the filter(which includes the 
subset and filter method) methods performed better than the wrapper 
methods.  Unfortunately, the results proved otherwise for the UK models.  
Nevertheless, this study has demonstrated that models developed based on 
sets of predictors selected by the ML algorithm possess competitive 
discriminative ability upon a number of classification algorithms.  For 
example, among our best models, i.e., model developed based on the UK 
datasets, using sets of predictors identified by CFS method (CFS_UK), 
which were developed using NB, LG, MLP, FT, and LMT had better 
predictive power than TIMI, PURSUIT, GRACE, EMMACE, SRI, and C-
ACS(Antman et al., 2000, Dorsch et al., 2001, Morrow et al., 2001, Huynh et 
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al., 2013, Boersma et al., 2000, Granger et al., 2003).  This study has also 
demonstrated the potential of the ML feature selection method as an 
alternative way of selecting predictors for model development. In traditional 
statistical modelling, potential predictors are commonly pre-selected by 
considering clinical reasoning, reviewing the literature on existing models or 
known risk factors, and opinions from experts(Han et al., 2016). In addition, 
most of the predictors extracted from executing ML feature selection 
methods were also among the predictors of the existing ACS models, such 
as TIMI, GRACE, and PURSUIT, indicating that ML feature selection 
outcomes are consistent with the outcomes from traditional statistical 
modelling. 
 Overall, the results showed that most ML algorithms successfully 
achieved AUC>0.8 when adopting predictors from existing ACS models.  
Although both the Malaysian and UK datasets were inclined towards varied 
sets of predictors, the results indicate that the predictors of existing ACS 
models were indeed important predictors for the study‘s datasets, and, most 
probably, for ACS mortality models, in general.  For Malaysian dataset, the 
best models was constructed adopting predictors from GRACE model 
(GRACE_MY) and for the UK dataset, the best models were constructed 
adopting predictors from a combination of predictors from 9 ACS models.  
Additionally, the models developed using ML algorithms displayed enhanced 
discriminatory ability when compared to those developed using traditional 
statistical methods. In fact, the best models constructed for the Malaysian 
and UK datasets(GRACE_MY and All_LR_UK)achieved competitively better 
predictive power in comparison to all the 11 reviewed ACS prediction 
models.  As such, this study has established important supporting evidence 
of the use of ML algorithm in clinical prediction modelling. 
 Nevertheless, both the Malaysian and UK models adopting predictors 
of AMIS and Serbia models (AMIS_MY, AMIS_UK, SERBIA_MY and 
SERBIA_UK) failed to achieved  better AUC value when compared one to 
one to the AMIS and Serbia model.  Although the best models did achieve 
AUC > 0.8, the scores were still below the published AUCs of AMIS and 
Serbia models.  AMIS model recorded an AUC of 0.875 on the AODE 
algorithm.  AODE algorithm was not evaluated in this research as AODE 
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only accepts categorical attributes(thus suggesting a loss of information 
when dichotomizing continuous attributes, as mentioned previously).  
Additionally, the "pre-hospital cardiopulmonary resuscitation" attribute, an 
attribute in the AMIS model, was unavailable for the datasets employed in 
this study (Kurz et al., 2009).  
 On the other hand, the Serbia model recorded an AUC score of 0.91 
using the ADT algorithm.  The cohorts used for the Serbia model originated 
from ACS patients who had undergone PCI, which reflected cohorts of 
STEMI patients.  Hence, the information in the predictors might not refer to 
the first entry for an event, which was applied as a criterion in this study‘s 
dataset.  In fact, this study considered all ACS patients, including those 
diagnosed with NSTEMI and UA, in addition to STEMI. Furthermore, 
troponin was excluded as a predictor due to the quality issue for this 
predictor in our datasets.  Biomarkers, such as troponin, are considered one 
of the essential predictors for ACS models(Khan et al., 2009, Granger et al., 
2003).  Other than that, the Serbia model applied cost sensitive learner to 
boost the predictive power of the ADT algorithm.   These could be possible 
reasons for the notable differences in the AUC score obtained by the models 
developed in this study, in comparison to the Serbia model.  
 Furthermore, selecting potential predictors based on clinical category, 
which was also implemented by GUSTO-I(Steyerberg, 2009),highlighted that 
selecting predictors based solely on demographic and patients' history 
categories is insufficient in terms of producing a good prediction model.  The 
performance of the model was enhanced after predictors from the clinical 
investigation, ECG, and baseline investigation categories were embedded in 
the model as predictors.  This implies that most of the important predictors 
for an ACS prediction model come from a combination of the clinical 
investigation, ECG, and baseline investigation categories.  Therefore, in 
order to construct a good ACS prediction model, the set of predictors must, 
at least, include predictors from the clinical investigation and ECG 
categories, in addition to the demographic and patient's medical history 
categories.  Besides, the sets of predictors for the nine ACS models 
reviewed in this study were also stretched into a similar combination of 
clinical categories. Furthermore, by applying a feature selection method, i.e. 
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CFS, on these combinations of clinical categories,  better AUC results were 
attained (CATA7).  The model with CFS illustrated a simpler structure with 
less computational cost. 
 Nonetheless, predictors from the history of medication received by a 
patient category  did not enhance the performance of the ACS prediction 
model.  This was demonstrated by reconstructing models using theCATA3, 
CATA4, and CATA5 groups, but excluding the predictors from history of 
medication received by patient category.  To be precise, better models were 
built without predictors from this category.  Moreover, predictors under this 
category were rarely selected by most of the evaluated feature selection 
methods (refer Table 6).  This outcome from the feature selection methods 
indicates additional supporting evidence that the predictors from the history 
of medication received by a patient category are not important for the ACS 
prediction model. 
 As concluded by Ali and Smith(2006),Tomar and Agarwal (2013),and 
Harper (2005),no specific classifier appeared to be best for all datasets.  
However, the findings obtained from this study suggest that a similar 
domain, i.e., ACS, with a similar target outcome and similar target ACS 
patients characteristics (e.g., first entry of ACS patients and all ACS types) 
may lead to the same best classification algorithms for the datasets. 
Perhaps the datasets with characteristics similar to the studied datasets 
would also attain the same best algorithms with which to construct a 
prediction model. Findings from the STATLOG studies, the largest algorithm 
comparison studies on a large number of different types of datasets, also 
concluded that the best algorithm to use mainly depends on the type of 
dataset being used(King et al., 1995).As such, this study concluded that 
LMT, BN, LG, NB, and ADT emerged as useful algorithms for the datasets, 
although slight variations were noted in the actual value of the predictive 
power (AUC).  ADT was also found to be the best algorithm with which to 
construct ACS models for patients submitted for PCI (Sladojević et al., 
2015). Nevertheless, DT, DS, RT, and REPT need to be added to the list 
algorithm found to be unsuitable in the previous chapter, which were VP, 
CR, Ridor, ZR, SVM, JRip, OneR, BFT, j48, SC, and KNN. 
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 Finally, the three best models from each of the three main tasks of this 
chapter have been established.  Although, the sample sizes for model 
development were reduced tremendously (approximately, on average, 
between 40-50% of the total baseline set for both datasets) due to missing 
values, we believe they are still sufficient to build reliable predictors.  
According to Mukherjee et al. (2003), for the ML classification problem, the 
minimum training size for model development in the treatment outcome 
problem is more than 50 samples.  Besides, some well-developed and ACS 
models were also created from small sample sizes, such as the TIMI 
(n=1957) and EMMACE (n=3684) models, and and some of the latest ACS 
models, for instance, the C-ACS (n=4627), Serbia (n=2030), and MACE 
(n=2930) models.  Furthermore, the best models established in this chapter 
have fewer predictors than the baseline models developed in Section 4.5.2.  
Since the dimensionality of the dataset has been reduced, the reduction in 
training sample size may not affect the outcome of the developed model. 
5.4. Conclusion 
 ML feature selection has demonstrated its potential for identifying 
potential predictors for ACS prediction models and eventually constructing a 
competitive model.  Comparing the subset and wrapper feature selection 
methods, the CFS method of subset feature selection emerged as the best 
method with which to determine the best set of predictors for the datasets.  
However, findings from the study are insufficient to conclude that the overall 
subset feature selection method is better than the wrapper feature selection 
method.  In developing good ACS predictors, a combination of predictors 
should embed information, at least, from predictors in the demographic, 
patient medical history, clinical presentation, and ECG categories.  In fact, 
predictors from only the demographic and patient medical history categories 
were proven to be insufficient for building competitive ACS prediction 
models.  Furthermore, predictors from the medication received by patients 
category were found to be not important and had very little impact in terms of 
enhancing the performance of ACS models 
 Overall, this chapter has identified the most outstanding algorithms to 
be LMT, BN, LG, NB, and ADT for both datasets.  And, the best sets of 
- 109 - 
predictors to construct ACS models from Malaysian dataset are : 1) age, 
heart rate, SBP, DBP, ECG Abnormalities - T-Wave inversion, and Lvef  2) 
age, heart rate, SBP, killip class, ACS symptoms before admission 3) age, 
history of premature CVD, history of heart failure, history of lung disease, 
history of renal failure, heart rate, SBP, DBP, ECG Abnormalities - T-Wave 
inversion, ECG Abnormalities - BBB, ECG Abnormalities - Non specific, 
ECG Abnormalities Location - Anterior Leads : V1 and V4, ECG 
Abnormalities Location - Right Ventricle : ST Elevation in Lead V4R, Low-
density lipoprotein cholesterol(LDL-C), FBG, Lvef, Low molecular weight 
heparin (LMWH) taken, Angiotensin converting enzyme (ACE)inhibitors 
taken, diuretics taken, and anti-arrhythmic taken.  As for the UK dataset, the 
best sets of predictors to construct ACS models are: 1) age, BB, SBP, 
cardiac arrest, and reinfarction2) age, gender, history of heart failure, on 
aspirin status, SBP, heart rate, cardiac arrest, ST-segment deviation of ECG  
3) age, history of cerebrovascular disease, history of chronic renal failure, 
history of heart failure, diabetics, smoking status, aspirin status, BB, SBP, 
cardiac arrest, reinfarction, ECG, and tropinin assay.   
 Hence, the best models identified in this chapter were further 
validated and evaluated.   
- 110 - 
Chapter 6:  Misclassification Analysis 
This chapter presents the analyses performed for misclassification instances 
upon the 15 Malaysian and 15 UK models developed in Chapter 5.  The 
objectives of this chapter are to explain the evaluation performed on the 
misclassified instances of these models to determine the reasons for 
misclassification.  Furthermore, a prediction model developed to predict the 
misclassified instances will be presented. 
6.1. Background 
 Performance measurements, such as accuracy, f-measures, 
precision, recall, and the AUC of classifiers, generally focus on the average 
or the overall performance of the constructed model.   However, no 
information is given on misclassified instances and the reasons for 
misclassification.  Misclassification instances generally occur due to 'bad' or 
'noisy' data and/or attributes.  'Bad' data or 'noise,' on the other hand, is 
defined as the factor of confusion in building classification models, a factor 
which could negatively affect accuracy.   Therefore, 'noisy' data or attributes 
must be reduced or eliminated so as to ensure the reliability of the model.  
As such, feature reduction is responsible for reducing 'noise'  at the attribute 
level.  At the instances level, 'noise' can be found mainly in the form of 
outliers (Seiffert et al., 2014) and overlapping classes(Smith, 2009, 
Stefanowski, 2013).  In addition, the performance of a model may also be 
affected due to a skewed dataset (Visa and Ralescu, 2005), as well as the 
existence of small disjoints within a dataset (Jo and Japkowicz, 2004, Weiss, 
2010).  Hence, these are some factors that could contribute to 
misclassification in developing a model. 
 Moreover, upon understanding the reason behind the misclassified 
instances in a specific dataset, appropriate measures can be customised to 
handle a specific problem in a  dataset.  As noted by Smith and Martinez 
(2011), the identification of outliers is rather difficult as there are no generic 
definitions and characteristics of outliers. Thus, this study sought to 
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understand the reasons of misclassification in working with ACS datasets.  
Additionally, this study also explored the predictors derived from ACS 
datasets that contributed to misclassified instances while building the model.   
Predictors  that contributed to misclassified instances for both the Malaysian 
and UK models were identified and used to develop models to predict 
misclassified instances for the datasets. 
 A number of studies have looked into identifying misclassified 
instances from a specific stance of misclassification. Specific to a breast 
cancer dataset, Thongkam et al. (2008)proposed a C-Support Vector 
Classification Filter (C-SVCF) to identify and remove the misclassified 
instances so as to improve model performance.   The study used  C-Support 
Vector Classification (C-SVC) with a radial basis kernel function to identify 
and eliminate outliers.  In comparison to several of ensemble filter methods, 
such as  AdaBoost, Bagging, and SVM ensembles, models using the C-
SVCF method achieved better performance.  In addition, Khoshgoftaar et al. 
(2004)presented a rule-based detection method using Boolean rules 
generated from the measurement data in detecting noisy instances. Earlier, 
Brodley and Friedl(1996) employed ensembles algorithms functioning as a 
filtering mechanism to eliminate misclassified instances of training data 
before actual model development.   Furthermore, Smith (2009)investigated 
misclassified instances in a broader perspective.  Their work analysed 
190,000 instances from 64 datasets developed on nine different 
classification algorithms and concluded that five properties of instances were 
mostly likely to be misclassified.  Moreover, class overlap appeared to be the 
main factor in instances of misclassification. This present research, on the 
other hand, focused on analysing misclassified instances only for ACS 
datasets, but from two varied populations.  This is because understanding 
the clinical characteristics of misclassified instances could shed light on 
automation bias in an ACS clinical DSS.  Eventually, this could further lead 
to the development of rule-based algorithms for DSS to reduce automation 
bias.  
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6.2. Method 
6.2.1 Misclassification Analysis 
 The misclassification analysis was performed upon instances 
extracted from three Malaysian models and three UK models constructed on 
the five best algorithms, which were NB, BN, LG, ADT, and LMT.  The three 
models employed were: 1) baseline models with missing values and outliers, 
2) models developed based on a combination of predictors from 9 selected 
existing ACS models(All_LR),  and 3) models developed based on predictors 
extracted from CFS method (CFS).  These models were retrieved from 
Chapters 4 and 5.  Note that the ALL_LR and CFS models were models 
developed based on datasets that are subsets of the baseline datasets. 
 Next, the identified misclassified instances were categorized as: 1) 
misclassified by > 3 algorithms, 2) misclassified by <3 algorithms, and 3) no 
misclassification by all the algorithms.  Furthermore, the focus of the 
evaluation relied on the instances that were misclassified by at least half of 
the five algorithms.   Therefore, from here on, in order to simplify the terms 
used,  the notion "misclassified instances" or "misclassified cases" refers to 
instances misclassified by at least three algorithms.  Furthermore, this study 
focused on the analysis of misclassified instances in minority classes, 
overlapping classes, outliers, and missing values.  Hence, the frequency of 
misclassified instances against the five algorithms has been recorded. 
 A minority class refers to instances found in the smallest class of an 
imbalance or skewed dataset.  In a classification task, a  skewed dataset 
turns into an issue when the target class becomes the minority class.  As 
such, a tendency to miscalculate the rate of accuracy is present as many 
classifiers only predict the majority class accurately, not the minority class. 
 On the other hand, an overlapping class reflects instances similar to 
those in another class.  These instances were detected by using the 
simplest and widely used clustering method, the K-Means algorithm (using 
Euclidean distance)(Zhang et al., 2008b).  The K-Means algorithm uses 
unsupervised learning, in which it partitions the datasets into k clusters by 
defining the cluster centre or mean (k-centroid) of each cluster.  Thus, an 
initial k-centroid point is identified in the space of dataset objects.  Next, 
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each object in the dataset is grouped based on the closeness of the object to 
a k-centroid point, which is calculated using Euclidean distance.  After that, 
the positions of the k-centroids are recalculated, and the objects of the 
dataset are reassigned until the k-centroid points remain the same. In 
WEKA, the algorithm is called SimpleKMeans.  Hence, to identify overlapped 
instances in the datasets, the instances were clustered based on the classes 
of the datasets. 
 Outliers in the studied context refer to values that were out of range of 
the specified range defined for an attribute.   
 The predictors of the models were also analysed to identify the 
patterns that indicate if a particular predictor could contribute to misclassified 
instances.  The mean of the numerical values or the percentage of  the 
categorical values of each predictor of misclassified instances were 
evaluated and compare against positive instances (died), negative instances 
(discharged), and overlapped misclassified instances.  In addition, the 
missing values of the predictors of misclassified instances were also 
analysed. 
6.2.2 Prediction Models for Misclassified Instances 
 The findings from analysing the predictors of misclassified instances 
turned into potential predictors that could have contributed to predict 
misclassified instances.  These potential predictors were used to construct 
models so as to predict the misclassified instances.  With that, the outcomes 
of the models were: 1) misclassified by > 3 algorithms, 2) misclassified by <3 
algorithms, and 3) no misclassification by all algorithms.  In fact, the 
predictors were obtained from the result of analysing predictors of 
misclassified instances. Furthermore, the models were built by using the five 
best algorithms identified in the previous chapters, which were BN, NB, LG, 
ADT, and LMT.  However, ADT was dropped from the model development 
process as ADT could only accept problems with two classes.  Next, the 
models were measured by using AUC and validated by using external 
datasets (the model developed using the Malaysian dataset was tested on 
the UK dataset and vice versa). 
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6.3. Results 
6.3.1 Overall Misclassification Analysis 
 As illustrated in Figure 13, on average, the total misclassified 
instances were 6.5% for the Malaysian datasetand3% for the UK dataset.  
Hence, the UK models exhibited better overall discrimination power (results 
from Chapters 4 and 5) when compared to the Malaysian models.  The 
following explains the variability in percentage of misclassified instances 
between these 2 datasets.  
 
 
Figure 13: Percentages of Misclassified Instances - Malaysian Vs UK 
models 
 
 In Figure 13, a majority of the same misclassified instances in the 
baseline models had been observed across All_LR and CFS models.  In 
addition, recall, ALL_LR, and CFS are models developed based on dataset 
that is subsets of the baseline dataset.  Thus, for the Malaysian models, 
81.3% of ALL_LR misclassified instances were also found to be 
misclassified in the baseline model, while 95.6% of ALL_LR misclassified 
instances were also misclassified in the CFS model.  Furthermore, 81.7% of 
CFS misclassified instances were also misclassified in the baseline model.  
On the other hand, for the UK models, 69.4% of ALL_LR misclassified 
instances were misclassified in the baseline model, whereas 86.1% of the 
misclassified instances were also misclassified in the CFS model.  
Additionally, 64.1% of CFS misclassified instances were misclassified in the 
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baseline model, while 88.6% of CFS misclassified instances were also 
misclassified in the ALL_LR model. 
6.3.2 Misclassification of Minority Classes 
 The results obtained for misclassification instances were further 
investigated by classes.  The results indicate that the misclassified instances 
for both datasets leant towards the minority class (died).  Furthermore, more 
than 85% of the misclassified instances lay on the minority class for both the 
Malaysian and UK models.  Table 16 presents the details of misclassified 
instances by classes for the evaluated datasets. 
Table 16 : Percentages of misclassified instances by classes 
  Malaysia UK 
  Died Discharged Died Discharged 

















































MI signifies misclassified instances 
 
6.3.3 Misclassification on Overlapping 
 Overlapping instances were identified after executing the K-Means 
upon the datasets.  Figure 14illustrates the overlapping percentage for each 
model.  .   
 
Figure 14: Percentage of Overlapping Instances 
- 116 - 
The percentages of overlapping instances for both the Malaysian and UK 
baseline models were similar as presented in Figure 14.  In fact, changes in 
the overlapping percentage were observed for All_LR and CFS models, 
most likely due to the various combinations of predictors for All_LR and 
CFS, thus resulting in varied overlapping instances.  For instance, 39.1% of 
the instances were overlapped in All_LR, while 24.5% of instances were 
found to overlap in CFS of Malaysian models.  In addition, extreme variability 
in overlapped instances was observed in All_LR (0%) and CFS (49.3%) of 
the UK models.  The detailed distribution of overlapping instances by 
classes is shown in Table 17.  Furthermore, Table 18portrays the 
overlapping instances that were misclassified (O-Misclassified).  From here 
on, to simplify, O-Misclassified is referred to overlapping instances that were 
misclassified.  
Table 17: Overlapping instances by classes 
 Malaysia UK 
 Died Discharged Total Died Discharged Total 
Baseline 335 (5.0%) 1921 (28.8%) 2256 (33.8%) 78 (2.9%) 905 (33.6%) 983 (36.5%) 
All_LR 89 (3%) 1002 (35.6.) 1091 (39.1%) 0 0 0 
CFS 168 (5%) 681 (19.7) 849 (24.5%) 25 (1.8%) 677 (47.5%) 702 (49.3) 
 
Table 18: Overlapping instances that were misclassifiedby classes 
 Malaysian The UK 
 Died  Discharge Died  Discharge 
Baseline 276 (4.1%) 15 (0.2%) 41 (1.5%) 4 (0.1%) 
All_LR 86 (3.1%) 2 (0.1%) NA NA 
CFS 160 (4.6%) 2 (0.1%) 15 (1.1%) 2 (0.1%) 
 
Although the percentages of overlapping instances varied in each model 
(Figure 14), for the three Malaysian models and two UK models (dismissing 
ALL_LR for the UK dataset),the percentages of O-Misclassified in each class 
were similar, as illustrated in Table 18.  For the Malaysian models, an 
average of 4% of O-Misclassified reflected cases that involved 'Died,' while 
0.1% of O-Misclassified were on 'Discharged' cases. Meanwhile, for the UK 
models (excluding All_LR), the average percentage of O-Misclassified was 
1.3% in 'Died' cases, whereas it was 0.1% for 'Discharged' cases. 
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 From a different light, by comparing the percentages of overlapping 
instances that were misclassified (Table 18) with the total misclassified 
instances (Table 16), for the Malaysian models, more than half of the 
misclassified instances were found to be overlapped, i.e., Baseline - 65%, 
ALL_LR - 53%, and CFS - 80%. For the UK models, the number of 
misclassified instances that overlapped fluctuated between various models, 
for example, Baseline - 63%, ALL_LR - 0%, and CFS -30%.  Nevertheless, 
in Malaysia and the UK models, more than 60% of overlapped instances in 
the minority class were misclassified.  In conclusion, the results suggest that 
overlapping in the minority class contribute to misclassified instances.  In 
fact, the overlapping instances in the minority class may indeed  be the 
underlying cause of misclassification in the minority class. 
6.3.4 Misclassification on Outliers 
 Outliers were only found in the baseline UK dataset. Table 19 
presents results of outliers versus misclassified instances. 
Table 19: Outlier instances that were misclassified and distributed by 
classes 
 UK 
 Died Discharged Total 
Overall Outliers 3 (0.1%) 30 (1.1%) 33 (1.2%) 
Outliers -Misclassified 1 (0.0%) 0 (0%) 1 (0.0%) 
 
The percentages of outliers were subtle (1.2% of the total dataset).  Thus, 
the results suggestthat outliers did not contribute to misclassified instances, 
as only 3% of the total outliers were found to be misclassified.   
6.3.5 Misclassification on Missing Values 
 Missing values were only available in the baseline models.  Referring 
to Table 16, the comparison of percentages between misclassified instances 
in models with missing values (baseline) and models without missing values 
(All_LR and CFS) showed no obvious variability.  Thus, from a higher level 
of observation, there is no obvious indication suggesting missing values as a 
main factor in misclassified instances.  
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6.3.6 Clinical Predictors on Misclassified Instances 
 This section illustrates the findings obtained from analysing the 
predictors of datasets against positive and negative instances, misclassified 
instances, and O-Misclassified.  The missing values of each analysed group 
were also observed.  Table 20 tabulates several selected key predictors of 
the models that highlight some essential patterns indicating the predictors 
that contributed to misclassified instances.  
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Table 20: Key predictors indicating potential in contributing to misclassified instances 
Characteristics Malaysia The UK 
Died  Discharge Misclassified O-Misclassified Died  Discharge Misclassified O-Misclassified 









































































































































































NA NA NA NA 
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Values are number (%) or mean (standard deviation) [% of missing values] 
The red-coloured values  represent the value of predictors for misclassified or O-Misclassified cases that have the same pattern as the 
minority cases; the blue-coloured values  denote the values of predictors for misclassified or O-Misclassified cases that have 
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From earlier findings, misclassified instances were found mostly in the 
minority class.  Therefore, the distribution of predictors of misclassified 
instances was also geared towards the minority class.  In addition, most of 
the O-Misclassified instances also seemed to follow the same pattern. 
Higher percentages of missing values were discovered in the O-
Misclassified instances, as presented in Table 20 (refer to column O-
Misclassified with the blue-coloured values ).  Although no obvious  
differences were found in the percentages of misclassified instances 
between the models with missing values and those without missing values, 
as concluded earlier,  noticeably higher percentages of missing values in O-
Misclassified hinted at the effect of missing values upon misclassified 
instances. 
 In addition, Table 21 lists all the predictors that indicated patterns 
suggesting a contribution to misclassified instances among the evaluated 
models.  As such, they appeared to be potential predictors for constructing 
models meant to estimate misclassified instances.  Twenty-four  and 18 
predictors were determined from the Malaysian and UK models, 
respectively.  Furthermore, the blue-coloured predictors denote generic 
predictors for both the Malaysian and UK datasets. 
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Table 21: Potential predictors for predicting misclassified instances for the 
ACS dataset 




Diastolic BP Heart rate* 
Heart rate* History of MI* 
History of MI* History of heart failure* 
History of cerebrovascular* History of cerebrovascular* 
History of heart failure* History of renal failure* 
History of diabetics* History of hypertension 
History of lung disease History of diabetics* 
Aspirin taken*  Aspirin taken* 
Smoking status* Current smoker* 
BB taken* BB taken* 
Low molecular weight heparin taken Statin taken 
ACE Inhibitors taken ECG - ST Depression* 
Diuretic taken  ECG - BBB* 
ECG - ST elevation Level 1 Cardiac arrest before admission 
ECG - ST elevation Level 2 Reinfarction 
ECG - ST Depression*   
ECG - T-Wave   
ECG - BBB*   
FBG   
Lvef   
The asterisked(*) predictors denote the generic predictors for both the Malaysian 
and UK datasets 
 
6.3.7 Model to Predict Misclassified Instances 
 The potential predictors listed in Table 21 were first fed into the CFS 
feature selection method in WEKA.  The set of predictors that were fed into 
WEKA were identified from: 1) all attributes listed in Table 21 for each of the 
Malaysian dataset (referred as MY_CFS) and the UK datasets (referred as 
UK_CFS),as well as 2) all common attributes of the Malaysian (referred as 
MY_C_CFS) and the UK datasets (referred as UK_C_CFS) listed in Table 
21. The results obtained upon performing the CFS feature selection method 
are presented in Table 22. 
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Table 22: Sets of important features that predicted the misclassified 
instances 
MY_CFS MY_C_CFS UK_CFS UK_C_CFS 
(8 attributes) (5 attributes) (5 attributes) (11 attributes) 
Age Age Age Age 
History of lung 
disease 
History of heart 
failure 
Gender Gender 
Heart rate  SBP History of MI History of MI 




ECG - BBB Death in hospital History of renal failure History of renal failure 
FBG  History of heart failure History of heart failure 
Lvef  History of diabetics History of diabetics 
Death in hospital  Smoking status Smoking status 
   Aspirin taken  Aspirin taken  
   BB taken BB taken 
   Statin taken Death in hospital 
   Reinfarction   
   ECG - ST Depression   
   ECG - BBB   
    Death in hospital   
 
Additionally, an additional predictor was embedded in  each set of predictors 
identified, which was overlapped, indicating if the instance was indeed 
overlapped or otherwise.  Furthermore, the models were constructed based 
on sets of predictors listed in Table 22.As a result, the related AUC scores of 
the models are presented in Table 23. 
In Table 23, MY_CFS and UK_CFS represent models developed for the 
Malaysian and the UK dataset to predict misclassified instances, 
respectively.  And, MY_C_CFS and MY_C_CFS represent models 
developed for the Malaysian and the UK dataset to predict misclassified 
instances using the common attributes of the two datasets, respectively.  All 
the models were internally validated.  On top of that, MY_C_CFS and 
UK_C_CFS were validated on external datasets.  
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Table 23: Performance of models to predict misclassified instance models 
  Malaysia UK 












BN 0.94 0.907 0.709 0.853 0.845 0.793 
NB 0.953 0.911 0.714 0.859 0.849 0.782 
LG 0.939 0.888 0.755 0.864 0.861 0.804 
LMT 0.94 0.886 0.742 0.863 0.861 0.816 
The blue-coloured values denote the best models 
 
 Referring to Table 23, NB (AUC=0.953 and AUC=0.911) emerged as 
the best algorithm for predicting misclassified instances for the Malaysian 
dataset, while LG (AUC=0.864 and AUC=0.861) appeared to be the best 
algorithm for the UK dataset. Meanwhile, both MY_CFS and UK_CFS were 
revealed as the best models for predicting misclassified instances for each 
dataset.  Nevertheless, when the models were built based on common 
predictors (MY_C_CFS and UK_C_CFS ), their performances displayed a 
slight drop.  Moreover, their performances continued to plunge when they 
were validated on external datasets. Overall, the models developed using 
the Malaysian dataset (MY_CFS and MY_C_CFS) obtained higher AUC 
scores compared to those developed using the UK dataset (UK_CFS and 
UK_C_CFS).  Nonetheless, when tested on an external dataset, UK_C_CFS 
outperformed MY_C_CFS.  Therefore, this study concluded that the best 
model for predicting misclassified instances for both the Malaysian and UK 
datasets was the UK_C_CFS, which was developed by using the LMT 
algorithm. 
6.4. Discussion and Conclusion 
 This chapter concludes that misclassification in the ACS datasets was 
mainly due to an imbalanced dataset, in which most of the misclassified 
instances were derived from the minority class.  In fact, this finding is in line 
with that obtained by Van Hulse et al.(2007), but differed from the results of 
Smith (2009),as his study discovered overlapping to be the main contributor 
to misclassified instances.  Nevertheless, our study found that the 
overlapping instances in the minority class are indeed another major factor 
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in misclassified instances. Furthermore, missing values and outliers had very 
minimal impact upon misclassified instances.  The impact of missing values 
on misclassified instances might be minimised by the strategies embedded 
in each algorithm to address missing values.  Nonetheless, only a few key 
predictors were mostly affected by missing values, such as heart rate and 
SBP from the UK dataset.  
 In addition, potential predictors that predicted misclassified instances 
were determined by investigating the patterns of the predictors on 
misclassified instances.  The outcome showed that each evaluated dataset 
had its own set of predictors to best predict misclassified instances.  
Moreover, the findings from the prior chapter suggested that the same 
classification algorithm performed the best and worst on a dataset from the 
same domain, i.e., ACS, with the same outcome and similar input 
characteristics.  Therefore, the prediction model that predicted misclassified 
instances generally supported both datasets, and could, perhaps, support 
other ACS datasets as well that have characteristics similar to those of this 
study.  However, further validation on the model has to be performed on 
other ACS  datasets. 
 Furthermore, age, gender, history of MI, history of cerebrovascular, 
history of renal failure, history of heart failure, diabetes, smoking status, 
aspirin taken, BB taken, and death in hospital functioned as the generic set 
of predictors that estimated misclassified instances for both the Malaysian 
and UK datasets.  Therefore, a promising prediction model that predicted 
misclassified instances was generated using the UK dataset with these 
predictors.  The model achieved an AUC = 0.861 when validated on the UK 
dataset, while it achieved an AUC=0.816 upon validation on an external 
dataset (Malaysian dataset). Thus, the models may add input to addressing 
the automation bias issue in the context of ACS prediction modelling.  In 
addition, a rule-based algorithm may be developed based on the model and 
findings, primarily to decrease automation biasness in a DSS of ACS 
domain. 
 The findings from this particular chapter highlight the major 
contribution that could affect the performance of ACS prediction models.  In 
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fact, the same issue may affect dataset with similar characteristics to those 
of study.  Hence, further studies concerning ACS prediction modelling 
should be targeted on resolving issues related to imbalanced datasets and 
overlapping of minority classes. 
 The following chapter depicts several strategies that could be 
implemented to address issues related to imbalanced datasets and missing 
values found among key predictors. 
- 127 - 
Chapter 7:  Model Optimization 
This chapter presents the proposed methods for handling imbalanced 
datasets and missing values so as to enhance the performance of the 
models.   
7.1. Background 
 The results obtained from the analysis of misclassification instances 
advocated that the main contributor of misclassified instances within the 
datasets was an imbalanced dataset. In fact, many cases concerning 
misclassified instances involved the minority class.  Besides, this finding was 
supported when a "RemoveMisclassified" function in WEKA was performed 
on the datasets.  "RemoveMisclassified" refers to a function found in WEKA 
that eliminates expected misclassified instances.  Thus, when the function 
was executed on both datasets, all instances of minority instances were 
discarded.  In addition, cases of overlap were also found to have a notable 
contribution to misclassified instances among the datasets. Further, the 
findings obtained by Denil and Trappenberg (2010) and Lopez et. al.(2013) 
implied that overlapped classes do hinder the performance of a classifier.   
Therefore, based on these two factors, this study proposed a new strategy to 
address issues related to imbalance datasets using the undersampling 
method(Liu et al., 2009).  
 Furthermore, the results from misclassification analysis also showed 
that missing values had a very minimal impact on misclassified instances.  
But, some of the key predictors showed a strong effect on misclassified 
instances. Therefore, in handling the missing values of the datasets, this 
study proposed a method called the mean-clustering-imputation method in 
dealing with the missing data. 
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7.2. Method 
7.2.1 Overlapped-Undersampling Method 
 In the undersampling method, the majority class is resampled to 
decrease the biasness of the majority class.  The simplest undersampling 
method refers to the random undersampling method, in which instances in 
the majority class are removed until a fair distribution is achieved. 
 This study proposed a strategy in which the instances to be deleted 
from the majority class were the overlapped instances of the majority class.  
The method is referred as the Overlapped-undersampling method.  
SimpleKMeans was applied to determine the overlapped instances. All of the 
overlapped instances from the majority class were then discarded from the 
training set.  After that, the AUC results of the new strategy were compared 
with the following approaches so as to address the issue of  an imbalanced 
dataset: 
1) No sampling method - the dataset was used as it was 
2) Random undersampling method - the instances in the majority class 
were discarded in a random manner(Yap et al., 2014). The ratio of 
majority and minority classes adhered to the ratio in Overlapped-
undersampling. 
3) Boosting - An ensemble method using similar classifier algorithms.  
The model is iteratively built based on the weight of each instance for 
each iteration, with initially equal weight for all instances. In each 
iteration, each instance is assigned a greater weight for a 
misclassified instance and a lower weight for a correctly classified 
instance.  This method is also called the AdaBoost in WEKA(Freund 
and Schapire, 1996).  The ADT is another Boosting method that uses 
DT based on the classifier found in WEKA. 
4) Bagging - An ensemble method using the same classifier.  This model 
is developed via random sampling replacement in each iteration 
(Breiman, 1996). 
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5) Voting - An ensemble method using different classifier 
algorithms(Kittler et al., 1998).  The classifiers employed in the 
method were BN, NB, LG, ADT, and LMT. 
6) Random Forest (RF) -  An ensemble method using tree classifier 
algorithms.  The model is developed by inducing bootstrap samples 
with random feature selection in the tree induction process (Breiman, 
2001).   
All of the above approaches (except for Voting and RF) were run on the five 
best algorithms determined in this study, which were BN, NB, LG, ADT, and 
LMT. 
7.2.2 Mean-Clustering-Imputation Method 
 One way of handling missing data in predictive modelling is to use the 
imputation method.  The imputation method is a process of substituting a 
missing value with a value.  The value can be decided either by identifying  a 
globally constant or mean value or by identifying the most probable value.  
The constant or mean value assumes the all missing values are of the same 
value, and this may lead to distortions in the data‘s distribution.  On the other 
hand, the proposed method, i.e. mean-clustering-imputation, proposes that 
the mean value (for numerical attributes) or most frequent value (for 
categorical attributes)  is calculated by clustered samples, instead of a single 
value.  This means that the training sample is first clustered using Simple 
EM (expectation maximisation), while ignoring class labels.  Then, for each 
cluster,  the mean (for numerical attributes) or the most frequently occurring 
value (for categorical attributes)are calculated as the imputation values for 
missing data.  Hence, each cluster has its own mean or most frequently 
occurring values to be imputed.  By grouping the instances of similar groups, 
the most probable means or most frequently occurring values can be 
acquired. The approach of the method is slightly different from the latest 
Hruschka et al.(2004) approach.  In their study, the clustering was done 
using a K-Means algorithm, then their method was applied to complete 
instances according to class labels, and the imputed values were calculated 
by finding the means of the corresponding attribute values of similar 
complete instances. 
- 130 - 
 Thus, all the missing values were filled in both datasets with the 
imputation values calculated using mean-clustering-imputation method.  
After that, the AUC results of the proposed imputation method were 
compared with the following approaches so as to address the issue of 
missing values: 
1) Single-imputation used mean values for continuous attributes and 
most frequently occurring values for categorical attributes 
2) removed instances with missing values  
3) allowed the algorithm to handle the missing values. In WEKA, each 
algorithm has its own way of handling missing values.  The strategy 
for handling the  missing values is embedded in the algorithm. 
 BN - uses ReplaceMIssingValuesFilter, which replaces the 
missing values with the mean (for numerical attributes) or the 
most frequent value (for categorical attributes)(Bouckaert, 
2008). 
 NB - ignores the missing 
attributes(weka.classifiers.bayes.NaiveBayes) (John and 
Langley, 1995) 
 LG - uses a ReplaceMIssingValuesFilter, which replaces the 
missing values with the mean (for numerical attributes).  All the 
categorical attributes are transformed into binary attributes 
using a 
NominalToBinaryFilter(weka.classifiers.functions.Logistic)(Le 
Cessie and Van Houwelingen, 1992) 
 ADT - the missing values are not propagated down the 
subtrees(Freund and Mason, 1999). 
 LMT - replaces the missing values with the mean (for 
numerical attributes) or the most frequent value (for categorical 
attributes)(Landwehr et al., 2005) 
The above approaches were run on the five best algorithms determined 
in this study, which were BN, NB, LG, ADT, and LMT. 
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7.3. Results 
7.3.1 Overlapped-Undersampling Method 
 The results that were obtained after applying the approaches in 
handling imbalanced datasets are tabulated in Table 24. 
Table 24:Comparison of model performance with varied approaches in 
handling imbalanced datasets 
 Malaysia The UK 
 BN NB LG ADT LMT BN NB LG ADT LMT 
CATA7 0.850 0.789 0.837 0.801 0.837 0.808 0.866 0.742 0.835 0.888 
CATA7_RM_Ovlp 0.830 0.793 0.811 0.707 0.830 0.808 0.863 0.735 0.846 0.813 
CATA7_RandUdrSmp 0.850 0.786 0.827 0.803 0.833 0.812 0.872 0.754 0.820 0.879 
CATA7_ADA_Boost 0.539 0.714 0.728 0.751 0.734 0.716 0.775 0.702 0.737 0.629 
CATA7_Bagging 0.822 0.789 0.832 0.837 0.769 0.831 0.866 0.776 0.842 0.831 
CATA7_RF 0.803 0.693 
CATA7_Voting 0.830 0.854 
GRACE 0.844 0.906 0.904 0.789 0.868 0.818 0.826 0.827 0.786 0.83 
GRACE_RM_Ovlp 0.692 0.709 0.694 0.681 0.693 0.743 0.766 0.827 0.758 0.72 
GRACE_RandUdrSmp 0.808 0.826 0.826 0.799 0.824 0.843 0.907 0.900 0.789 0.895 
GRACE_ADA_Boost 0.766 0.695 0.713 0.777 0.699 0.713 0.867 0.870 0.842 0.804 
GRACE_Bagging 0.828 0.825 0.825 0.826 0.810 0.890 0.903 0.902 0.886 0.893 
GRACE_RF 0.828 0.782 
GRACE_Voting 0.833 0.879 
ALL_LR 0.843 0.845 0.842 0.807 0.861 0.872 0.917 0.874 0.799 0.639 
ALL_LR_RM_Ovlp 0.696 0.726 0.710 0.678 0.714 NA 
ALL_LR_RandUdrSmp 0.764 0.799 0.793 0.763 0.789 NA 
ALL_LR_ADA_Boost 0.742 0.671 0.721 0.792 0.720 0.743 0.880 0.808 0.855 0.829 
ALL_LR_Bagging 0.787 0.800 0.804 0.792 0.705 0.908 0.917 0.887 0.882 0.881 
ALL_LR_RF 0.821 0.840 
ALL_LR_Voting 0.794 0.883 
CFS 0.762 0.794 0.801 0.773 0.802 0.793 0.889 0.869 0.794 0.868 
CFS_RM_Ovlp 0.679 0.702 0.703 0.698 0.484 0.681 0.726 0.781 0.635 0.607 
CFS_RandUdrSmp 0.766 0.795 0.801 0.763 0.500 0.834 0.890 0.872 0.801 0.848 
CFS_ADA_Boost 0.698 0.705 0.732 0.769 0.681 0.630 0.784 0.800 0.806 0.694 
CFS_Bagging 0.784 0.796 0.801 0.785 0.737 0.846 0.887 0.870 0.848 0.871 
CFS_RF 0.758 0.713 
CFS_Voting 0.798 0.861 
The red-shaded rows are models that were developed without any optimization 
strategy; the grey-shaded rows denote the results of the proposed method; 
the red-coloured values indicate that the models with an optimization strategy 
outperformed the models with anon-optimization strategy. 
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 In Table 24, the extension name attached to each model i.e. 
RM_Ovlp, RandUdrSmp, ADA_Boost, Bagging, RF and Voting represent the 
Overlapped-undersampling,  Random undersampling, Boosting, Bagging, 
Random Forest and Voting approaches, respectively, in handling 
imbalanced dataset.  
 The results of Table 24 show that no improvement was established 
upon implementing the new strategy (rows shaded in grey)to address an 
imbalanced dataset.  In fact, in most cases, they attained the lowest AUC 
score when compare to other approaches. 
 To be precise, all the imbalanced optimisation approaches were found 
to be inappropriate for the Malaysian dataset.  In fact, the Malaysian dataset 
was better enhanced when no optimisation strategy was employed (rows 
shaded in red).  Unlike the Malaysian dataset, the UK dataset demonstrated 
improvement when Bagging and Random undersampling approaches were 
applied. 
7.3.2  Mean-Clustering-Imputation Method 
Table 25 compares the AUC results of the proposed imputation method, i.e., 
mean-clustering-imputation , with single-imputation method, no missing 
values in the datasets, and using the method embedded in a algorithm.    
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Table 25: Comparison of model performance with varied approaches in 
handling missing values 
  Malaysia UK 
  BN NB LG ADT LMT BN NB LG ADT LMT 
  Missing Numerical/Categorical attributes 
- 1/2 




0.794 0.796* 0.798 0.783* 0.797 0.803 0.830* 0.830* 0.806* 0.828 
GRACE_MEAN_IM 0.793 0.795 0.797 0.783 0.797 0.803 0.833 0.831 0.816 0.827 
GRACE_NO_ 
MISSING 
0.844 0.906 0.904 0.789 0.868 0.818 0.826 0.827 0.786 0.826 
GRACE_ALGRTHM 0.777 0.805 0.797 0.794 0.797 0.791 0.834 0.830 0.808 0.827 
  Missing Numerical/Categorical attributes 
- 4/3 




0.758 0.730 0.778 0.765* 0.779 0.813 0.826* 0.825 0.803 0.826 
All_LR_MEAN_IM 0.754 0.767 0.776 0.764 0.776 0.804 0.825 0.824 0.806 0.825 
All_LR_NO_ 
MISSING 
0.769 0.800 0.798 0.734 0.793 0.872 0.917 0.874 0.799 0.639 
All_LR_ALGRTHM 0.746 0.776 0.776 0.782 0.776 0.794 0.829 0.824 0.808 0.824 
 
 
  Missing Numerical/Categorical attributes 
- 4/0 




0.771 0.768* 0.774 0.765 0.774 0.787 0.815* 0.797 0.808* 0.825 
CFS_MEAN_IM 0.761 0.503 0.742 0.736 0.742 0.785 0.813 0.822 0.805 0.823 
CFS_NO_MISSING 0.762 0.794 0.801 0.773 0.802 0.793 0.889 0.869 0.794 0.868 
CFS_ALGRTHM 0.751 0.777 0.774 0.760 0.772 0.785 0.828 0.822 0.825 0.822 
 Missing Numerical/Categorical attributes 
- 6/8 




0.830 0.788* 0.804 0.795 0.801 0.784 0.812 0.780 0.752 0.784 
CATA7_MEAN_IM 0.800 0.785 0.801 0.740 0.790 0.816 0.821 0.806 0.802 0.810 
CATA7_NO_ 
MISSING 
0.850 0.789 0.837 0.801 0.837 0.808 0.866 0.742 0.835 0.888 
CATA7_ALGRTHM 0.776 0.803 0.798 0.773 0.785 0.806 0.834 0.805 0.83 0.81 
The grey-shaded rows denote the results of the proposed method; the blue- 
coloured values indicate the best models for a particular algorithm; the 
underlined values indicate that the proposed method is better than the 
MEAN_MI and ALGRTHM methods; the asterisked (*)  values indicate that 
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In Table 24, the extension name attached to each model i.e. 
MEAN_CLSTR_IM, MEAN_MI, NO_MISSING and ALGRTHM represent the 
mean-clustering-imputation method, single-imputation method, no missing 
values in the datasets, and using the method embedded in a algorithm, 
respectively, in handling missing values.  
 Overall, the results in Table 25show that the best models were 
achieved when all instances with missing values were removed from the 
training sets (NO_MISSING).  This scenario was observed in both the 
Malaysian and UK datasets.   
 Specifically for the Malaysian datasets, the results highlighted that the 
proposed methods were generally better than the MEAN_IM and ALGRTHM 
methods, specifically on the BN, LG, and LMT algorithms. In addition, in 
most of the other algorithms, the proposed methods were better than the 
MEAN_IM method. 
 On the other hand, for the UK dataset,  the proposed methods 
produced the worst models on the CATA7 dataset.  However, for the other 
UK data, the results demonstrate almost similar results to the Malaysian 
data, in which the BN, LG, and LMT algorithms, incorporating the proposed 
imputation method, built better models compared to models built with the 
MEAN_IM and ALGRTHM methods.  And, in most of the other algorithms, 
the proposed method produced better models than models developed using 
the MEAN_IM method. 
 Even though models using the MEAN_CLSTR_IM method built better 
models in most cases compared to the models applying the MEAN_IM and 
ALGRTHM methods, the improvements of these models were not vivid (i.e. 
the AUC score was the same or very minimally increased by 0.001 or 
0.002).This scenario might be due to the fact that the imputed values for 
missing values of categorical attributes in each cluster were the same, i.e. 
the frequent value of the attribute. For example, the most frequent value of a 
categorical attribute in Cluster 1 was 'No.' The value was noted to be the 
same in all other clusters with the same categorical attribute. Hence, all the 
categorical attributes with missing values in Malaysian dataset were had this 
scenario.  Similar scenarios were also observed in all the UK datasets 
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except for the CATA7 datasets. To the contrary, in CATA7, there were three 
categorical attributes with missing values that had various imputed values.  
Surprisingly, applying the MEAN_CLSTR_IM method to theCATA7 dataset 
did not help improve the classification performance.  In fact, the MEAN_IM 
and ALGRTHM methods produced considerably better models on the 
CATA7 dataset.   
 Nevertheless, better models were built with the proposed imputation 
method when the number of numerical attributes with missing values 
exceeded two in a dataset. This scenario was observed in CFS and 
CATA7for the Malaysian dataset.  However, as noted in Table 27, none of 
the UK datasets had more than two numerical attributes with missing values. 
7.4. Discussion and Conclusion 
 From the findings obtained regarding the effect of overlapping 
instances upon misclassified instances, this study suggested a new strategy 
to overcome the issue of imbalanced datasets via the undersampling 
method.  This suggested strategy removed overlapping instances found in 
the majority class from the training set.  Nonetheless, the strategy failed to 
produce satisfactory results.  This was probably due to the removal of 
important information from the training data.  The deleted overlapped 
instances might have actually contained some vital information for training a 
model.   Furthermore, the Malaysian dataset performed better when no 
approach was taken to tackle an imbalanced dataset.  Perhaps, the size of 
the training set for the Malaysian dataset could be the reason for this 
scenario.  As according to Japkowicz et al. (2002), when a sample is large 
enough to represent sub-clusters in each class, an imbalanced dataset does 
not hinder the performance of a classifier.  The sample size of the Malaysian 
dataset was obviously larger than that of the UK dataset.  On the other hand, 
the UK dataset displayed better results when Bagging and Random 
undersampling approaches were applied.   Therefore, UK models with 
applications of Bagging and Random undersampling approaches were 
further validated, with the details presented in the next chapter. 
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 Moreover, in terms of handling missing values, this study proposed a 
method for establishing the imputed value for missing data.  The method 
was named the mean-clustering-imputation method.  In the method, training 
sample were first clustered.  The imputed value was established by 
calculating the mean (for numerical attributes) or the most frequent value (for 
categorical attributes) of each cluster.  The results demonstrated that 
removing instances with missing values resulted in the best models 
produced for both the Malaysian and UK datasets.  However, removing 
instances with missing values could result in reducing the sample size 
enough to affect the reliability of the model.  Thus, in this study, we applied 
feature selection before removing the instances with missing values.  By 
reducing the number of predictors for model development (feature selection), 
the number of instances with missing values were eventually reduced, and, 
thus, an appreciable amount of observations remained for the training 
samples. Nevertheless, this approach is only applicable if a dataset is large 
enough to maintain a reasonable number of observations for the training 
samples after removing the instances with missing values. 
 Better models were constructed with the proposed imputed method 
compared to the single-imputation method and methods embedded in an 
algorithm, specifically  when the models were developed on BN, LG, and 
LMT algorithms.  In fact, the proposed method built notably satisfactory 
models when the number of numerical attributes with missing values was 
greater than two.  Otherwise, the performance of models using the proposed 
imputed method were about the same or slightly better than models 
developed using the single-imputation method and methods embedded in an 
algorithm. However, the performance of the models using the proposed 
imputed method showed no improvement when there were more missing 
values in categorical attributes as opposed to numerical attributes. 
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Chapter 8:  Model Validation 
This chapter presents the model validation process of the best selected 
models from the previous chapter.  The objective of the chapter is to further 
validate the models using internal and external datasets.    
8.1. Method 
 The models were tested for internal and external validation.  Internal 
validation involves testing the models using similar underlying populations, 
whereas external validation denotes testing the models on other populations.  
The final stage is to present the calibration so as to evaluate the 
performances of the predictions versus the actual outcome of the best 
models.  Lastly, the overall calibration performances of the best models are 
measured by using the BS, while the visual agreement of the actual 
outcomes and predictions are presented on calibration plots. 
8.1.1 Internal Validation 
 The best models identified in Chapter 5, which were CATA7, ALL_LR, 
GRACE, and CFS, were validated against the testing dataset using the five 
best algorithms: BN, NB, LG, ADT, and LMT.  The testing set was reserved 
earlier during the pre-processing phase, as elaborated in Chapter 4.  No 
exclusions were made on the testing dataset, except for incomplete cases 
with missing values.   Initially, a total of 3,178 testing observations were 
assigned to testing for the Malaysian dataset, whereas 1,283 observations 
were assigned to testing for the UK dataset. Both of these numbers were 
assigned prior to discarding incomplete cases. Table 26 tabulates the total 
testing samples for each model employed for internal validation after the 
exclusion of incomplete cases. 
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CATA7 740 536 
ALL_LR 1353 780 
GRACE 2316 925 
CFS 1656 658 
 
Table 26 illustrated that the testing size for almost all models has been 
reduced to as low as 50% of the originally reserved observations for the 
testing set.  The largest loss of testing observations was observed on the 
Malaysian CATA7 model, which contained only 740 observations.  Despite 
the reduction of the testing set, the sample is still reasonable for validation.  
Results from Beleites et al.‘s(2013) study suggested that a minimum of 75-
100 samples is required to achieve reasonable precision in validating an ML 
classification model.  Thus, the testing samples used to validate our models 
were sufficient.  
 As the UK models exhibited improvements upon applying the random 
undersampling approach, all models developed with the random 
undersampling approach were also validated. 
 The best models (CATA7, ALL_LR, GRACE, and CFS)  was also 
prepared to be validated on the best generic model.  The generic model is a 
model that is suitable for both the Malaysian and  UK datasets.  The 
predictors of the generic model should be common to both datasets. Thus,  
the best predictors were adjusted to only consider common predictors of the 
two datasets.   As such, CATA7_CMM, ALL_LR_CMM, GRACE_CMM, and 
CFS_CMM were referred to as the generic models of CATA7, ALL_LR, 
GRACE, and CFS, respectively.  The same testing samples (as in Table 26 ) 
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8.1.2 External Validation 
 In order to validate a model, the testing set must have similar 
predictors as those found in the derived model.  For instance, if the model is 
built with four predictors: 1) age,2) heart rate,  3) SBP, and 4) height, similar 
predictors must also exist in the testing set.  Hence, only generic models are 
applicable for external validation.  Among  the generic models 
(CATA7_CMM, ALL_LR_CMM, GRACE_CMM, and CFS_CMM), only the 
best models identified from internal validation were further validated on an 
external dataset.  
8.2. Results 
8.2.1 Internal Validation 
Tables 27,28, and 29present the results of internal validation.  As such, 
Table 27 illustrates the results of the original best models, while Table 28 
shows the results of the best models using the undersampling method, and 
Table 29 portrays the results of the generic models.  In the validation 
process, the study considered a model with an AUC score of 0.75 and above 
as a good model. 
Table 27: Results of internal validation of the best models 
 Malaysia UK 
 BN NB LG ADT LMT BN NB LG ADT LMT 
CATA7 0.798 0.756 0.724 0.765 0.739 0.810 0.772 0.563 0.732 0.679 
ALL_LR  0.781 0.768 0.770 0.733 0.767 0.816 0.836 0.792 0.795 0.639 
GRACE 0.824 **0.827 0.822 0.797 0.822 0.811 0.828 0.773 0.790 **0.847 
CFS 0.753 0.755 0.762 0.733 0.760 0.770 0.781 0.685 0.747 0.786 
The coloured values indicate the models with AUC>0.75; the grey-shaded values 
denote the best model for each set of models; the double asterisked (**)  
values represent the best model for the Malaysian and UK datasets 
 
 The results of Table 27showthat the best models for Malaysian and 
the UK datasets were models adopting predictors from GRACE model 
(GRACE).  The best Malaysian model was developed by using NB, whereas 
the best UK model was constructed on the LMT algorithm.  Nonetheless, NB 
and LMT emerged as the two best algorithms for constructing an ACS 
prediction model for both the Malaysian and UK datasets.  The GRACE of 
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Malaysian model built using LMT algorithm had a slightly lower AUC score of 
0.822in comparison to an AUC of 0.827 for NB.  Similarly, for the GRACE of 
UK model, the NB algorithm also displayed the ability to generate a 
considerably good prediction model with an AUC of 0.828. 
Table 28: Results of internal validation - Models with random undersampling 
method (UK dataset) 
  UK 
  BN NB LG ADT LMT 
CATA7 0.810 0.772 0.563 0.732 0.679 
CATA7 _RandUdrSmp 0.799 0.766 0.526 0.733 0.727 
ALL_LR  0.816 0.836 0.792 0.795 0.639 
ALL_LR _RandUdrSmp NA 
GRACE 0.811 0.828 0.773 0.790 0.847 
GRACE_ RandUdrSmp 0.812 0.828 0.774 0.792 0.840 
CFS 0.770 0.781 0.685 0.747 0.786 
CFS_ RandUdrSmp 0.783 0.781 0.686 0.746 0.777 
The underlined values indicate that the models with the random undersampling 
method are better than the models without the random undersampling 
method; the blue-coloured value represents the best model 
 
 Furthermore, it is important to note here that only the UK models had 
demonstrated improvements when the random undersampling approach 
was implemented.  Although the models with the random undersampling 
approach seemed to have enhanced performance during development, 
these performances were generally at par with those models without the 
random undersampling approach when tested upon testing datasets.  Table 
28compares the results of internal validation of the models for both with and 
without the application of the random undersampling approach. 
CATA7_RandUdrSmp, All_LR_RandUdrSmp, GRACE_RandUdrSmp, and 
CFS_RandUdrSmp represent CATA7, All_LR, GRACE, and CFS models 
with random undersampling approach. 
 Out of the tested 15 models, only seven models appeared to have  a 
higher AUC in comparison to models without the random undersampling 
approach. Furthermore, only CATA7_RandUdrSmpwith the LMT algorithm 
and CFS_RandUdrSmp with the BN algorithm displayed improvements upon 
implementation of the random undersampling approach.  Otherwise, 
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improvement by 0.001 were noted for GRACE__RandUdrSmp on BN, 
CATA7_RandUdrSmp on ADT, and CFS_RandUdrSmp on LG.  In addition, 
eight models exhibited lower performance than those without the random 
under sampling approach.  Therefore, this study concluded that imposing a 
random undersampling approach had no notable contribution towards 
enhancing overall model performance.  
Table 29: Results of internal validation for generic models 
 Malaysia UK 
 BN NB LG ADT LMT BN NB LG ADT LMT 
CATA7_CMM 0.764 0.756 0.749 0.710 0.500 0.744 0.726 0.741 0.645 0.500 
ALL_LR_CMM 0.761 0.759 0.765 0.729 0.500 0.724 0.753 0.767 0.636 0.500 
GRACE_CMM 0.742 0.771 0.754 0.726 **0.773 0.705 0.743 0.747 0.711 0.500 
CFS_CMM 0.713 0.751 0.748 0.704 0.500 0.761 0.774 ** 0.779 0.756 0.500 
The underlined values indicate the models with AUC>0.75; the blue-coloured 
values denote the best model for each set of models; the double asterisked 
(**)  values represent the best model for the Malaysian and UK datasets 
 
 As expected, the performance of the generic models as represented 
in Table 29was lower than that of the models exclusively developed for each 
individual dataset.  Nonetheless, the best generic model developed based 
on the Malaysian dataset was the GRACE_CMM using the LMT algorithm 
(AUC=0.773), whereas the best generic model built based on the UK dataset 
was  the CFS_CMM using the LG algorithm (AUC= 0.779). 
8.2.2 External Validation 
 External validation was performed only on Malaysian generic model of 
GRACE_CMM and the UK generic model of CFS_CMM,  as they appeared 
to be the best generic models discovered from internal validation.  The 
Malaysian generic model was validated on the testing set of the UK dataset 
(n= 925), whereas the UK generic model was validated on the testing set of 
the Malaysian dataset (n=1424).  Table 30 presents the result of external 
validation of the generic models.  As in Table 30, the results of external 
validation are compared with the results of internal validation.   
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Table 30: Results of external validation 
 Malaysia UK 
 GRACE_CMM GRACE_CMM_Ext CFS_CMM CFS_CMM_Ext 
BN 0.742 0.665 0.761 0.607 
NB 0.771 0.708 0.774 0.705 
LG 0.754 0.701 0.779 ** 0.720 
ADT 0.726 0.665 0.756 0.579 
LMT 0.773 0.702 0.500 0.500 
The underlined values indicate the models with AUC>0.7; the blue-coloured values 
denote the best model for each set of models; the double asterisked (**) 
values represent the best generic model 
  
 In Table 30, GRACE_CMM_Ext and CFS_CMM_Ext represent the 
models that have been validated externally for Malaysian and UK models, 
respectively. 
 The AUC scores obtained for the models from external validation were 
anticipated to be lower than those validated on internal datasets.  Thus, an 
AUC score of 0.700 was considered acceptable when tested on externally.  
As presented in Table 30, the best generic models for both the Malaysian 
and UK datasets was CFS_CMM.  CFS_CMM  is  a model developed based 
on UK dataset using LG algorithm has obtained AUC of 0.779 when 
validated on similar cohorts, and an AUC of 0.720 when validated on the 
external dataset. 
8.2.3 Calibration 
 Based on the results derived from internal validation, the best models 
revealed for both the Malaysian and UK datasets were GRACE on the NB 
algorithm (referred to as MY_GRACE_NB) and GRACE on the LMT 
algorithm (referred to as UK_GRACE_LMT).  In addition, the best generic 
model was CFS_CMM, developed on UK datasets using LG algorithm 
(referred to as UK_CFS_CMM _LG).   As such, the BS and calibrated plots 
of MY_GRACE_NB, UK_GRACE_LMT and  UK_CFS_CMM _LG are 
illustrated in Figures 15, 16, and 17, respectively.  Additionally, Figure 16 
portrays the BS and calibration plots for UK_CFS_CMM _LG validated on an 
external dataset(referred to as UK_CFS_CMM_LG_Ext).  
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 As a whole, the BSs of the calibrated models mainly approached zero, 
and all of the BSs of the models were less than 0.07,indicatingthat the 
models were indeed well-calibrated.  In fact, UK_CFS_CMM_LG obtained 
the best BS of 0.025, followed by UK_GRACE_LMT (BS = 0.032),  
UK_CFS_CMM_LG_Ext (BS = 0.062), and MY_GRACE_NB (BS = 0.063). 
  
Figure 15:Calibration plot for the MY_GRACE_NB model 
 
 An obvious miscalibration was noted on bins 10 and 8 of  the 
MY_GRACE_NB model depicted in Figure 15.  This is because the model 
over-estimated the occurrence of the "Died" cases on bin 10, but under-
estimated the same event on bin 8.    
 
Figure 16 : Calibration plot for the UK_GRACE_LMT model 
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 The calibration plot (Figure 16) of the UK_GRACE_LMT  model 
depicts that most of the points for the bins were nearly on the 45-degree line, 
except for bin 10.  Nevertheless, the distance of the point on bin 10 to the 
diagonal line was small.  Therefore, one can claim that the 
UK_GRACE_LMT was calibrated significantly well. 
  
Figure 17 : Calibration plot for the UK_CFS_CMM_LG model 
  
 Likewise, for UK_GRACE_LMT, the calibration plot for the 
UK_CFS_CMM_LG model (Figure 17) also points out good calibration.   
With probability 0.02, an indicator of an over-estimated true value was 
present, but the difference of the estimation from the actual value was only 
0.05.   
 
Figure 18: Calibration plot for the CFS_CMM_LG_Ext model 
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 The calibration plot of UK_CFS_CMM_LG_Ext (Figure 18) signifies 
that the model under-estimated the actual output for all the bin points.  The 
variance in mean predicted probability and actual output was 0.0009 on bin 
1, 0.0149 on bin 2, 0.0251 on bin 3, 0.0314 on bin 4, 0.0595 on bin 5, 0.0362 
on bin 6, 0.0373 on bin 7, 0.0395 on bin 8, 0.0892 on bin 9, and 0.1333 on 
bin 10.  Although the model under-estimated the outcome for all bin points, 
the differences between the predicted and true values were not obvious. 
8.3. Discussion and Conclusion 
 The main objective of this chapter was to identify the best model for 
both the Malaysian and UK cohorts.  For that reason, internal and external 
validation was performed.  The number of predictors for the best models 
identified from internal validation was reduced to allow the external validation 
processes.  Other than that, calibration is another essential measure that 
determines the performance of a prediction model.  This study measured the 
calibration by using BS and projected the calibration on calibration plots.
 As a result, the findings concluded that the best models that predicted 
ACS mortality specific to the Malaysian and UK cohorts were models derived 
from the set of predictors of the GRACE model.  Although the predictors of 
the model were based on those of the GRACE model, only predictors 
available in the Malaysian and UK datasets were incorporated into the 
models.  As such, instead of eight predictors that present in the GRACE 
model (Granger et al., 2003), the best model for Malaysian dataset only 
incorporated five predictors, whereas the best model for UK dataset only 
considered four predictors.  Furthermore, the Malaysian best model 
performed the best on NB (AUC=0.827), while the UK best model performed 
the best on LMT (AUC=0.847).  In addition, the BSs of the models indicated 
that all the models were indeed well-calibrated.  The calibration plots further 
supported the BS results as satisfactory. 
 On top of that, the models that displayed improvement in the model 
optimization process were also validated.   In the previous chapter, the 
results showed that the application of the random undersampling approach 
on the UK dataset had improved the AUC scores of the models.  
Nonetheless, when the models with random undersampling approach were 
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validated, no notable enhancements were observed.  The results further 
signified that, even with an imbalanced dataset, a good AUC (> 0.80) could 
still be attained. 
 Additionally, the external validation emphasised a common best 
model that predicted both the Malaysian and UK datasets.  Therefore, the 
best generic model was constructed based on the UK cohort, using 
predictors extracted from CFS method and developed using the LG 
algorithm (UK_CFS_CMM_LG).  Furthermore, the model was derived from  
a set of predictors determined by the CFS automated feature selection 
approach.  In addition, the predictors of the best generic model were 
comprised of age, SBP, and BB taken.  As a result, the model achieved an 
AUC=0.779 when validated on the same cohorts and an AUC=0.720 when 
validated on external cohorts.  For external validation, the study considered 
an AUC of 0.70 as an acceptable and good model.  Furthermore, the BS of 
the UK_CFS_CMM_LG model suggested good calibration measure.  
Nevertheless,  the calibration plot of the model demonstrated under-
estimated prediction for all the bin points.  Nonetheless, the variance of 
probability predicted and true values was small. 
  
 
- 147 - 
Chapter 9:  Discussion, Future Research, and Conclusion 
This chapter presents the summary of the study findings and discusses the 
perspectives derived from the findings. 
9.1. Overall Findings 
9.1.1 ACS Prediction Models on ML Algorithm 
 This study has successfully demonstrated a practical way of 
constructing ACS prediction models by using ML algorithms on registry 
datasets.  The major finding is that ML algorithms present a competitive 
alternative with which to build ACS prediction models.  Furthermore, a 
number of  ML algorithms have exhibited superior discriminative ability when 
compared to existing models developed with traditional statistical methods.  
For example, the models utilizing a CSF feature section method on the UK 
dataset, built using the NB, LG, MLP, FT, and LMT algorithms, achieved 
higher predictive power than TIMI, PURSUIT, GRACE, EMMACE, SRI, and 
C-ACS (Antman et al., 2000, Dorsch et al., 2001, Morrow et al., 2001, Huynh 
et al., 2013, Boersma et al., 2000, Granger et al., 2003). 
 Furthermore, the models built on an ML algorithm with predictors from 
an existing ACS model displayed enhanced performance, in comparison to 
the original model.  As presented in Section 5.2.2,  the best derivation 
models constructed for the Malaysian and  UK datasets attained higher AUC 
values than all the 11 reviewed ACS models (Table 1).  For instance, 11 out 
of 17 algorithms used to developed models adopting predictors from the 
GRACE model, based on the Malaysia dataset, had higher AUC values, i.e., 
c-statistics, than the GRACE model (AUC = 0.83)(Granger et al., 2003).  In 
fact, when validated, the same model, using cohorts from the UK, attained 
reasonable AUC values greater than the cut-off of 0.70.  
 On top of that, different datasets from 2 differing regions presented 
varied patient characteristics due to disparities in the quality of the 
healthcare system, demographic diversity, lifestyle, and other factors.  This 
variability seemed to contribute to the varying performance values among 
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the models.  However, the datasets did have the same range of ACS, 
targeted the same outcomes, and had approximately similar requirements of 
cohorts, so the same classification algorithms resulted in rather similar 
performances.  As noted in the findings from the STATLOG studies, the 
largest algorithm comparison studies on a large number of different types of 
datasets, there is no one best algorithm that best fits all datasets, but the 
same algorithms work best on datasets with similar characteristics (King et 
al., 1995).  These findings were supported by other studies, such as Harper 
(2005) and Ali and Smith (2006).  Thus, this study concludes that NB, BN, 
LG, ADT, and LMT appear to be the range of algorithms best suited for 
prediction modelling on ACS, and they are probably applicable to CVD, in 
general, and other medical datasets with similar dataset characteristics.  
Simple datasets characteristic measures, as outlined by Ali and Smith 
(2006),were made transparent in the study along the model development 
process as reference.  The characteristics are: 1) number of predictors, 2) 
number of samples, 3) percentage of minority and majority classes, 4) 
percentage of categorical and numerical predictors, and 5) percentage of 
missing values.  This set of algorithms (NB, BN, LG, ADT, and LMT) can be 
used as guideline for relatively naive medical users who wanted to attempt 
ML prediction modelling. 
 However, our findings are not consistent with a study by Potter (2007).  
In his study, Potter examined 56 WEKA algorithms on two breast cancer 
datasets.  He found that no single algorithm that worked well for both 
datasets, even though the two datasets were similar and had a similar 
domain.  The best classification algorithms found changed when the number 
of predictors differed.  Even the top five algorithms were different for the two 
datasets.  Our findings, on the other hand, even with slight differences in the 
actual performance values of each dataset, showed that similar domains 
(even with different populations and distributions of samples) and similar 
datasets characteristics resulted in a consistently similar set of classification 
algorithms.  The similar performances of the algorithms were also noticed 
even  when feature selection was applied to the datasets.  In addition, this 
study also found that the same set of classification algorithms was not 
suitable for both datasets (i.e. VP, CR, Ridor, ZR, SVM, JRip, OneR, BFT, 
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j48, j48Graft, SC, KNN, DT, DS, RT, and REPT).  Our results are consistent 
with Harper‘s (2005) study.  Harper‘s study evaluated four classification 
algorithms for four different medical datasets.  The findings indicated CART 
algorithms performed consistently well in terms of the accuracy rate, but that 
regression and ANN had a similar accuracy performance for almost all the 
datasets, and discriminant analysis (DA) as the worst algorithms for all of the 
datasets.   In addition, King et. al (1995) found that the Bayes learner 
seemed to worked best on medical datasets and that NB is one of the best 
algorithms for our datasets. Furthermore, Wu et. al (2010)identified the LG  
algorithm as being better than SVM and boosting algorithms in evaluating 
EHR datasets.  In fact, in the study, SVM was found to be the worst 
algorithm due to imbalanced datasets.  Again, these findings are consistent 
with our study.  In our study, LG was discovered to be one of the best 
algorithms, and SVM was among the non-performing algorithms, most likely 
due to the same reason, i.e., imbalanced datasets. Specifically related to 
ACS prediction modelling, our results showed that ADT was one of the best 
algorithms, which was also claimed by Sladojević et al.(2015)in his study. 
 It  has been found that most highly evaluated classification algorithms 
in the ACS-related domain were DT, NN, SVM, and LG (Yoo et al., 2012, 
Liao et al., 2012, Patel and Patel, 2016). This study, on the other hand, 
evaluated29 ML algorithms on two datasets on the ACS domain derived 
from populations from different regions and with varying combinations of 
predictors.  Furthermore,  the AMIS and Serbia models, which also were 
compared on several WEKA algorithms, were developed from one dataset 
and on one identified set of predictors.   Given this, it is believed that the 
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9.1.2 Data Quality 
 Even with adequate validation and cleaning-up processes done prior 
to transferring the data from hospital admission records/EHRs to the 
registries, data quality still appeared to be a challenge when working with 
this EHR-based registry data.  Thus, pre-processing and data preparation 
was time consuming.  Time was also consumed scrutinizing the attributes in 
the datasets so as to ascertain that only valuable attributes were selected for 
research analysis and model development. The study has presented the 
effect on model development time when dealing with issues of data quality in 
a dataset. 
 Furthermore, the study has also presented the effect on quality issues 
when losing a large portion of  a sample.  As specified in Section 4.4.1, 
quality issues in the datasets resulted in losing approximately 90% of the UK 
dataset.  Since we had quite a large raw dataset, the loss did not affect the 
reliability of our models.  But, the risk of losing a large number of 
observations must be considered when dealing with a dataset with quality 
issues that might consist mostly of EHR data or medical data, in general.  
This is an important note. made to encourage better quality of EHR data for 
further utilization of EHR data in research. 
 This study suggests that a good reference for data definition and 
description, such as data dictionary, is indeed an important asset in working 
with registry data.  Incomplete, vague, wrong, and nil descriptions of 
attributes are some instances of issues discovered in the data dictionary of 
the studied datasets.   When the registry is open for research, an extensive 
and detailed data dictionary should be made available, especially for users 
who are unfamiliar with medical data.  The description of  an attribute, 
measurement of a value, and the event or condition, complete with specific 
measurement metrics, have to be clearly defined. In addition, an introduction 
to a specific domain (e.g., ACS) and standard hospital practices would serve 
as added value for the researcher in better comprehending the data. 
 Furthermore, this study also found that the granularity of the 
information and how the ACS data should be stored differed between 
Malaysia and the UK.  In fact, some information was not mutually available 
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in both regions.  Hence, in order to attain the most advantageous prediction 
model, it has been essential to develop a prediction model customized by 
region- either by constructing a model for a specific region or updating the 
model in accordance to that region. 
9.1.3 Predictors of ACS Models 
 Another major finding obtained from this study is related to the 
predictors for constructing ACS prediction models.  In the study,  in addition 
to producing a simpler model,  ML feature selection method has 
demonstrated its capability in identifying a set of predictors able to construct 
a competitive ACS prediction model. For example, the models developed 
with the CFS feature selection method on the Malaysian dataset using the 
LMT algorithm had better predictive power than the TIMI, EMMACE, SRI, 
and C-ACS models (Antman et al., 2000, Dorsch et al., 2001, Morrow et al., 
2001, Huynh et al., 2013).  Even though there is no finding on a totally new 
predictors for ACS mortality, this different set of predictors could suggest a 
better ACS prediction model.  Furthermore, the potential predictors resulting 
from ML feature selections are consistent with the existing risk factors, 
indicating that the ML feature selection method can identify the same risk 
factors as clinical trials/ medical opinions can.  Thus, this study has 
demonstrated that the ML feature selection method could be competitive in 
discovering new sets of predictors for prediction modelling. In traditional 
clinical trial, predictors are determined by pre-selecting several potential 
predictors  and then calculate the coefficient of the pre-selected predictors 
against the outcome to select significant predictors for the model. On the 
contrary, with the advent of the big data era, the growth of medical data is 
extremely rapid and sizeable, ML can be utilized for screening larger risk 
factor collections.  These large datasets can be screened for potential 
predictors, as well as allowing the machine to identify the best set of 
predictors or even new research questions.  With that, any new or vital 
predictors could be easily determined, and the findings can be supported 
and validated by scientific clinical trial. 
 This study concluded that the CFS of filter method is  better than the 
two wrapper methods investigated in the study.  However, this study does 
not totally agree with the finding by Hall (2000), which concluded that, in 
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general, the filter method is better than the wrapper method.  In this study, 
no concrete pattern was found suggesting that the filter method is indeed 
better than the wrapper method. Even though the CFS of filter method 
resulted in better prediction models for both the Malaysian and UK datasets, 
the filtersubset of another filter method produced the worst models when 
compared to the two wrapper methods on the UK dataset. 
 In another perspective, this study showed that most of the predictors 
of the existing ACS prediction model are still good enough to be used as the 
basis of predictors in building prediction models.   In Section 5.2.2, the 
results demonstrated that models developed adapting the set of predictors 
from the GRACE model were able to produce better models than the original 
GRACE model.  In fact, for the Malaysian dataset, almost half of the 
algorithms out of 17 evaluated algorithms were able to construct models with 
better predictive performance than the original model. In addition, models 
developed adopting combination of predictors from nine ACS models also 
resulted in competitive models for both the Malaysian and UK datasets.  This 
is an important message, suggesting that existing predictors can be adopted 
in developing a simple ACS model using ML customized to specific cohorts.  
This will save an extensive amount of model development time.  This finding 
suggests that, despite varying characteristics of the populations and the 
different quality in healthcare systems between Asia and Western regions, 
the effect of traditional risk factors upon the outcome seemed to remain 
constant. 
 On top of that, in evaluating predictors of different clinical categories, 
this study has discovered that, in order to build a good ACS prediction 
model, the predictors must reflect a combination of information from varied 
phases of clinical events.  As the information is varied from multiple clinical 
events, a better model could be developed.  Nonetheless, in order to build a 
good model using basic or first-contact patient information,  the predictors 
must cover at least data from the demographic, medical history, and clinical 
presentation categories.  Moreover, this study also found predictors from the 
medication received before admission category (i.e. specific medicine, such 
as a statin or BB, that was prescribed to a patient before the ACS event) do 
not contribute towards improving the performance of prediction models.  The 
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outcomes of the ML feature selection method support this finding. In all the 
evaluated feature selection methods, with the exception of the wrapper 
method on the Malaysian dataset, predictors from the medication received 
before admission category were hardly selected.  Nevertheless, each 
dataset from a different population had its own preferred set of predictors for 
producing the best models. As a result, the study has found that  the best 
sets of predictors to construct ACS models from Malaysian dataset are : 1) 
age, heart rate, SBP, DBP, ECG Abnormalities - T-Wave inversion, and Lvef  
2) age, heart rate, SBP, killip class, ACS symptoms before admission  3) 
age, history of premature CVD, history of heart failure, history of lung 
disease, history of renal failure, heart rate, SBP, DBP, ECG Abnormalities - 
T-Wave inversion, ECG Abnormalities - BBB, ECG Abnormalities - Non 
specific, ECG Abnormalities Location - Anterior Leads : V1 and V4, ECG 
Abnormalities Location - Right Ventricle : ST Elevation in Lead V4R, Low-
density lipoprotein cholesterol(LDL-C), FBG, Lvef, Low molecular weight 
heparin (LMWH) taken, Angiotensin converting enzyme (ACE)inhibitors 
taken, diuretics taken, and anti-arrhythmic taken .  As for the UK dataset, the 
best sets of predictors to construct ACS models are: 1) age, BB, SBP, 
cardiac arrest, and reinfarction  2) age, gender, history of heart failure, on 
aspirin status, SBP, heart rate, cardiac arrest, ST-segment deviation of ECG  
3) age, history of cerebrovascular disease, history of chronic renal failure, 
history of heart failure, diabetics, smoking status, aspirin status, BB, SBP, 
cardiac arrest, reinfarction, ECG, and tropinin assay.  On the other hand, the 
predictors of the best generic model are  age, SBP, and BB taken.   
9.1.4 Misclassification Instances 
 In evaluating the problem that tempered the performance of the ACS 
model for the datasets, the study identified imbalanced datasets as the main 
problem.  Due to this, a new approach to the undersampling method was 
introduced, i.e. Overlapped-undersampling, to handle the imbalanced 
datasets.  In the Overlapped-undersampling approach, all the overlapped 
instances in the majority class were removed to achieve a fair balance 
distribution as existed in the minority class.  This method was then 
compared with the existing methods for handling imbalanced datasets, such 
as random undersampling, boosting, voting, and using RF algorithms. The 
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study showed that the proposed approach made no obvious improvement 
over the existing approaches on the datasets, with the exception of boosting.  
Even so, the boosting method only worked on the UK dataset and only on 
the BN, ADT, and LMT algorithms.  In fact, this study found that, with 
sufficient sample size, an imbalance dataset could be better addressed 
without the need for these methods. The finding is consistent with the study 
by Japkowicz et al.(2002).  That study concluded that, with a sufficient 
sample size for each sub-cluster in a dataset, imbalanced datasets should 
not pose a problem(Japkowicz et al., 2002).  This is indeed an interesting 
point to make for a registry dataset used for prediction modelling. 
 In addition, this study also discovered that overlapping instances in 
the minority class are yet another reason for performance degradation. 
Nonetheless, we  believed that this reflects the underlying problem of 
imbalanced datasets.  In an earlier study, Denil and Trappenberg (2010) had 
pointed to the same argument. They suggested that, when instances of 
imbalanced and overlapped data are present in a dataset, decline in 
performance could be expected.  Their study evaluated the effect of overlap 
and imbalance issues, as well as their relationships to the size of the training 
set, specifically on the SVM algorithm.  Our study has given a deeper 
perspective on overlapped instances  and imbalanced datasets since our 
study found overlapped instances in minority class is indeed causing the 
problem.  And, unlike Denil and Trappenberg‘s(2010) study, we evaluated 
on five ML algorithms instead of one ML algorithm. 
 As missing values are a major concern when developing models from 
a registry, a proper way of handling these missing values should be carried 
out.  Discarding attributes with missing values is always an unwise strategy 
when dealing with a high-dimensionality dataset with a large number of 
missing data.  A very limited number of complete cases or no complete 
cases can be achieved when trying to remove instances with missing data in 
this case.  As described in Section  4.4.1.1, no complete instances were 
formed for the UK dataset, and only 318 complete instances could be 
extracted.   Thus, as applied in this study, for a dataset that contains a large 
number of attributes with a large number of missing values, it is well-advised 
to first identify the best set of predictors for model development before 
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removing the instances with missing values.  Also, eliminating instances with 
missing values does not hamper the performance of a model if the training 
dataset is of substantial size. 
 On the other hand, the study also has introduced a new approach for 
identifying imputation values for the missing values in a dataset, i.e., the 
mean-clustering-imputation method.  Unlike the simple imputation method, 
which imputes the mean or the most frequent value, our imputation values 
were derived from clusters of the datasets.  The datasets were first clustered 
using Simple EM, and the imputation value derived by calculating the mean 
(for numerical attributes) or the most frequent value (for categorical 
attributes) of each cluster. The mean-clustering-imputation  method attained 
better models compared to the simple imputation method and methods 
embedded in specific algorithms, especially the BN, LG, and LMT 
algorithms. In fact, the mean-clustering-imputation method is more 
competent when more than two numerical attributes with missing values are 
in the dataset.  However, the mean-clustering-imputation method is not 
suitable for use when the missing values are found more frequently in 
categorical attributes. 
 Finally, the study proposes a prediction model to predict misclassified 
instances using clinical properties as the predictors.  The model was 
developed based on the UK dataset, using the LMT algorithm.  Furthermore, 
the model could benefit an ACS DSS by reducing automation bias. 
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9.2. Main Research Contributions 
 The main contributions to research have been to achieve the 
Objectives of the study, as listed in Chapter 1: 
Objective 1:  This research has developed ACS mortality prediction models 
using DM and ML techniques that fit the Malaysian and UK datasets, and a 
generic dataset geared to both demographics. 
Objective 2:  This research has investigated ML feature selection methods 
and techniques for building simpler models with improved prediction power.  
The research also has evaluated the potency of existing sets of predictors to 
be adapted to other ACS registries data.  Furthermore, the strength of 
predictors from different clinical categories in contributing to model 
development has also investigated. 
Objective 3: This research has analysed the misclassification cases in 
constructing the prediction models and has identified the causes of 
performance degradation for the datasets.  A prediction model to predict 
misclassified instances of the dataset using clinical information as predictors 
has also developed. 
Objective 4:  This research has investigated and evaluated ML optimization 
strategies to  address an imbalanced dataset and missing values.  The new 
overlapped-undersampling method to handle imbalanced datasets and 
mean-clustering-imputation method  to handle missing values have been 
developed and compared with existing methods. 
9.3. Limitations and Future Researches 
 Even though we have built competitive models specific to the 
Malaysian and UK datasets, and also a model that can support both cohorts, 
we noted that the models still need further validations on new datasets from 
various cohorts and settings.  Particularly in the case of the Malaysian 
dataset, the collaboration will continue to validate the model on the latest 
NCVD data. 
 The sets of algorithms that best suit the studied datasets need to 
further validated on other medical datasets, as well as datasets of different 
domains but with similar characteristics, to further affirm generalizability of 
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the algorithms towards those datasets which have similar characteristics.  In 
addition, the study has observed the effect of ML algorithms on datasets 
limited to only simple dataset characteristics, such as number of predictors,  
number of samples,  percentages in the minority and majority classes,  
percentage of categorical and numerical predictors, and percentage of 
missing values in evaluating the best set of algorithms for the datasets.  This 
work should be extended further by measuring statistical characteristics of 
the datasets, such as kurtosis, skewness, and correlations, as applied in the 
comparison of ML algorithms studies by King et al. (1995) and Ali and Smith 
(2006). 
 In the misclassification analysis study, the study only evaluated 
misclassified instances limited to the five best algorithms found in this study.  
Misclassification analysis of other popular algorithms, such as NN, RF, and 
DT, should provide deeper insight into the matter.  In fact, the results of 
model development on other algorithms in the study are sufficient to be 
extracted and further analysed the matter. 
 In this study, overlapped instances in the minority class were found to 
be the underlying problem of the minority class.  This is an important finding 
for future research, especially in the context of an imbalanced dataset. 
 Future research also should extend this work to assess the feasibility 
and benefits of the model in a practical clinical setting, especially in 
Malaysia, as the NCVD registry is now more easily accessed by the author 
as a result of this research .  Furthermore, there is a bright opportunity to  
develop further a long-term ACS prediction model for the Malaysian dataset 
after considering the availability of PCI treatment information for ACS 
patients in the NCVD registry.  In fact, PCI-specific prognosis models may 
also be constructed, thus leading to another vital contribution towards 
improving overall cardiac care in Malaysia. 
 On top of that, improvement strategies will also be brought forward to 
the NCVD team based on the findings and experiences gained from this 
study.  The enhancement is targeted mainly on improving the quality of the 
data dictionary and supporting documents to better prepare the registry for 
adverse body of researchers.  
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 In addition, it is suggested that the NCVD dataset to be made publicly 
available.  For instance, with strict de-identification of patients, the sample of 
the dataset can be shared with 
theUCIMLrepository(https://archive.ics.uci.edu/ml/datasets.html).  This 
allows the dataset to be accessed by not only to medical researchers, but 
also by other groups, such as DM and ML communities or those involved in 
big data studies.  Moreover, this offers an opportunity for new and 
unexpected research questions, apart from stimulating innovative ideas.  For 
instance, ML researchers can look further into overlapped instances in 
minority classes so as to address the underlying problem of an imbalanced 
dataset. 
9.4. Conclusion 
 The value of developing ACS prediction models using ML has been 
successfully presented in this study.  Competitive ACS prediction models 
using ML have been developed by demonstrating the practical application of 
different ML algorithms and methods.  Evaluation of predictors of existing 
ACS models, and of different clinical categories, has provided insight into 
how to construct better ACS prediction models.  Misclassification analysis 
has identified the underlying problem of imbalanced datasets as overlapped 
instances in the minority classes.  In addition, missing values were also 
found to be one of the critical problems in misclassified instances in the 
datasets.  The proposed correction method, i.e., the overlapped-
undersampling method, used to handle imbalanced datasets failed to 
improve model performance.  Other existing methods of handling 
imbalanced datasets, such as bagging, random undersampling, and voting, 
also seemed to fail in improving the overall performance of the models.  
Nonetheless, having a larger sample size was found to be a convincingly 
better way to tackle issue of imbalanced datasets.   Furthermore, the 
proposed mean-clustering-imputation method for filling in missing values 
displayed improvement in terms of model performance in comparison to the 
simple imputation method and the algorithms‘ built-in methods.  However, 
removing instances with missing values after feature selection is indeed the 
best way of handling missing values for the datasets. 
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Appendix A : The Datasets 
A.1  Malaysian Dataset 
A.1.1 Summary of Attributes 
No Attributes Description Data Element Clinical Category Data Type 
1 patientid Patient Id DB   ID 
2 patientnotifid Patient Notification Id DB   ID 
3 sdpid Centre/Hospital Id Clinical Admission ID 
4 contactinstitutionname Centre/Hospital Name Clinical Admission Categorical 
5 dateadmission Date of Admission Clinical Admission Categorical 
6 ptdatebirth Date of birth Clinical Demographic Date 
7 yradmit Year admit Clinical Admission Numerical 
8 yrDOB Year date of birth Clinical Demographic Numerical 
9 currentptoutcomeid Outcome id Clinical Clinical Outcome ID 
10 siteid Centre/Hospital Id Clinical Admission ID 
11 patientoutcomeid Outcome id Clinical Clinical Outcome ID 
12 patientfuid **Unknown **Unknown **Unknown ID 
13 ptoutcome30 30 days outcome Clinical Clinical Outcome Categorical 
14 dateoutcome Date of In-hospital outcome Clinical Clinical Outcome Date 
15 jpn_dateofdeath JPN date of death Non-Clinical JPN Date 
16 jpn_causeofdeath JPN cause of death Non-Clinical JPN Categorical 
17 jpnmatchingstatus JPN matching status Non-Clinical JPN Categorical 
18 outdate30 Date of 30 days outcome Clinical 30 days outcome Date 
19 deathdate Death date Clinical Clinical Outcome Date 
20 ptoutcome In-hospital outcome Clinical Clinical Outcome Categorical 
21 yr_outcome Year of outcome Clinical Clinical Outcome Numerical 
22 ptsex Gender Clinical Demographic Categorical 
23 ptrace Race Clinical Demographic Categorical 
24 ptraceothermsian Other Malaysian race Clinical Demographic Categorical 
25 ptraceothermsianspecify Other specified Malaysian race Clinical Demographic Categorical 
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26 ptraceforeignspecify Other specified foreign race Clinical Demographic Categorical 
27 ptnationality Nationality Clinical Demographic Categorical 
28 acsstratum ACS Stratum Clinical Clinical Diagnosis Categorical 
29 troponini Peak Troponin TnI Clinical Clinical Investigations and 
Examinations 
Numerical 
30 troponinive Peak Troponin TnI - Positive Clinical Clinical Investigations and 
Examinations 
Categorical 
31 troponint Peak Troponin TnT Clinical Clinical Investigations and 
Examinations 
Numerical 
32 troponintve Peak Troponin TnT- Positive Clinical Clinical Investigations and 
Examinations 
Categorical 
33 ultroponini Reference upper limit for Troponin TnI Clinical Clinical Investigations and 
Examinations 
Numerical 
34 ultroponint Reference upper limit for Troponin TnT Clinical Clinical Investigations and 
Examinations 
Numerical 
35 ptageatnotification Age at notification Clinical Demographic Numerical 
36 smokingstatus Smoking status Clinical Status Before Event - Smoking 
Status 
Categorical 
37 statusaspirinuse Status of aspirin use Clinical Status Before Event - Aspirin 
Used 
Categorical 
38 cdys History of dyslipidaemia Clinical Status Before Event - Past 
Medical History 
Categorical 
39 cdm History of diabetes Clinical Status Before Event - Past 
Medical History 
Categorical 
40 chpt History of hypertension Clinical Status Before Event - Past 
Medical History 
Categorical 
41 cpremcvd History of premature cardiovascular disease Clinical Status Before Event - Past 
Medical History 
Categorical 
42 cmi History of MI Clinical Status Before Event - Past 
Medical History 
Categorical 
43 ccap History of documented cad > 50% stenosis Clinical Status Before Event - Past 
Medical History 
Categorical 
44 canginamt2wk History of chronic angina more than 2 weeks ago Clinical Status Before Event - Past 
Medical History 
Categorical 
45 canginapast2wk History of chronic angina less than 2 weeks ago Clinical Status Before Event - Past 
Medical History 
Categorical 
46 cheartfail History of heart failure Clinical Status Before Event - Past 
Medical History 
Categorical 
47 clung History of chronic lung disease Clinical Status Before Event - Past 
Medical History 
Categorical 
48 crenal History of renal disease Clinical Status Before Event - Past Categorical 
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Medical History 
49 ccerebrovascular History of cerebrovascular disease Clinical Status Before Event - Past 
Medical History 
Categorical 
50 cpvascular History of peripheral vascular disease Clinical Status Before Event - Past 
Medical History 
Categorical 
51 cnone None of the stated history disease Clinical Status Before Event - Past 
Medical History 
Categorical 
52 dateonsetacs Date on ACS Clinical Onset Presentation Date 
53 timeonsetacs Time onset ACS Clinical Onset Presentation Date 
54 timeonsetacsna (Not Applicable) Time onset ACS Clinical Onset Presentation Categorical 
55 dateptpresented Date presented  ACS Clinical Onset Presentation Date 
56 timeptpresented Time presented ACS Clinical Onset Presentation Date 
57 timeptpresentedna (Not Applicable) Time presented ACS Clinical Onset Presentation Categorical 
58 transferred Is patient transferred from another centre Clinical Onset Presentation Categorical 
59 anginaepisodeno Number of distinct episode of angina in past 24hrs Clinical Clinical Presentation Numerical 
60 anginaepisodena (Not Applicable) Number of distinct episode of 
angina in past 24hrs 
Clinical Clinical Presentation Categorical 
61 heartrate Heart rate Clinical Clinical Presentation Numerical 
62 bpsys SBP Clinical Clinical Presentation Numerical 
63 bpdias Diastolic BP Clinical Clinical Presentation Numerical 
64 height Height Clinical Clinical Presentation Numerical 
65 heightna (Not Applicable) Height Clinical Clinical Presentation Categorical 
66 weight Weight Clinical Clinical Presentation Categorical 
67 weightna (Not Applicable) Weight Clinical Clinical Presentation Categorical 
68 bmi BMI Clinical Clinical Presentation Numerical 
69 waistcircumf Waist Circumference Clinical Clinical Presentation Numerical 
70 waistcircumfna (Not Applicable) Waist Circumference Clinical Clinical Presentation Categorical 
71 hipcircumf Hip Circumference Clinical Clinical Presentation Numerical 
72 hipcircumfna (Not Applicable) Hip Circumference Clinical Clinical Presentation Categorical 
73 whr WHR Clinical Clinical Presentation Categorical 
74 killipclass Killip class Clinical Clinical Diagnosis Categorical 
75 ecgabnormtypestelev1 ECG Abnormalities - ST - segment elevation >=1mm 
in >=2 contiguous limb leads 
Clinical ECG Categorical 
76 ecgabnormtypestelev2 ECG Abnormalities - ST - segment elevation >=2mm 
in >=2 contiguous limb leads 
Clinical ECG Categorical 
77 ecgabnormtypestdep ECG Abnormalities - ST - segment elevation >=0.5mm 
in >=2 contiguous limb leads 
Clinical ECG Categorical 
78 ecgabnormtypetwave ECG Abnormalities - T-Wave inversion Clinical ECG Categorical 
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79 ecgabnormtypebbb ECG Abnormalities - Bundle Branch Block Clinical ECG Categorical 
80 ecgabnormtypenonspecific ECG Abnormalities - Non specific Clinical ECG Categorical 
81 ecgabnormtypenone ECG Abnormalities - None Clinical ECG Categorical 
82 ecgabnormtypenotstated ECG Abnormalities - Not stated Clinical ECG Categorical 
83 ecgabnormlocationil ECG Abnormalities Location - Inferior leads : II, III, 
aVF 
Clinical ECG Categorical 
84 ecgabnormlocational ECG Abnormalities Location - Anterior Leads : V1 and 
V4 
Clinical ECG Categorical 
85 ecgabnormlocationll ECG Abnormalities Location - Lateral Leads - I, sVL, 
v5 and v6 
Clinical ECG Categorical 
86 ecgabnormlocationtp ECG Abnormalities Location - True Posterior : V1, v2 Clinical ECG Categorical 
87 ecgabnormlocationrv ECG Abnormalities Location - Right Ventricle : ST 
Elevation in Lead V4R 
Clinical ECG Categorical 
88 ecgabnormlocationnone ECG Abnormalities Location - None Clinical ECG Categorical 
89 ecgabnormlocationnotstated ECG Abnormalities Location - Not Stated Clinical ECG Categorical 
90 ckmb Peak CKMB Clinical Clinical Investigations and 
Examinations 
Numerical 
91 ulckmb Upper limit Peak CKMB Clinical Clinical Investigations and 
Examinations 
Numerical 
92 notdoneckmb (Not done) Peak CKMB Clinical Clinical Investigations and 
Examinations 
Categorical 
93 ck Peak CK Clinical Clinical Investigations and 
Examinations 
Numerical 
94 ulck Upper limit Peak CK Clinical Clinical Investigations and 
Examinations 
Categorical 
95 notdoneck (Not done) Peak CK Clinical Clinical Investigations and 
Examinations 
Categorical 
96 notdonetroponint (Not done) Peak troponin TNT Clinical Clinical Investigations and 
Examinations 
Categorical 
97 notdonetroponini (Not done) Peak troponin TN1 Clinical Clinical Investigations and 
Examinations 
Categorical 
98 tc Total Cholesterol Clinical Clinical Investigations and 
Examinations 
Numerical 
99 notdonetc (Not done) Total Cholesterol Clinical Clinical Investigations and 
Examinations 
Categorical 
100 hdlc HDL-C Clinical Clinical Investigations and 
Examinations 
Numerical 
101 notdonehdlc (Not done) HDL-C Clinical Clinical Investigations and 
Examinations 
Categorical 
102 ldlc LDL-C Clinical Clinical Investigations and 
Examinations 
Numerical 
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103 notdoneldlc (Not done) LDL-C Clinical Clinical Investigations and 
Examinations 
Categorical 
104 tg Triglycerides Clinical Clinical Investigations and 
Examinations 
Numerical 
105 notdonetg (Not done) Triglycerides Clinical Clinical Investigations and 
Examinations 
Categorical 
106 fbg Fasting Blood Glucose Clinical Clinical Investigations and 
Examinations 
Numerical 
107 notdonefbg (Not done) Fasting Blood Glucose Clinical Clinical Investigations and 
Examinations 
Categorical 
108 lvef Left Ventricular Ejection Fraction  Clinical Clinical Investigations and 
Examinations 
Numerical 
109 notdonelvef (Not done) Left Ventricular Ejection Fraction Clinical Clinical Investigations and 
Examinations 
Categorical 
110 timiscorestemi TIMI Score for STEMI Clinical Clinical Diagnosis Numerical 
111 timiscorenstemi TIMI Score for NSTEMI/UAP Clinical Clinical Diagnosis Numerical 
112 fbstatus Fibrinolytic Therapy status Clinical Treatment and Interventions Categorical 
113 fbdrugused Fibrinolytic Drugs used Clinical Treatment and Interventions Categorical 
114 dateivfb Date intravenous fibrinolytic therapy Clinical Treatment and Interventions Date 
115 timeivfb Time intravenous fibrinolytic therapy Clinical Treatment and Interventions Date 
116 doortoneedletime Door to needle time Clinical Treatment and Interventions Numerical 
117 cardiaccath Patient undergo Cardiac catheterization Clinical Treatment and Interventions Categorical 
118 pci Patient undergo PCI Clinical Treatment and Interventions Categorical 
119 pcistemi Patient received PCI STEMI Clinical Treatment and Interventions Categorical 
120 pcistemiurgent Patient received PCI STEMI - Urgent Clinical Treatment and Interventions Categorical 
121 pcistemielective Patient received PCI STEMI - Elective Clinical Treatment and Interventions Categorical 
122 pcinstemi Patient received PCI NSTEMI Clinical Treatment and Interventions Categorical 
123 pcinstemielective Patient received PCI NSTEMI - elective Clinical Treatment and Interventions Categorical 
124 disvesselno Number of diseased vessels Clinical Treatment and Interventions Numerical 
125 lminvolve Left main stem involvement Clinical Treatment and Interventions Categorical 
126 culpritartery Culprit artery  Clinical Treatment and Interventions Categorical 
127 date1stangioballoon Date of First balloon inflation - for urgent PCI Clinical Treatment and Interventions Date 
128 time1stangioballoon Time of First balloon inflation - for urgent PCI Clinical Treatment and Interventions Date 
129 doortoballoontime Door to balloon time - Urgent PCI Clinical Treatment and Interventions Numerical 
130 iraprepci TIMI flow classification pre-PCI Clinical Treatment and Interventions Categorical 
131 iraintract Present of Intra-coronary thrombus Clinical Treatment and Interventions Categorical 
132 irapostpci TIMI flow classification post-PCI Clinical Treatment and Interventions Categorical 
133 pcitype PCI Type Clinical Treatment and Interventions Categorical 
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134 pcitypestentdirect Is PCI Type (Stenting) - Direct Stenting Clinical Treatment and Interventions Categorical 
135 pcitypestentpredilat Is PCI Type (Stenting) - Pre dilatation Clinical Treatment and Interventions Categorical 
136 pcitypestentbms Is PCI Type (Stenting) - Drug Eluting Clinical Treatment and Interventions Categorical 
137 pcitypestentdes Is PCI Type (Stenting) - Bare-metal Clinical Treatment and Interventions Categorical 
138 cabg CABG therapy given during admission? Clinical Treatment and Interventions Categorical 
139 datecabg Date of CABG therapy  Clinical Treatment and Interventions Date 
140 asapre Aspirin Clinical Medical - Pre Admission Categorical 
141 asa Aspirin Clinical Medical - During Admission Categorical 
142 asapost Aspirin Clinical Medical - Post Admission Categorical 
143 adpapre ADP Antagonist Clinical Medical - Pre Admission Categorical 
144 adpa ADP Antagonist Clinical Medical - During Admission Categorical 
145 adpapost ADP Antagonist Clinical Medical - Post Admission Categorical 
146 gpripre GP receptor inhibitor Clinical Medical - Pre Admission Categorical 
147 gpri GP receptor inhibitor Clinical Medical - During Admission Categorical 
148 gpripost GP receptor inhibitor Clinical Medical - Post Admission Categorical 
149 heparinpre Unfrac Heparin Clinical Medical - Pre Admission Categorical 
150 heparin Unfrac Heparin Clinical Medical - During Admission Categorical 
151 heparinpost Unfrac Heparin Clinical Medical - Post Admission Categorical 
152 lmwhpre LMWH Clinical Medical - Pre Admission Categorical 
153 lmwh LMWH Clinical Medical - During Admission Categorical 
154 lmwhpost LMWH Clinical Medical - Post Admission Categorical 
155 bbpre Beta Blocker Clinical Medical - Pre Admission Categorical 
156 bb Beta Blocker Clinical Medical - During Admission Categorical 
157 bbpost Beta Blocker Clinical Medical - Post Admission Categorical 
158 aceipre ACE Inhibitor Clinical Medical - Pre Admission Categorical 
159 acei ACE Inhibitor Clinical Medical - During Admission Categorical 
160 aceipost ACE Inhibitor Clinical Medical - Post Admission Categorical 
161 arb Angiotensin II Receptor blocker Clinical Medical - During Admission Categorical 
162 arbpre Angiotensin II Receptor blocker Clinical Medical - Pre Admission Categorical 
163 arbpost Angiotensin II Receptor blocker Clinical Medical - Post Admission Categorical 
164 statinpre Statin Clinical Medical - Pre Admission Categorical 
165 statin Statin Clinical Medical - During Admission Categorical 
166 statinpost Statin Clinical Medical - Post Admission Categorical 
167 lipidlapre Other lipid lowering agent Clinical Medical - Pre Admission Categorical 
168 lipidla Other lipid lowering agent Clinical Medical - During Admission Categorical 
169 lipidlapost Other lipid lowering agent Clinical Medical - Post Admission Categorical 
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170 diureticpre Diuretics Clinical Medical - Pre Admission Categorical 
171 diuretic Diuretics Clinical Medical - During Admission Categorical 
172 diureticpost Diuretics Clinical Medical - Post Admission Categorical 
173 calcantagonistpre Calcium antagonist Clinical Medical - Pre Admission Categorical 
174 calcantagonist Calcium antagonist Clinical Medical - During Admission Categorical 
175 calcantagonistpost Calcium antagonist Clinical Medical - Post Admission Categorical 
176 oralhypoglypre Oral Hypoglycaemic agent Clinical Medical - Pre Admission Categorical 
177 oralhypogly Oral Hypoglycaemic agent Clinical Medical - During Admission Categorical 
178 oralhypoglypost Oral Hypoglycaemic agent Clinical Medical - Post Admission Categorical 
179 insulinpre Insulin Clinical Medical - Pre Admission Categorical 
180 insulin Insulin Clinical Medical - During Admission Categorical 
181 insulinpost Insulin Clinical Medical - Post Admission Categorical 
182 antiarrpre Anti-Arrhythmic Clinical Medical - Pre Admission Categorical 
183 antiarr Anti-Arrhythmic Clinical Medical - During Admission Categorical 
184 antiarrpost Anti-Arrhythmic Clinical Medical - Post Admission Categorical 
185 dayccu Number of days in CCU Clinical Clinical Outcome Numerical 
186 dayicu Number of days in ICU Clinical Clinical Outcome Numerical 
187 totaldaystay Total number of stay in the hospital Clinical Clinical Outcome Numerical 
188 diagatdischarge Diagnosis at Discharge Clinical Clinical Outcome Categorical 
189 bleedingepisodecriteria Bleeding Complication Clinical Clinical Outcome Categorical 
190 zdaygenward Number of days in general hospital Clinical Clinical Outcome Categorical 
191 diff_op **Unknown **Unknown **Unknown Categorical 
192 sdpcode Centre/Hospital code Clinical Admission Categorical 
193 state State of the admission centre/hospital Clinical Admission Categorical 
194 agegp Age group Clinical Demographic Categorical 
195 deathcause Cause of death Clinical Clinical Outcome Categorical 
196 deathcausespecify Cause of death - specify Clinical Clinical Outcome Text 
197 transfercentre Transfer centre Clinical Clinical Outcome Categorical 
198 transfercentrespecify Specified transfer centre Clinical Clinical Outcome Text 
199 yeardeath Year of death Clinical Clinical Outcome Numerical 
200 totaladmday total admission day Clinical Clinical Outcome Numerical 
201 ptoutcome1 Patient outcome Clinical Clinical Outcome Categorical 
202 fbstatus_new Fibrinolytic Therapy status Clinical Treatment and Interventions Categorical 
203 dateoutcome30 Date of 30 days outcome Clinical Clinical Outcome Date 
204 deathcause30 Cause of death of 30 days outcome Clinical Clinical Outcome Categorical 
205 deathcausespecify30 Specified cause of death of 30 days outcome Clinical Clinical Outcome Text 
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206 transfercentre30 Transfer centre Clinical Clinical Outcome Categorical 
207 transfercentrespecify30 Specified transfer centre Clinical Clinical Outcome Text 
208 _merge **Unknown **Unknown **Unknown Categorical 
209 ptoutcome30a 30 days outcome Clinical Clinical Outcome Categorical 
210 ind **Unknown **Unknown **Unknown Categorical 
211 admission_revised **Unknown **Unknown **Unknown Numerical 
212 admission_string **Unknown **Unknown **Unknown Categorical 
213 DOB_revised **Unknown **Unknown **Unknown Numerical 
214 DOB_string **Unknown **Unknown **Unknown Numerical 
215 age_admit Age at notification Clinical Demographic Numerical 
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A.1.2 List of Duplicate Attributes 




The attributes represents the 
centre/ hospital that a patient 
admitted to.  
Retained only sdpid.  
However, the reference name 
of each hospital is kept.  The 
name of each hospital is 
represented by attribute 
contactinstitutionname. 
patientidpatientnotifid Since it has been decided to have 
only the first entry of each 
patient, patientid and 
patientnotifid attributes are now 
considered duplicates as they are 
both represents unique values. 
Patientid is used as the 




ptageatnotification, age_admit Both attributes represent the age 
of a patient on admission. 
Ptageatnotification is 
specified in the NCVD data 
dictionary.  Thus, it is 
assumed that 
ptageatnotification is the 
true referred attribute for 
age on admission. 
Removed age_admit. 
ptoutcome/ptoutcome1 The attributes hold the in-hospital 
mortality outcome of a patient. 
ptoutcome is specified in the 
NCVD data dictionary.  Thus, 
it is assumed that ptoutcome 
is the true referred attribute 
in-hospital mortality 
outcome.   
Removed ptoutcome1. 
ptoutcome30, ptoutcome30a The attributes hold the 30 days 
hospital mortality outcome of a 
patient. 
Removed ptoutcome30a. 
dateadmission,Admission_revised The attributes hold the date of 
admission of each patient in the 
dataset. 
dateadmission is specified in 
the NCVD data dictionary.  
Thus, it is assumed that 
dateadmission is the true 
referred attribute for date of 
admission. 
Removed Admission_revised. 
ptdatebirth, DOB_revised The attributes hold the date of 
birth of each patient in the 
dataset. 
ptdatebirth is specified in the 
NCVD data dictionary.  Thus, 
it is assumed that ptdatebirth 
is the true referred attribute 
for date of birth 
Removed DOB_revised. 
totaldaystay, totaladmday The attributes hold the number of 
days stay in the hospital of each 
patient in the database.   
totaldaystay is specified in 
the NCVD data dictionary.  
Thus, it is assumed that 
totaldaystay is the true 
referred attribute for date of 
birth 
Removed totaladmday 
fb_status/fb_statusnew The attributes hold the fibrinolytic 
therapy status of each patient in 
the database.   
Removed fb_statusnew 
outcomedate, deathdate.  The attributes hold the outcome 
date of each patient in the 
database.   
Deathdate - The value is in 
number which cannot be 
identified on the date.  The date 
Values in deathdate are in 
numbers which cannot be 
identified as date.  The date 
of death of a patient is 
actually the outcome date as 
we considered death as one 
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of death of a patient can be 
identified by using dateoutcome 
 
 
of ACS outcome.   
Removed deathdate 
 
A.1.3 List of Database Attributes 
Attributes Descriptions Decision/Action Taken 
patientoutcomeid The id was generated once the 
outcome decision is made. 
Removed. There is no pattern 
that will affect the outcome 
 
A.1.4 List of Unknown Attributes 
Attributes Description 
currentptoutcomeid Value is either 3, 5 or blanks. But no specific 
description of each value representation.   
patientfuid Value is either zero or blanks. But no specific 
description of each value representation.   
outdate30 Each value is  unique in numbers and does not 
represent any pattern 
diff_op Each value is  unique in numbers and does not 
represent any pattern 
admission_string Each value is  unique in numbers and does not 
represent any pattern 
DOB_string Each value is  unique in numbers and does not 
represent any pattern 
_merge Values are either 1, 3 or Blanks 
zdaygenward Probably number of days in general ward.   
ptnationality Probably the nationality of a patient.   The value is 
either 0, 1 or 2.  But no specific description of each 
value representation.   
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A.1.5 List of Irrelevant Attributes 
Attributes Description 
ptraceothermsian The attribute represents a very specific race yet 
minority group in Malaysia.  The filled out value is 
very small i.e. only n=29 which might not effect 
anything towards the outcome.  Also, the attribute is 
very specific towards Malaysian population. 
 
ptraceothermsianspecify The attribute represents a very specific race yet 
minority group in Malaysia.  The value is captured in 
text format which may not have any standard.  The 
existing filled out value is very small i.e. only n=59 
which might not effect anything towards the 
outcome.   
Also, the attribute is very specific towards Malaysian 
population. 
ptraceforeignspecify The attribute represents the race of foreign patients 
that are admitted for ACS The value is captured in text 
format which may not have any standard.  The 
existing filled out value is very small i.e. only n=131 
which might not effect anything towards the 
outcome.   
Also, the attribute is very specific towards Malaysian 
population. 
ptnationality Supposedly, the attribute represents the nationality of 
a patient.  The value is either 0, 1, 2, 8888 or 9999.  
No logical indication can be made from the values and 
it is not specified in the NCVD data dictionary.   
Also, since it is a national registry all, patients are 
mainly Malaysian.  Non-Malaysian can be identified by 
the attribute ptrace.  This attribute may eventually a 
duplicate to ptrace. 
 













These are attributes that describe in details on each 
therapy or procedure given to a patient.  
Therapy or procedure is given after doctor has 
diagnosed the patient.  Since the aim of the models is 
to help doctors or medical practitioners in making 
diagnosis, therapy or procedure information is not 
considered as predictors. 
However, information on type of therapy/procedure a 
patient received can be the marker to in hospital 
mortality.  It will be beneficial as to use the 
information to evaluate/analyse the population 
characteristic.  Thus, the information on basic type of 










These are attributes that capture information from 
NRDM.  These have no relation to any of ACS event. 
gpripost, heparinpost, lmwhpost 
 
These are attributes that are not captured at all but 
the attributes exists in the dataset.  All values is either 
‘Missing’ or ‘blanks’ 
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A.1.6 List of Non-standardized Data Collection Attributes 
Attributes 
1)    troponini 
2)    troponinive 
3)    troponint 
4)    Troponintve 
5)    Ultroponini 
6)    ultroponint 
7)    ckmb 
8)    ulckmb 





A.1.7 List of Dependant Missing Attributes 
Attributes 
1)    timeonsetacsna 
2)    timeptpresentedna 
3)    heightna 
4)    weightna 
5)    waistcircumfna 
6)    hipcircumfna 
7)    anginaepisodena 
 
A.1.8 List of New Attributes 
No Attributes  Descriptions Type Value 
1 DAYS_ACS_SYMPTOMS_TO
_ADMISSION 
Number of days the patient get the symptoms 
(from the day of admission). 
 
Formula: 
Date of onset of ACS symptoms - Date of 
admission 
 
**NEGATIVE value indicates that ACS 
symptom before the admission 
**POSITIVE value indicates that ACS symptom 
after the admission 
Number 0-365 
- 185 - 
2 ACS_SYMPTOMS_BEFORE_
ADMISSION 
Indicator whether ACS symptoms were 




   If the 
DAYS_ACS_SYMPTOMS_TO_ADMISSION < 0 
and <=  -30 then 1 
   if ( DAYS_ACS_SYMPTOMS_TO_ADMISSION 
>  0  and  < 30 days) then  2 













  TRUE - if all past medical history is FALSE 
  FALSE - if any of the past medical history is 
TRUE 
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A.2  The UK dataset 
A.2.1 Summary of Attributes 





1 ID Id created for the requested dataset Link DB ID ID 
2 Digest Pseudonymised ID  SystemOne DB ID ID 
3 UNID Unique ID  
** Used for information linkage process 
Link DB ID ID 
4 Freq Indicating multiple records in HES Link Clinical Admission Numerical 
5 STARTAGE Age at start of episode  HES Clinical Demographic Numerical 
6 ETHNOS Ethnic category HES Clinical Demographic Categorical 
7 SEX Sex of patient HES Clinical Demographic Categorical 
8 ADMIDATE Date of admission HES Clinical Admission Date 
9 ADMI_CFL **Unknown **Unknown ** Unknown ** Unknown Numerical 
10 ADMIMETH Method of Admission HES Clinical Admission Categorical 
11 ADMISORC Source of Admission HES Clinical Admission Categorical 
12 FIRSTREG First regular day or night admission HES Clinical Admission Categorical 
13 DISDATE Date of discharge HES Clinical Clinical 
Outcome 
Date 
14 DIS_CFL Discharge date check flag HES Clinical Clinical 
Outcome 
Categorical 
15 DISDEST Destination on discharge HES Clinical Clinical 
Outcome 
Categorical 
16 DISMETH Method of discharge HES Clinical Clinical 
Outcome 
Categorical 
17 SPELDUR Duration of spell HES Clinical Clinical 
Outcome 
Numerical 
18 SPELEND End of spell HES Clinical Clinical 
Outcome 
Categorical 
19 EPIORDER Episode order HES Clinical Clinical 
Outcome 
Categorical 
20 DIAG_01 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
21 DIAG_02 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
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22 DIAG_03 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
23 DIAG_04 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
24 DIAG_05 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
25 DIAG_06 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
26 DIAG_07 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
27 DIAG_08 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
28 DIAG_09 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
29 DIAG_10 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
30 DIAG_11 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
31 DIAG_12 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
32 DIAG_13 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
33 DIAG_14 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
34 DIAG_15 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
35 DIAG_16 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
36 DIAG_17 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
37 DIAG_18 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
38 DIAG_19 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
39 DIAG_20 All diagnosis codes HES Clinical Clinical 
Diagnosis 
Categorical 
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52 OPERTN_13 ** Unknown 
** All values are 'NA' 




53 OPERTN_14 ** Unknown 
** All values are 'NA' 




54 OPERTN_15 ** Unknown 
** All values are 'NA' 




55 OPERTN_16 ** Unknown 
** All values are 'NA' 
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56 OPERTN_17 ** Unknown 
** All values are 'NA' 




57 OPERTN_18 ** Unknown 
** All values are 'NA' 




58 OPERTN_19 ** Unknown 
** All values are 'NA' 




59 OPERTN_20 ** Unknown 
** All values are 'NA' 




60 OPERTN_21 ** Unknown 
** All values are 'NA' 




61 OPERTN_22 ** Unknown 
** All values are 'NA' 




62 OPERTN_23 ** Unknown 
** All values are 'NA' 




63 OPERTN_24 ** Unknown 
** All values are 'NA' 
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73 Column_70 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
74 Column_71 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
75 Column_72 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
76 Column_73 ** Unknown ** Unknown ** Unknown ** Unknown ** 
Unknown 
77 Column_74 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
78 Column_75 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
79 Column_76 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
80 Column_77 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
81 Column_78 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
82 Column_79 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
83 Column_80 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
84 Column_81 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
85 Column_82 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
86 Column_83 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
87 Column_84 ** Unknown  
All values are 'NA' 
** Unknown ** Unknown ** Unknown ** 
Unknown 
88 Column_85 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
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89 Column_86 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
90 Column_87 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
91 Column_89 ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
92 dthdate ** Unknown 
Used for information linkage process 
Link DB ** Unknown ** 
Unknown 
93 dthcode ** Unknown 
Used for information linkage process 
Link DB ** Unknown ** 
Unknown 
94 ADMDATE_COUNT ** Unknown 
Used for information linkage process 
Link DB ** Unknown ** 
Unknown 
95 CVTD_ADMIDATE ** Unknown 
Formatted date from ADMIDATE by Steve 
mm/dd/yyyy 
Link ** Unknown ** Unknown Date 
96 Ethnicity Ethnicity ** Unknown Clinical Demographic Categorical 
97 X107_Gender Gender MINAP Clinical Demographic Categorical 
98 X306_EventDate Admission date MINAP Clinical Admission Date 
99 AdmissionDate Admission date and time MINAP Clinical Admission Date 
100 X107.Gender Gender MINAP Clinical Demographic Categorical 
101 Ethnic.Group...V83 Ethnic Group ** Unknown Clinical Demographic Categorical 
102 X201.Admission.Diagnosis Initial Diagnosis MINAP Clinical Clinical 
Diagnosis 
Categorical 
103 Method.of.Admission...V83 Method of Admission ** Unknown Clinical Admission Categorical 
104 X203.ECG.Determining.Treatment ECG determining treatment MINAP Clinical ECG Categorical 
105 X204.Where.Aspirin.Given Where was aspirin/other antiplatelet given MINAP Clinical Status Before 
Event - Status 
of Aspirin 
Categorical 
106 X205.Previous.AMI  Previous AMI MINAP Clinical Status Before 




107 X206.Previous.Angina Previous angina MINAP Clinical Status Before 




108 X207.Hypertension History of Hypertension MINAP Clinical Status Before 




109 X208.Hypercholesterolaemia History of  Hypercholesterolaemia MINAP Clinical Status Before 
Event - Past 
Categorical 
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Medical 
History 
110 X209.Peripheral.Vascular.Disease History of Peripheral Vascular Disease MINAP Clinical Status Before 




111 X210.Cerebrovascular.Disease History of Cerebrovascular Disease MINAP Clinical Status Before 




112 X211.Asthma.or.COPD History of Asthma or COPD MINAP Clinical Status Before 




113 X212.Chronic.Renal.Failure History of Chronic Renal Failure MINAP Clinical Status Before 




114 X213.Heart.Failure History of Heart Failure MINAP Clinical Status Before 




115 X214.Enzymes.Elevated History of Enzymes Elevated MINAP Clinical Status Before 














118 X217.Diabetes History of Diabetes MINAP Clinical Status Before 




119 X218.Previous.PCI Previous PCI MINAP Clinical Status Before 
Event - Past 
Treatment 
Categorical 
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120 X219.Previous.CABG Previous CABG MINAP Clinical Status Before 
Event - Past 
Treatment 
Categorical 
121 X220.Systolic.BP SBP MINAP Clinical Clinical 
Presentation 
Numerical 
122 X221.Heart.Rate Heart Rate MINAP Clinical Clinical 
Presentation 
Numerical 
123 X222.Admitting.Consultant Type of admitting consultant MINAP Clinical Admission Categorical 
124 X223.Place.ECG.Performed Place ECG Performed MINAP Clinical ECG Categorical 
125 X224.Beta.Blocker Beta Blocker MINAP Clinical Medical - Pre 
Admission 
Categorical 
126 X225.ACE.I.or.ARB ACE.I or ARB MINAP Clinical Medical - Pre 
Admission 
Categorical 
127 X226.Statin Statin MINAP Clinical Medical - Pre 
Admission 
Categorical 
128 Clopidogrel Clopidogrel ** Unknown Clinical Medical - Pre 
Admission 
Categorical 
129 X228.Glucose Serum glucose MINAP Clinical Clinical 
Presentation 
Numerical 
130 X229.Height Height MINAP Clinical Clinical 
Presentation 
Numerical 
131 X230.Weight Weight MINAP Clinical Clinical 
Presentation 
Numerical 





133 X232.Family.History.of.CHD Family History of CHD MINAP Clinical Status Before 














136 X235.Haemoglobin Haemoglobin MINAP Clinical Clinical 
Investigations 
Numerical 
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and 
Examinations 
137 X236.Site.of.Infarction Site of Infarction MINAP Clinical ECG Categorical 
138 X237.ECG.QRS.Complex.duration ECG QRS Complex duration MINAP Clinical ECG Categorical 
139 X238.Thienopyridine.inhibitor.use Thienopyridine inhibitor use MINAP Clinical Medical - Pre 
Admission 
Categorical 
140 X239.Admission.Method Admission.Method MINAP Clinical Admission Categorical 
141 X240.Patient.location.at.STEMI.onset Patient location at STEMI onset MINAP Clinical Onset 
Presentation 
Categorical 
142 X241.Killip.Class Killip Class MINAP Clinical Clinical 
Presentation 
Categorical 
143 X301.Symptom.Onset Date Symptom Onset MINAP Clinical Onset 
Presentation 
Date 
144 X302.Call.for.Help Date Call for Help MINAP Clinical Admission Date 
145 X303.Arrival.1st.Responder Date Arrival.1st.Responder MINAP Clinical Admission Date 
146 X304.Arrival.Ambulance Date Arrival Ambulance MINAP Clinical Admission Date 
147 X306.Arrival.at.Hospital Date Arrival at Hospital 
 
** Arrival at the hospital is the same as date of 
admission 
MINAP Clinical Admission Date 




















153 X313.1st.Cardiac.Arrest Cardiac arrest date/time - FIRST ARREST ONLY MINAP Clinical Onset 
Presentation 
Date 
154 X314.Where.cardiac.arrest Cardiac arrest location MINAP Clinical Onset 
Presentation 
Categorical 
155 X315.Presenting.Rhythm Arrest presenting rhythm MINAP Clinical Onset Categorical 
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Presentation 
156 X316.Outcome.of.arrest Outcome of arrest MINAP Clinical Onset 
Presentation 
Categorical 
157 X317.Admission.Ward Admission ward MINAP Clinical Admission Categorical 






















163 Other.Oral.Antiplatelet...V7 ** Other Oral Antiplatelet ** Unknown Clinical Medical Categorical 
























170 X331.Warfarin Warfarin MINAP Clinical Medical - Categorical 
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During 
Admission 
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185 X346.Arrival.at.non.interventional.hospital Arrival at non. intervention hospital MINAP Clinical Admission Date 
186 X347.Assess.at.non.intevention.hospital Assess at non-intervention hospital MINAP Clinical Admission Categorical 
187 X348.Assess.at.Intervention.Centre Assess at Intervention Centre MINAP Clinical Admission Categorical 

















192 X401.Discharge.Date X401.Discharge.Date MINAP Clinical Clinical 
Outcome 
Date 
193 X402.Discharge.Diagnosis X402.Discharge.Diagnosis MINAP Clinical Clinical 
Outcome 
Categorical 
194 X403.Bleeding.Complications X403.Bleeding.Complications MINAP Clinical Clinical 
Outcome 
Categorical 
195 X404.Death.in.Hospital X404.Death.in.Hospital MINAP Clinical Clinical 
Outcome 
Categorical 
















200 X409.Cardiac.Rehab X409.Cardiac.Rehab MINAP Clinical Clinical Categorical 
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Outcome - 
Rehab 
























206 X415.Referral.Date Referral Date MINAP Clinical Admission Date 
207 X416.Discharge.Destination Discharge Destination MINAP Clinical Clinical 
Outcome 
Categorical 
208 X417.Daycase.Transfer.date Day case Transfer date MINAP Clinical Clinical 
Outcome 
Date 








211 X423.Followed.up Followed up MINAP Clinical Clinical 
Outcome 
Categorical 
212 X424.Reinfarction Reinfarction MINAP Clinical Onset 
Presentation 
Categorical 




214 X426.Return.to.Referring.Hospital Return to Referring Hospital MINAP Clinical Clinical 
Outcome 
Categorical 
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220 CTH ** Unknown ** Unknown ** Unknown ** Unknown Numerical 
221 DTN ** Unknown ** Unknown ** Unknown ** Unknown Numerical 
222 CTN ** Unknown ** Unknown ** Unknown ** Unknown Numerical 
223 OTH ** Unknown ** Unknown ** Unknown ** Unknown Numerical 
224 OTN ** Unknown ** Unknown ** Unknown ** Unknown Numerical 
225 Age.At.Admission Age at admission MINAP Clinical Demographic Numerical 
226 Apollo...Pseudonymised.103.NHS.Number Pseudonymised NHS Number Link Clinical ID ID 
227 Hermes...Pseudonymised.101.Hospital.Code Pseudonymised Hospital Code Link Clinical ID ID 
228 Artemis...Pseudonymised.101.Hospital.Code...102.
Hospital.Numbe 
Pseudonymised Hospital Number Link Clinical ID ID 
229 Geo...IMDScore ** Unknown 
Geographical score 
** Unknown Non-Clinical Geographical-
Score 
Numerical 
230 Geo...IMDRank ** Unknown 
Geographical score 
** Unknown Non-Clinical Geographical-
Score 
Numerical 
231 Geo...HealthScore ** Unknown 
Geographical score 
** Unknown Non-Clinical Geographical-
Score 
Numerical 
232 Geo...HealthRank ** Unknown 
Geographical score 
** Unknown Non-Clinical Geographical-
Score 
Numerical 
233 Geo...Easting ** Unknown 
Geographical score 
** Unknown Non-Clinical Geographical-
Score 
Numerical 
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234 Geo...Northing ** Unknown 
Geographical score 
** Unknown Non-Clinical Geographical-
Score 
Numerical 
235 validNHS ** Unknown ** Unknown ** Unknown ** Unknown Categorical 
236 Sex Sex of patient ** Unknown Clinical Demographic Categorical 
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A.2.2 List of Duplicate Attributes 
Set of attributes Description Decision/Action Taken 
STARTAGE, Age.At.Admission Both attributes represent the age 
of a patient on admission. 
Removed STARTAGE. 
SEX, X107_Gender, X107.Gender, Sex All attributes represent the gender 
of a patient 




ETHNOS, Ethnicity, Ethnic.Group...V83 The attributes hold the information 
about the ethnic group of a patient 
ETHNOS is specified in the 







The attributes hold the information 
on admission date of a patient 
X306_EventDate and 
AdmissionDate are from 
MINAP.  AdmissionDate is 
selected because it 









The attributes hold method of 
admission 
Removed X239.Admission 
Method  because it has all 
blanks values except for 1 
record 
 
Decided that ADMINMETH 
and Method of Admission 
v83 is two different things 
DISDATE, X401.Discharge.Date The attributes hold the date of 
discharge of a patient 
X401.Discharge.Dateis 
from MINAP.   
Since DISDATE is removed, 
DIS_CFL is also removed 
since the attribute relates 




A.2.3 List of Database Attributes 
Attributes 
1)    Digest 
2)    Apollo...Pseudonymised.103.NHS.Number 
3)    Hermes...Pseudonymised.101.Hospital.Code 
4)    Artemis...Pseudonymised.101.Hospital.Code...102.Hospital.Numbe 
5)    ADMDATE_COUNT 
6)    CVTD_ADMIDATE 
7)    UNID 
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A.2.4 List of One-value Attributes 
Attributes Descriptions 
SPELEND All values are ‘Y’ 
DIAG_15 All values are ‘NA’ 
DIAG_16 All values are ‘NA’ 
DIAG_17 All values are ‘NA’ 
DIAG_18 All values are ‘NA’ 
DIAG_19 All values are ‘NA’ 
DIAG_20 All values are ‘NA’ 
OPERTN_13 All values are ‘NA’ 
OPERTN_14 All values are ‘NA’ 
OPERTN_15 All values are ‘NA’ 
OPERTN_16 All values are ‘NA’ 
OPERTN_17 All values are ‘NA’ 
OPERTN_18 All values are ‘NA’ 
OPERTN_19 All values are ‘NA’ 
OPERTN_20 All values are ‘NA’ 
OPERTN_21 All values are ‘NA’ 
OPERTN_22 All values are ‘NA’ 
OPERTN_23 All values are ‘NA’ 
OPERTN_24 All values are ‘NA’ 
Column_73 All values are ‘NA’ 
Column_74 All values are ‘NA’ 
Column_75 All values are ‘NA’ 
Column_76 All values are ‘NA’ 
Column_77 All values are ‘NA’ 
Column_78 All values are ‘NA’ 
Column_79 All values are ‘NA’ 
Column_80 All values are ‘NA’ 
Column_81 All values are ‘NA’ 
Column_82 All values are ‘NA’ 
Column_83 All values are ‘NA’ 
Column_84 All values are ‘NA’ 
ADMI_CFL All values are ‘0’ 
validNHS All values are ‘1’ except for 3 records 
KillipClass All values are ‘NA’ 
 
A.2.5 List of Unknown Attributes 
Attributes Description 
OPERTN_01, OPERTN_02, OPERTN_03, OPERTN_04, 
OPERTN_05, OPERTN_06, OPERTN_07, OPERTN_08, 
OPERTN_09, OPERTN_10, OPERTN_11, OPERTN_12 
Probably the operation procedure 
received by the patient.  Values 
are in specific code but details 
about the attributes are not 
specified in either HES or MINAP 
data dictionary. 
OPDATE_01, OPDATE_02, OPDATE_03, OPDATE_04, 
OPDATE_05, OPDATE_06, OPDATE_07, OPDATE_08, 
OPDATE_09,  
Probably the date of operation 
procedure received by the patient.  
Values are in date format but 
details about the attributes are 
not specified in either HES or 
MINAP data dictionary. 
Column_70, Column_71, Column_72, Values are in date format but 
details about the attributes are 
not specified in either HES or 
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MINAP data dictionary. 
Column_85, Column_86, Column_87, Column_89 Values are in numeric format  but 
details about the attributes are 
not specified in either HES or 
MINAP data dictionary. 
Who.took.treatment.decision...V7 Probably the person who made 
the decision for the treatment.  
But do not sure for which 
treatment and details about the 
attributes are not specified in 
either HES or MINAP data 
dictionary. 
Other.Oral.Antiplatelet...V7 Probably the medication of other 
oral antiplatelet given to the 
patient.  But do not sure when the 
medication is given to the patient 
and details about the attributes 
are not specified in either HES or 
MINAP data dictionary. 
Spironolactone...V7 Probably the medication of 
Spironolactone given to the 
patient .  But do not sure when 
the medication is given to the 
patient and details about the 
attributes are not specified in 
either HES or MINAP data 
dictionary. 
CTH, DTN, CTN, OTH, OTN Values are in numeric format  but 
details about the attributes are 
not specified in either HES or 
MINAP data dictionary. 
Geo...IMDScore, Geo...IMDRank, Geo...HealthScore, 
Geo...HealthRank, Geo...Easting, Geo...Northing 
Probably kind of geographical 
scores or ranks.  But do not sure 
the meaning of the score or ranks 
and  details about the attributes 
are not specified in either HES or 
MINAP data dictionary. 
 
A.2.6 List of Irrelevant Attributes 
Attributes Description 
dthdate, dthcode The attribute was created by the data manager 
for the purposes of linkage procedure and have 
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A.2.7 List of New Attributes 
No Attributes  Descriptions Type Value 
1 ADMISSION_YEAR Year of admission for the patient Categorical 2003 2010 
2 ADMISSION_MONTH Month of admission for the patient Categorical 01-12 
3 ATTEND_NON_INTERVENTIO
NAL_HOSPITAL 
Indicate that the patient went 
through non interventional hospital 













Based on X302.Call.for.Help  If the 
date exists, then TRUE else FALSE 
Categorical 1-TRUE 
2- FALSE 
5 DEATH_IN_HOSPITAL Indicate whether the patient has died 
in the hospital or not 
 
FORMULA 
Based on X404.Death.in.Hospital.   
    If the (0. No), then 0 else (1. From 
MI, 2. From complication of 
treatment, 4. Other cardiac cause,  3. 
Other non cardiac related cause) 1 




Number of days the patient get the 




    Date of onset of ACS symptoms - 
Date of admission 
 
**NEGATIVE value indicates that ACS 
symptom before the admission 
**POSITIVE value indicates that ACS 
symptom after the admission 
 





Indicator whether the ACS symptoms 




   If the 
DAYS_ACS_SYMPTOMS_TO_ADMISSI
ON < 0  then 1 
   if ( 
DAYS_ACS_SYMPTOMS_TO_ADMISSI
ON >  0  ) then  2 
   else 99 
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A.3 The Mapping of Malaysia and The UK dataset 
Category Attribute Description The Malaysian Attributes The Malaysian attributes Value The UK Attributes  The UK attributes Value 
Admission 1 Admission Year Yradmit [2006 - 2010] ADMISSION_YEAR [2003 - 2010] 
Demographics 2 Age ptageatnotification Number Age.At.Admission Number 
3 Gender Ptsex [Female, Male] X107_Gender [F,M] 
Status before 
Event - Past 
Medical History 
4 Myocardial Infraction Cmi [Yes, No, Unknown] X205.Previous.AMI [Yes, No, Unknown] 
5 Previous Angina canginamt2wk & 
canginapast2wk 
[Yes, No, Unknown] X206.Previous.Angina [Yes, No, Unknown] 
6 Hypertension chpt [Yes, No, Unknown] X207.Hypertension [Yes, No, Unknown] 
7 Peripheral Vascular 
Disease 
cpvascular [Yes, No, Unknown] X209.Peripheral.Vascular.Disease [Yes, No, Unknown] 
8 Cerebrovascular 
Disease 
ccerebrovascular [Yes, No, Unknown] X210.Cerebrovascular.Disease [Yes, No, Unknown] 
9 Renal Disease crenal [Yes, No, Unknown] X212.Chronic.Renal.Failure [Yes, No, Unknown] 
10 Heart Failure cheartfail [Yes, No, Unknown] X213.Heart.Failure [Yes, No, Unknown] 
11 Diabetics cdm [Yes, No, Unknown] X217.Diabetes [Yes, No, Unknown] 
Status before 
Event - Smoking 
Status 
12 Smoking status smokingstatus [Current (any tobacco use 
within last 30 days), Former 
(quit >30 days), Never, 
Unknown ] 
X216.Smoking.Status [0. Never smoked, 1. Ex 
smoker, 2. Current 
smoker, 3. Non smoker 
- smoking history 
unknown, 9. Unknown] 
Status before 
Event - Medical 
Used 
13 Beta Blocker bbpre [Yes, No, Unknown] X224.Beta.Blocker [1. Yes, 0. No, 9. 
Unknown] 
14 ACE Inhibitor or 
Angiotensin II receptor 
Blocker 
aceipre&arbpre [Yes, No, Unknown] X225.ACE.I.or.ARB [1. Yes, 0. No, 9. 
Unknown] 





16 Heart Rate heartrate Number X221.Heart.Rate Number 
17 SBP bpsys Number X220.Systolic.BP Number 
18 Height height Number X229.Height Number 
19 Weight weight Number X230.Weight Number 
20 BMI bmi Number BMI Number 
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ECG 21 ECG Abnormalities 
Type 
ecgabnormtypestelev1 & [TRUE, FALSE] X203.ECG.Determining.Treatment [1. ST segment 
elevation, 2. Left bundle 
branch block, 3. ST 
segment depression, 4. 
T wave changes only, 5. 
Other abnormality, 5. 
Other acute 
abnormality , 6. Normal 





22 ECG Abnormalities 
Location 
ecgabnormlocational& [TRUE, FALSE] X236.Site.of.Infarction [1. Anterior, 2. Inferior, 
3. Posterior, 4. Lateral, ,  








23 Cholesterol tc Number X215.Cholesterol Number 
Treatment & 
Interventions 
24 PCI pci [Yes, No] X414.Coronary.Intervention [1. Percutaneous 
coronary intervention] 
25 CABG cabg [Yes, No] X414.Coronary.Intervention [2. CABG] 
Medical - During 
Admission 
26 Unfrac Heparin heparin [Yes, No, Unknown] X320.Unfractionated.Heparin [1. Yes, 0. No, 9. 
Unknown] 
27 Low molecular weight 
heparin (LMWH) 
lmwh [Yes, No, Unknown]   [1. Yes, 0. No, 9. 
Unknown] X321.Low.molecular.weight.heparin 




29 Overnight Stays totaldaystay Number SPELDUR Number 
30 Bleeding Complication bleedingepisodecriteria [Major, Minor, Missing,  None, 
Not Available, Not 
stated/Inadequately described] 
X403.Bleeding.Complications [0. None, 9. Unknown ] 
31 Outcome ptoutcome [Died, Discharge] DEATH_IN_HOSPITAL [0, 1] 
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A.4 The Common Dataset 
No Predictors Type of Predictors Malaysian Dataset The UK Dataset 
1 Admission year Categorical 9533(100%) [0%] 3845(100%) [0%] 
2 Age Numerical 59.0 (12.1) [0%] 68.8 (13.4) [0%] 
3 Male Categorical 7225 (75.8%) [0%] 2464 (64.1%) [0%] 
4 SBP Numerical 139.1 (28.7) [1.7%] 147.8 (242.8) [23.1%] 
5 Height Numerical 161.7 (8.3) [45%] 166.1 (65) [70.9%] 
6 Weight Numerical 67.6 (14.1) [38.1%] 78.3 (18.2) [60.6%] 
7 Heart rate (beats/mins) Numerical 83.6 (21.3) [1.7%] 83.7 (34.8) [23.1%] 
8 Cholesterol Numerical 5.31 (1.3) [28%] 11.8 (140.9) [40%] 
9 Previous MI Numerical 1569 (16.5%) [20.8%] 2623 (22.1%) [9.7%] 
10 History of heart failure Categorical 616 (6.5%) [17.2%] 207 (6.5%) [17.3%] 
11 History of stroke 
(cerebrovascular) 
Categorical 328 (3.4%) [19.5%] 272 (7.1%) [18.1%] 
12 History of peripheral vascular 
disease 
Categorical 74 (1.0%) [20.7%] 195 (5.9%) [13%] 
13 History of renal failure Categorical 586 (7.6%) [19.4%] 159 (5.0%) [18%] 
14 History of hypertension Categorical 5773 (60.6%) [13.8%] 1566 (40.7%) [10.6%] 
15 Current smoker Categorical 3231 (33.9%) [5%] 1009 (26.2%) [12.7%] 
16 History of diabetics Categorical 3964 (41.6%) [17.1%] 567 (14.8%) [8.9%] 
17 BB given Categorical 2269 (27%) [11.9%] 1654(60.5%) [28.9%] 
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A.5 Characteristic of AMIS Model vs. The UK Datasets and Malaysian Datasets. 
 (AMIS)-Plus registry The UK Dataset Malaysian Dataset 






Years 1997 –2005 2003-2010 2006- 2010 
Number of Patients 7520 3846 9533 
Source of Patients 
54 (out of 106) hospitals 
treating STEMI in 
Switzerland 
Leeds -selected GP who are 
using SystemOne, and 
registered as inpatient and 
outpatient in the hospitals 
Leeds 
18 hospitals who serve 
cardiac services in Malaysia 
 
Range of ACS UA, NSTEMI, STEMI UA, NSTEMI, STEMI UA, NSTEMI, STEMI 
Predictors Age >65 






History of heart failure 




Killip Class  
SBP 
Heart Rate 
History of heart failure 






History of heart failure 
History of cerebrovascular 
disease 
 
In-Hospital Mortality  7.5% 4.8% 7.1% 
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Appendix B: Results of Methodology Review 
B.1 WEKA Classification Algorithms 
The grey shaded rows are the 'unsuitable' algorithms. 




Malaysian The UK Malaysian The UK Malaysian The UK 
1 BN 0.778 0.878 0.747 0.726 0.777 0.722 
2 NB 0.746 0.803 0.754 0.64 0.805 0.656 
3 LG 0.819 0.809 0.781 0.776 0.797 0.78 
4 MLP 0.802 0.818 0.718 0.878 0.761 0.756 
5 SVM 0.500 0.675 0.500 0.500 0.576 0.500 
6 VP 0.500 0.500 0.500 0.500 0.500 0.500 
7 KNN 0.615 0.500 0.512 0.495 0.685 0.621 
8 LWL 0.752 0.849 0.735 0.738 0.762 0.728 
9 CR 0.500 0.500 0.500 0.500 0.500 0.500 
10 DT 0.727 0.673 0.781 0.500 0.741 0.500 
11 DTNB 0.594 0.819 0.435 0.465 0.741 0.500 
12 Jrip 0.533 0.674 0.521 0.500 0.538 0.500 
13 OneR 0.505 0.683 0.512 0.500 0.512 0.500 
14 PART 0.703 0.776 0.761 0.729 0.737 0.500 
15 Ridor 0.500 0.587 0.509 0.500 0.528 0.500 
16 ZR 0.500 0.500 0.500 0.500 0.500 0.500 
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17   ADT 0.813 0.868 0.794 0.772 0.794 0.760 
18 BFT 0.575 0.662 0.589 0.500 0.562 0.500 
19 DS 0.680 0.672 0.68 0.689 0.603 0.689 
20   FT 0.721 0.800 0.625 0.500 0.797 0.500 
21   J48 0.663 0.677 0.615 0.500 0.62 0.500 
22    J48Graft 0.664 0.677 0.615 0.500 0.62 0.500 
23 LT 0.732 0.694 0.745 0.753 0.672 0.737 
24   LMT 0.823 0.851 0.777 0.773 0.797 0.500 
25   NBT 0.631 0.79 0.752 0.748 0.797 0.745 
26 RF 0.760 0.767 0.763 0.738 0.714 0.698 
27 RT 0.638 0.689 0.619 0.648 0.634 0.629 
28   REPT 0.697 0.670 0.755 0.500 0.768 0.629 
29 SC 0.589 0.662 0.589 0.500 0.614 0.500 
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B.2 Missing Values 





















BN 0.702 0.766 0.765 0.775 0.786 0.717 0.746 0.812 0.816 0.739 
NB 0.703 0.779 0.776 0.785 0.796 0.724 0.759 0.824 0.820 0.819 
LG 0.707 0.793 0.793 0.799 0.805 0.728 0.753 0.776 0.769 0.771 
MLP 0.633 0.715 0.738 0.728 0.732 0.693 0.821 0.801 0.772 0.739 
LWL 0.680 0.728 0.719 0.747 0.753 0.712 0.745 0.789 0.779 0.801 
DT 0.500 0.635 0.635 0.647 0.647 0.500 0.500 0.730 0.730 0.730 
DTNB 0.500 0.449 0.481 0.489 0.596 0.684 0.528 0.637 0.792 0.763 
PART 0.626 0.638 0.687 0.639 0.684 0.550 0.633 0.786 0.671 0.738 
ADT 0.682 0.778 0.778 0.778 0.778 0.726 0.736 0.784 0.784 0.805 
  DS 0.618 0.615 0.615 0.615 0.615 0.689 0.689 0.669 0.669 0.669 
  FT 0.538 0.624 0.659 0.734 0.659 0.741 0.606 0.721 0.678 0.718 
LT 0.684 0.751 0.751 0.751 0.751 0.740 0.728 0.780 0.780 0.780 
  LMT 0.700 0.782 0.782 0.773 0.789 0.733 0.755 0.794 0.798 0.787 
  NBT 0.701 0.673 0.637 0.604 0.645 0.715 0.744 0.819 0.818 0.818 
  RF 0.692 0.744 0.757 0.772 0.777 0.673 0.677 0.766 0.762 0.793 
  RT 0.538 0.577 0.584 0.581 0.580 0.512 0.517 0.603 0.610 0.640 
  REPT 0.632 0.664 0.677 0.686 0.686 0.649 0.500 0.676 0.676 0.676 
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Appendix C: Sets of Predictors 




Malaysian The UK 












CATA1 1) ptsex 6673 2860 18 1) Age.At.Admission 2659 1134 18 
  2) ptrace       2) X107_Gender       
  3) ptageatnotification       3) ETHNOS       
  4) smokingstatus       4) X205.Previous.AMI       
  5) statusaspirinuse       5) X206.Previous.Angina       
  6) cdys       6) X207.Hypertension       
  7) cdm       7) X208.Hypercholesterolaemia       
  8) chpt       8) X209.Peripheral.Vascular.Disease       
  9) cpremcvd       9) X210.Cerebrovascular.Disease       
  10) cmi       10) X211.Asthma.or.COPD       
  11) ccap       11) X212.Chronic.Renal.Failure       
  12) canginamt2wk       12) X213.Heart.Failure       
  13) canginapast2wk       13) X217.Diabetes       
  14) cheartfail       14) X232.Family.History.of.CHD       
  15) clung       15) X216.Smoking.Status       
  16) crenal       16) X204.Where.Aspirin.Given       
  17) ccerebrovascular       17) X218.Previous.PCI       
  18) cpvascular       18) X219.Previous.CABG       
  19) CNONE                 
CATA2 1) ptsex 6673 2860 34 1) Age.At.Admission 2659 1134 23 
  2) ptrace       2) X107_Gender       
- 213 - 
  3) ptageatnotificatin       3) ETHNOS       
  4) smokingstatus       4) X205.Previous.AMI       
  5) statusaspirinuse       5) X206.Previous.Angina       
  6) cdys       6) X207.Hypertension       
  7) cdm       7) X208.Hypercholesterolaemia       
  8) chpt       8) X209.Peripheral.Vascular.Disease       
  9) cpremcvd       9) X210.Cerebrovascular.Disease       
  10) cmi       10) X211.Asthma.or.COPD       
  11) ccap       11) X212.Chronic.Renal.Failure       
  12) canginamt2wk       12) X213.Heart.Failure       
  13) canginapast2wk       13) X217.Diabetes       
  14) cheartfail       14) X232.Family.History.of.CHD       
  15) clung       15) X216.Smoking.Status       
  16) crenal       16) X204.Where.Aspirin.Given       
  17) ccerebrovascular       17) X218.Previous.PCI       
  18) cpvascular       18) X219.Previous.CABG       
  19) CNONE       19) X224.Beta.Blocker       
  20) asapre       20) X225.ACE.I.or.ARB       
  21) adpapre       21) X226.Statin       
  22) gpripre       22) Clopidogrel       
  23) heparinpre       23) X238.Thienopyridine.inhibitor.use       
  24) lmwhpre                
  25) bbpre                
  26) aceipre                
  27) arbpre                
  28) statinpre                
  29) lipidlapre                
  30) diureticpre                
  31) calcantagonistpre                
  32) oralhypoglypre                
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  33) insulinpre                
  34) antiarrpre                
CATA3 1) ptsex 6673 2860 35 1) ID 2659 1134 26 
  2) ptrace       2) Age.At.Admission       
  3) ptageatnotification       3) X107_Gender       
  4) smokingstatus       4) ETHNOS       
  5) statusaspirinuse       5) X205.Previous.AMI       
  6) cdys       6) X206.Previous.Angina       
  7) cdm       7) X207.Hypertension       
  8) chpt       8) X208.Hypercholesterolaemia       
  9) cpremcvd       9) X209.Peripheral.Vascular.Disease       
  10) cmi       10) X210.Cerebrovascular.Disease       
  11) ccap       11) X211.Asthma.or.COPD       
  12) canginamt2wk       12) X212.Chronic.Renal.Failure       
  13) canginapast2wk       13) X213.Heart.Failure       
  14) cheartfail       14) X217.Diabetes       
  15) clung       15) X232.Family.History.of.CHD       
  16) crenal       16) X216.Smoking.Status       
  17) ccerebrovascular       17) X204.Where.Aspirin.Given       
  18) cpvascular       18) X218.Previous.PCI       
  19) CNONE       19) X219.Previous.CABG       
  20) ACS_SYMPTOMS_ 
BEFORE_ADMISSION 
      20) X224.Beta.Blocker       
  21) anginaepisodeno       21) X225.ACE.I.or.ARB       
  22) heartrate       22) X226.Statin       
  23) bpsys       23) Clopidogrel       
  24) bpdias       24) X238.Thienopyridine.inhibitor.use       
  25) height       25) X220.Systolic.BP       
  26) weight       26) X221.Heart.Rate       
  27) waistcircumf       27) X228.Glucose       
  28) hipcircumf       28) X229.Height       
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  29) asapre       29) X230.Weight       
  30) adpapre       30) ONSET_SYMPTOMS_ 
BEFORE_ADMISSION 
      
  31) gpripre       31) X314.Where.cardiac.arrest       
  32) heparinpre       32) X315.Presenting.Rhythm       
  33) lmwhpre                
  34) bbpre                
  35) aceipre                
  36) arbpre                
  37) statinpre                
  38) lipidlapre                
  39) diureticpre                
  40) calcantagonistpre                
  41) oralhypoglypre                
  42) insulinpre                
  43) antiarrpre                
CATA4 1) ptsex 6673 2860 46 1) ID 2659 1134 30 
  2) ptrace       2) Age.At.Admission       
  3) ptageatnotification       3) X107_Gender       
  4) smokingstatus       4) ETHNOS       
  5) statusaspirinuse       5) X205.Previous.AMI       
  6) cdys       6) X206.Previous.Angina       
  7) cdm       7) X207.Hypertension       
  8) chpt       8) X208.Hypercholesterolaemia       
  9) cpremcvd       9) X209.Peripheral.Vascular.Disease       
  10) cmi       10) X210.Cerebrovascular.Disease       
  11) ccap       11) X211.Asthma.or.COPD       
  12) canginamt2wk       12) X212.Chronic.Renal.Failure       
  13) canginapast2wk       13) X213.Heart.Failure       
  14) cheartfail       14) X217.Diabetes       
  15) clung       15) X232.Family.History.of.CHD       
- 216 - 
  16) crenal       16) X216.Smoking.Status       
  17) ccerebrovascular       17) X204.Where.Aspirin.Given       
  18) cpvascular       18) X218.Previous.PCI       
  19) CNONE       19) X219.Previous.CABG       
  20) ACS_SYMPTOMS_ 
BEFORE_ADMISSION 
      20) X224.Beta.Blocker       
  21) anginaepisodeno       21) X225.ACE.I.or.ARB       
  22) heartrate       22) X226.Statin       
  23) bpsys       23) Clopidogrel       
  24) bpdias       24) X238.Thienopyridine.inhibitor.use       
  25) height       25) X220.Systolic.BP       
  26) weight       26) X221.Heart.Rate       
  27) waistcircumf       27) X228.Glucose       
  28) hipcircumf       28) X229.Height       
  29) ecgabnormtypestelev1       29) X230.Weight       
  30) ecgabnormtypestelev2       30) ONSET_SYMPTOMS_ 
BEFORE_ADMISSION 
      
  31) ecgabnormtypestdep       31) X314.Where.cardiac.arrest       
  32) ecgabnormtypetwave       32) X315.Presenting.Rhythm       
  33) ecgabnormtypebbb       33) X424.Reinfarction       
  34) ecgabnormtypenonspecific       34) X237.ECG.QRS.Complex.duration       
  35) ecgabnormlocationil       35) X203.ECG.Determining.Treatment       
  36) ecgabnormlocational       36) X236.Site.of.Infarction       
  37) ecgabnormlocationll       37) DEATH_IN_HOSPITAL       
  38) ecgabnormlocationtp                
  39) ecgabnormlocationrv                
  40) asapre                
  41) adpapre                
  42) gpripre                
  43) heparinpre                
  44) lmwhpre                
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  45) bbpre                
  46) aceipre                
  47) arbpre                
  48) statinpre                
  49) lipidlapre                
  50) diureticpre                
  51) calcantagonistpre                
  52) oralhypoglypre                
  53) insulinpre                
  54) antiarrpre                
CATA5 1) ptsex 6673 2860 46 1) ID 2659 1134 33 
  2) ptrace       2) Age.At.Admission       
  3) ptageatnotification       3) X107_Gender       
  4) smokingstatus       4) ETHNOS       
  5) statusaspirinuse       5) X205.Previous.AMI       
  6) cdys       6) X206.Previous.Angina       
  7) cdm       7) X207.Hypertension       
  8) chpt       8) X208.Hypercholesterolaemia       
  9) cpremcvd       9) X209.Peripheral.Vascular.Disease       
  10) cmi       10) X210.Cerebrovascular.Disease       
  11) ccap       11) X211.Asthma.or.COPD       
  12) canginamt2wk       12) X212.Chronic.Renal.Failure       
  13) canginapast2wk       13) X213.Heart.Failure       
  14) cheartfail       14) X214.Enzymes.Elevated       
  15) clung       15) X217.Diabetes       
  16) crenal       16) X232.Family.History.of.CHD       
  17) ccerebrovascular       17) X216.Smoking.Status       
  18) cpvascular       18) X204.Where.Aspirin.Given       
  19) CNONE       19) X218.Previous.PCI       
  20) ACS_SYMPTOMS_ 
BEFORE_ADMISSION 
      20) X219.Previous.CABG       
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  21) anginaepisodeno       21) X224.Beta.Blocker       
  22) heartrate       22) X225.ACE.I.or.ARB       
  23) bpsys       23) X226.Statin       
  24) bpdias       24) Clopidogrel       
  25) height       25) X238.Thienopyridine.inhibitor.use       
  26) weight       26) X220.Systolic.BP       
  27) waistcircumf       27) X221.Heart.Rate       
  28) hipcircumf       28) X228.Glucose       
  29) ecgabnormtypestelev1       29) X229.Height       
  30) ecgabnormtypestelev2       30) X230.Weight       
  31) ecgabnormtypestdep       31) ONSET_SYMPTOMS_ 
BEFORE_ADMISSION 
      
  32) ecgabnormtypetwave       32) X314.Where.cardiac.arrest       
  33) ecgabnormtypebbb       33) X315.Presenting.Rhythm       
  34) ecgabnormtypenonspecific       34) X424.Reinfarction       
  35) ecgabnormlocationil       35) X237.ECG.QRS.Complex.duration       
  36) ecgabnormlocational       36) X203.ECG.Determining.Treatment       
  37) ecgabnormlocationll       37) X236.Site.of.Infarction       
  38) ecgabnormlocationtp       38) X215.Cholesterol       
  39) ecgabnormlocationrv       39) X231.LVEF       
  40) tc       40) X337.Troponin.Assay       
  41) hdlc                
  42) ldlc                
  43) tg                
  44) fbg                
  45) lvef                
  46) asapre                
  47) adpapre                
  48) gpripre                
  49) heparinpre                
  50) lmwhpre                
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  51) bbpre                
  52) aceipre                
  53) arbpre                
  54) statinpre                
  55) lipidlapre                
  56) diureticpre                
  57) calcantagonistpre                
  58) oralhypoglypre                
  59) insulinpre                
  60) antiarrpre                 
 
 
